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Chapter 1 
Introduction 
Streptococcus pneu11Ioniae (the pneumococcus) is a lancet-shaped gram-positive bacterium, 
which grows in pairs or short chains (Fig. 1), The pneumococcus is a human pathogen that 
Fig. I. Electron micrograph of S. )!lIeIlIllOlliae. 
forms a leading cause of invasive diseases including pneumonia, bacteremia and meningitis. 
S. pneullloJliae is also the worlds major cause of otitis media and sinusitis. These are less 
serious non-invasive discases, which, however, have a significant impact on health-care costs 
because of their high prevalence. The incidence of pneulllococcal disease is highest in young 
children, elderly and immullocompromised individuals. Invasive pneumococcal infections arc 
associated with significant mortality, paliicularly in developing countries where many 
children under the age of five years die each year from pneumococcal pneumonia. 
History 
S. pneulllolliae was first isolated in 1881 by George M. Sternberg (107) and Louis Pasteur 
(85). Both scientists have isolated the pneumococcus from carriers. The association of the 
pneumococcus with pneumonia and with infections of other body sites ,vas elucidated in the 
8 
General introduction 
same decade. Studies on the pneumococcus have contributed to the understanding of many 
fundamental biological principles (for revie\v see references 5, 6,116). Gram has developed a 
staining procedure that is still in evelyday use in bacteriological laboratories (44). The 
pneumococcus was one of the first pathogenic bacteria observed by the GramRstain. The 
pneumococcllS has also played a role in the discovery of the protective value of antisenllll. 
The Klemperers have shO\vn that senun from rabbits injected \vith heatRkilJcd pneumococci 
contained factors that conferred protection against reinfection with the same strain. More 
importantly, rabbits were protected against infection by infusion of sen1111 from a previously 
immunized animal (66). These studies have resulted in the development and successful 
application of sennll therapy. lssaeff has shown that the protective sel11111 was not directly 
bactericidal but did promote uptake of pneumococci by phagocytic cells of the immune 
system (61). Neufeld has described the Quellung reaction or the macroscopic agglutination 
and microscopically visible swelling of the external capsule upon addition of specific 
antisenll11 to a suspension of pneumococci (81). This technique, designated serotyping, has 
become an important tool for bacterial typing. The antigenicity of polysaccharides has first 
been demonstrated with capsular polysaccharides from the pneumococcus, Furthenllore, anti-
polysaccharide antibodies have shown to provide type-specific protection against 
pneumococcal challenge (53, 54). This has opened the way for the development of vaccines 
ofpneumococcal capsular polysaccharides. Tn 1929, Fleming has discovered the antibacterial 
properties of a fungus-derived substance (41). The first patient that showed clinical benefit 
from this substance, which was called penicillin, was suffering from pneumococcal 
conjuctivitis. Since then, penicillin has been the antibiotic of choice to treat pneumococcal 
infections. The introduction of penicillin has dramatically reduced the mOliality associated 
with invasive pneumococcal infections. The most important contribution to biology arising 
from studies on the pneUlllOCOCCUS, is the discovelY of the principle of capsular 
transformation, Griffith has discovered that mice injected with living rough (nol1-
encapSUlated) pneumococci and mice injected with heat-killed smooth (encapsulated) 
pneumococci survived. However, mice injected with both living rough pneumococci and 
heat-killed smooth pneumococci died. He was able to isolate live smooth pneumococci from 
blood (46). At that time, the significance of this transforming principle was not understood. 
In 1944, Avery and coworkers have shown that "acidic compoundsu (DNA) constituted the 
genetic material that as a result of transfonnation was responsible for the phenotypic changes 
(9). 
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Epidemiology 
The serotyping method described by Neufeld is used for epidemiological studies. To date, as 
many as 90 different serotypes of S. plleu11Io1liae have been identified on the basis of 
antigenic differences in their capsular polysaccharides (55). CC11aill serotypes arc known to 
be more vil111ent than others. Most of the infections are caused by a restricted number of 
serogroups and scrotypes. In addition, the distribution of serotypes varies in time and in 
different age groups, populations and geographic areas (26, 82, 100, 102). The serogroups 
causing most invasive diseases in adults are I, 3, 4, 7, 8, 9, 12 and 14, while the most 
frequently occurring invasive serogroups in children arc 4, 6, 9, 14, 18, 19 and 23. The latter 
serogroups are most prevalent ill the United States (78% of the isolates), Finland (84% of the 
isolates), and Australia (78% of the isolates). However, in Rwanda (33% of the isolates) and 
Papua New Guinea (31% of the isolates) these serogroups playa minor role in pediatric 
invasive disease (23). 
Until the 1960s, pneumococci were considered uniformly susceptible to penicillin. Hmvever, 
in the last 30 years, increasing numbers of penicillillMresistant pneumococcal clinical isolates 
with rising MIC values are isolated all over the world (47). PenicillinMresistance is mostly 
associated with IJpediatric!l serogroups 6, 9, 14, 19 and 23 (47). Many penicillinMresistant 
isolates are multiple antibiotic-resistant and isolates with resistance to tetracycline, 
chloramphenicol, rifampicin and elythromycin are increasingly encountered (4, 56). The 
emergence of highMlevel resistance to penicillin, particularly in combination with other 
resistance detenninallts, is a serious threat for the effectiveness of CutTent treatment 
strategies. Serious pneumococcal infections caused by multiple antibiotic-resistant 
pneumococci are usually treated with third generation cephalosporills and/or vancomycin. 
However, high-level cephalosporin resistance is increasingly present within the 
pneumococcal population (40). Recently, clinical isolates with tolerance to vancomycin, the 
antibiotic oflast resoli, were isolated (72, 84). Antibiotic tolerance, which is characterized by 
the ability of bacteria to survive but not grow in the presence of antibiotics, is of clinical 
significance, since it has been shmvn that the inability to eradicate tolerant bacteria leads to 
£'lilure of antibiotic therapy. Furthermore, tolerance is thought to promote the development of 
antibiotic resistance (83). 
In addition to serotyping and the detennination of antibiotic resistance, DNA fingerprinting 
methods have been used for epidemiological surveys. The last methods are required to 
provide greater discrimination and complementary information (48). DNA typing methods 
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such as pulsed field gel electrophoresis) BOX peR fingelprinting and restriction fragment 
end labeling provide genomic information that is suitable to identify the genetic relatedness 
between strains (58). Fingerprinting of the penicillin-binding protein genes adds further 
infollllation to the analysis of penicillin-nonsllsceptible strains. The use of a combination of 
typing methods has led to the knowledge that this naturally transformable species undcrgoes 
frequent horizontal gene transfer) which has resulted in a freely recombining population 
stmcture with epidemic spread of successful clones (49). The worldwide increase in 
antibiotic resistance and the clinical implications of penicillin resistance has focused most 
shldies on the molccular epidemiological characteristics of penicillin-resistant isolates. Soares 
et al. have reported the epidemic spread of a multi-resistant serogroup 6 pneumococcal clone 
in Iceland) and have suggested that this single clone has been imported from Spain to Iceland 
(106). Munoz and colleagues have documented the intercontinental spread of a multi-resistant 
clone of serotype 23F from Spain to the United States (78). Gasc et al. have dcscribed the 
relatedness between French serogroup 9 isolates and earlier Spanish isolates indicating the 
sprcad of this penicillin-resistant clone fonn Spain to France (43). The serotype 23F and 9V 
clones have been identified in many countries all over the world (56) 57) 104). In addition) 
novel penicillin-resistant and multi-resistant clones tend to spread in an epidemic manner 
within other countries (26, 39, 94, 105, 124). 
l\'1echanisms of antibiotic resistance 
Penicillin resistance has emerged in S. plleU11l0n;ae through the development of altered 
penicillin-binding proteins (PBPs) with decreased affinity for penicillin and other ~-lactmn 
antibiotics. The pneumococcus possesses five high molecular weight PBPs (la, lb, 2a, 2b) 
2x) and the low molecular weight PBP3. Altered PBPs are encoded by mosaic genes that 
have emerged by recombination events between pbp genes of pneumococci and their 
homologues in closely related streptococcal species. Some mosaic pbp genes are composed 
of a single block) and others are more complex being the result of genetic recombination with 
several donors (36). Furthermore) there is an enormous diversity of mosaic pbp genes, 
suggesting that resistance to penicillin has arisen on many occasions around the ,vorld. 
Resistance to third generation cephalosporins is also based on changes in the penicillin-
binding proteins (27). 
II 
Chapter 1 
In contrast, resistance to non~p-lacta1l1 antibiotics is based 011 other mechanisms, 
Erythromycin resistance is often the result of modification of the ribosome through 
methylation of 23S rRNA. This methylation is the result of methylase activity, encoded by 
ermAM. Resistance to ctythromycin can also be the result of efflux of the antibiotic from the 
cell by an efflux pump encoded by mejE (122). The production of chloramphenicol 
acetyitransfcrase, an enzyme capable of catalyzing the conversion of chloramphenicol to its 
nonfunctional derivates, leads to chloramphenicol resistance, Chloramphenicol 
acetyl transferase is encoded by cat identical to cat fro111 a Staphylococcus alll'eliS plasmid 
(122). Resistance to tetracycline occurs through ribosomal protection encoded by the genes 
letAI and tetO, although the precise resistance m.cchanism remains unclear (122). 
Trimethoprim resistance is mediated through a single amino acid substitution in the 
chromosomal dihydrofolate reductase, which is thought to disrupt the bond with trimethoprirn 
without affecting the action of dihydrofolate reductase (122). Sulphonamide resistance results 
from repetitions of one or two amino acids in the chromosomal dihydropteroate synthase 
(122). Rifampin resistance in S. pnelll1loniae has been shown to be due to mutations within 
the target of the antibiotic, the p-subunit of RNA polymerase encoded by IpoB (37). 
Fluoroquinolone resistance is mediated by changes in the target of fluoroquinolones i.e. DNA 
gyrase (gyrA) andlor topoisomerases (pare, parE), and/or decreased intracellular 
accumulation as a result of enhanced efflux by the efflux pump PnuA (89). Recently, the 
mechanism of vancomycin tolerance in S. pnelllllolliae has been repOlied to be the result of 
loss of function of the VncS histidine kinase of a two-component sensor-regulator system. 
Two-component systems monitor environmental parameters through a sensor 
histidine/phosphatase, which phosphOlylates/dephosphOlylates the response regulator that in 
turn mediates changes in gene expression. Novak and colleagues have suggested that signal 
transduction is critical for the bactericidal activity of vancomycin (84). 
The pathogenesis of pneumococcal infections 
The human nasopharynx forms the normal ecological niche of S. pneul1Ioniae. The entire 
human population is colonized once or several times during their life by the pneumococcus. 
At one time, up to 60% of the individuals can be can-ier (7). The prevalence of catTiage is 
especially high in young children, elderly and immunocompromised persons, and in crowded 
places such as day care centers, hospitals, militmy academies, jails and nursing homes. 
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During carriage, more than one serotype can co-exist (8). Nasopharyngeal carriage of 
particular pneumococcal capsular types is often accompanied by the development of 
protection against infection by these types. Most infections do not occur after prolonged 
carriage but follow the acquisition of recently acquired strains (45). Pneumococcal infections 
statt with the adherence and colonization of the epithelial cells of the nasopharynx. From 
there, pneumococci can spread locally, either into the Eustachian hlbe and into the middle ear 
cavity to produce otitis media, or into the alveoli of the lower respiratOlY tract to cause 
pneumonia. In some cases, pneumococci are able to enter the bloodstream and cause 
bacteremia or cross the blood-brain barrier and cause meningitis. 
Virulence factors 
The pneumococcus synthesizes several factors that play a role in the pathogenesis of 
infections (Fig. 2, Table 1). Most of these factors are surface-associated. 
Capsule. The polysaccharide capsule has since long been recognized as the most imp0l1ant 
vimlence factor. Experimental proof has been provided using transposon mutagenesis. 
Specific interntption of capsule production results in an increase of the lethal dose by a 
million fold (115). Studies with strains differing only in their capsular type have shown that 
the capsule has a major effect on vil1llence. However, the genetic background is also 
il11pOltal1t, indicating that other components also contribute to pneumococcal vimlence (62). 
The capsulc provides resistance to phagocytosis (21), and thereby promotes the escape of 
pneumococci from the immune system of the host. 
Cell wall and cell wall polysaccharides. The cell wall is mainly composed of peptidoglycan: 
glycan chains of alternating N-acetylgtucosamine and N-acetylmuramic acid residues, cross-
linked to each other through peptide side-chains. The peptidoglycan layer anchors the 
capsular polysaccharides and cell wall polysaccharides. The cell wall polysaccharides consist 
of teichoic acids and phosphorylcholille (2). The latter stmchlre forms an anchor for at least 
eight choline-binding proteins (96). It is also patt of platelet-activating factor (PAF), and is 
therefore suggested to be imp0l1ant in the attachment to cytokine-activated human cells via 
the PAF receptor by stl1lctural mimiclY (31). 
The celJ wall and cell wall polysaccharides induce inflammation similar to that observed 
during pneumococcal infection (110-112). Inflammation is caused by the activation of the 
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alternative complement pathway. During complement activation) the anaphylatoxins C3a and 
C5a are produced, which results in the enhancement of vascular permeability, induction of 
mast cell degranulation and chemoattractioll of polymorphonuclear leucocytes to the 
inflammation site (2). 
Cell Membrane Autolysin 
SpsA I CbpA I PspC 
Hyaluronidase 
PsaA 
~~~~~~J~K IgA1protease 
Cell Wall 
Neuraminidase 
Capsular 
polysaccharides 
Fig. 2. Hypothetical representation ofa pneumococcus. Adapted from Briles ct al. (18). 
Pneulllolysill. Pneul1lo1ysin is one of the best characterized pneumococcal virulence proteins 
(for review see reference 76). This protein is produced by virtually all clinical isolates. 
Pllculllolysin is an intracellular hemolysin and member of the family of thiol-activated 
cytolysins. It has a range of biological activities. Plleumolysin is lytic for all eukaryotic cells 
that have cholesterol in their membrane. The protein binds to membrane cholesterol and 
inserts into the lipid bilayer, followed by lateral diffusion and assembly of a transmembrane 
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pore stmcturc. Pneumolysin is able to injure a range of eukalyotic cells and is presumed to 
account for much of the histopathology of pneumococcal infections (76), In addition, 
pneumolysin has a range of physiological effccts on cells at sUblytic concentrations, \vhich 
can lead to inhibition of certain cellular functions such as bacterial killing by 
polymorphonuclear leucocytes and monocytes (79), and to stimulation of other pathways 
sllch as cytokine production, phospholipase activity (97) and activation of the classical 
complement pathway by binding to the Fc portion of antibody (77, 88), Fmthennore, 
pneumolysin interferes with nonspecific host defense mechanisms such as slowing the cilial 
beat of human nasal epithelium and inhibiting the function of ciliated ependymal cells (76), 
Studies with mutants in which the pneumolysin gene has been dismpted, have demonstrated 
that pneumolysin clearly plays a role in the pathogcnesis of pulmonary and systemic 
infections, although its role in meningitis is presumed to be limited (16). 
Autolysin, Autolysin (N-acetylmuramyl-L-alanine amidase; LytA) is a cell wall degrading 
enzyme, which is anchored to the choline residues in the cell wall. The enzyme is nonnally 
inactive but under conditions when cell wall biosynthesis stops, such as nutrient starvation or 
penicillin treatment, the enzyme is activated and causes autolysis of the bacterial cell (75). 
Autolysis contributes to virulence, although indirectly, by releasing degradation products of 
the cell wall, which are highly inflanullatoty, and toxic cytoplasmic components such as 
pneumolysin (67), 
Neuraminidase. Neuraminidase is an enzyme which cleaves N-acetyilleuraminic acid from 
mucin, glycolipids, glycoproteins, and oligosaccharides on host cell surfaces (101), It has 
been proposed that neuraminidase is able to enhance colonization by decreasing the viscosity 
of mucus or by exposing cell slll-face receptors (3). All clinical isolates examined to date 
produce neuraminidase. The pneumococcus has at least two neuraminidases, NanA and NanB 
(24). The specific activity of NanA is much greater than NanB and NanB has a significant 
100ver pH optimum (12). Examination of the partial S. pnellll10niae genome sequence 
indicated the presence of a third neuraminidase exhibiting approximately 50% amino acid 
sequence identity to NanB, NanC (14), 
Hyaluronidase. Hyaluronidase depoiymerizes hyaluronic acid. The degradation of this 
important component of connective tissues and extracellular matrixes has been postulated to 
contribute to invasion. Tn addition, this enzyme may contribute to vimlence or survival of the 
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pneumococcus in the host by scavenging potential carbon sources such as glucose and 
glucoronic acid (13). Virtually all clinical isolates produce hyaluronidase (86). Mulagenesis 
of the hyaluronidase gene has no significant impact on vimlence in a mouse intraperitoneal 
challenge model (14). 
Table I, Characteristics of the major virulence factors of S. pllellf11olliae. Adapted tl'om 
Alonso DeVelasco et al. (2). 
Vintlcnce factor Proposed mechanism ofvimlence* 
Capsule Resistance to phagocytosis 
Lnck of immunity of some capsuillf types 
References 
(21 ) 
(59,60) 
Cell wall and cell wall Inflammatory effects (110-112) 
(31) polysaccharides Mediator of attachment to host celLs 
Pncumolysin Cytolytic at high concentrations (76) 
(76) 
(76) 
(77,88) 
Autolysin 
Neuraminidase 
Hyaluronidase 
IgAl protease 
PsaA 
PspA 
CbpA 
Cytotoxic at lower concentrations 
Stimulation of cytokinc production 
Activation of classical complement pathway 
Release ofpnculllolysin and cell wall components (67) 
Decrease of the viscosity of mucus or exposure of cell surtiee (3, 10 1) 
receptors 'J 
Degradation ofCOllnectivc tissue 
Inhibition of mucosal defense mechanisms? 
Cellular adhesion 
Zinc and manganese transport 
Trigger for autolysin expression 
Inhibition of complement activation 
Involvement in iron uptake? 
Cellular adhesion 
Cellular invasion 
Reduction of bacterial clearance 
(13) 
(63) 
(15) 
(34) 
(83) 
(109) 
(50) 
(96) 
(95) 
(51) 
*Thc mechanisms marked "1" have been suggested but not demonstrated. Most of the mechanisms listed arc 
observed only in vitro, their significance for vimlence remains UUktlO\Vll. 
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Immunoglobulin Al protease. Immunoglobulin Al (lgAI) protease is a metailoprotease 
that specifically cleaves the hcavy chain of human IgA I (93, 114). IgA I is the predominant 
class of immunoglobulins on mucosal membranes. Because of the specificity for human 
IgAl, no relevant animal models are available to test the biological fUllction of IgAl 
protenses. However, several lines of evidence suggest that IgA 1 protease activity enables 
pneumococci to evade the local mucosal defense system and is an important colonization 
factor (63). Almost all clinical isolatcs sholV JgAI protease activity (69). 
Pneumococcal surface adhesin A. Pneumococcal surf..1ce adhesin A (PsaA) is a 37 kDa 
protein present on the surf..1cc of the bacterium and expressed by all pneumococcal strains 
studied so far (98, 99). psaA is part of the psa locus, which encodes an ATPwbinding cassette 
type manganese permease complex (34). The protein is essential for villlience as judged by 
intranasal and intraperitoneal challenge of mice (l5). Mutagenesis of psaA results in 
defective adhesion (15), reduced transformation frequency (34), and penicillin tolerance (83). 
The latter effect is explained by the involvement ofPsaA iu triggcring autolysin (83). 
Pneumococcal surface protein A. Pneumococcal surface protein A (PspA) is, like LytA, a 
cholinewbinding protein (l25). PspA is found on all pneumococci and is required for full 
vimlence. Mutants lacking PspA are cleared more rapidly from the blood of infected mice 
than the parent strains (74). Recently, it has been shown that heat-killed pneumococci lacking 
PspA fix more complement than heat-killed pneumococci possessing PspA (18, 19). Tu and 
colleagues have examined the influence of PspA on complement activation in vivo (109). 
These investigators have demonstrated that PspA inhibits complement activation. More C3b 
is detectable on PspAwdeficient pneumococci than on PspA Wild-type pneumococci, 
suggesting that PspA interferes with deposition of C3b on pneumococci. PspA is presumed to 
exert its virulence function by blocking recmitment of the alternative complement pathway, 
thereby reducing the effectiveness of complement receptor-mediated pathways of clearance 
(l09). Recently, Hammerschmidt and colleagues have postulated that PspA might function as 
a lactoferrin-binding protein, suggesting the involvement of PspA in iron uptake, and thus its 
contribution to the pneumococcal growth under ironwlimited conditions, i.e. the human host 
(50). 
Choline binding protein A. Choline-binding protein A (CbpA) has been characterized as an 
adhesill and a detel1uinant of vimlence. CbpA-negative mutants have reduced adherence to 
17 
Chapter I 
human epithelial and endothelial cells, and reduced virulence in an infant rat model of 
nasopharyngeal ean-iage (96). In addition, CbpA is involved in invasion through 
microvascular endothelial cells (95). The same protein is also designated S, pllellmolliae 
secretOlY immunoglobulin A-binding protein (SpsA), and has been shown to bind human 
secretory IgA and secretory component via a hexapeptide motif (51, 52). Hammerschmidt 
and colleagues have hypothesized that SpsA might contribute to virulence by the reduction of 
bacterial clearance. Finally, the protein is designated pneumococcal surface protein C (pspC) 
by Brooks-Walter et al., who have described that PspC is homologous to PspA, elicits cross-
reactive antibodies to PspA, and provides protection to pneumococcal bacteremia in mice 
(20). 
Phase variation 
S. plleumoniae undergoes spontaneous, reversible variation (phase variation), which is 
apparent as differences in colony opacity on transparent agar surfaces (118), These 
differences in colony morphology appear to be relevant to the pathogenesis of pneumococcal 
infections. Only transparent variants arc able to establish dense and stable colonization of the 
mucosal surface of the nasophmynx in an animal model for pneumococcal carriage, whereas 
isogenic opaque variants are deficient in colonization (118), This correlates with the 
enhanced binding of transparent pneumococci to buccal epithelial cells and their 
glycoconjugate receptors when compared to opaque pneumococci (31). Similarly, the 
adherence of transparent pneumococci is enhanced to cytokine-stimulated human type II lung 
cells, and human vascular endothelial cells, as well as the receptors (N-acetyl-D-glucosamine 
and PAF receptor) that appear on these cells after cytokine stimulation (31). On the other 
hand, the opaque variant is more vim lent in a mouse model for systemic infection (65). The 
increased vi111ience of the opaque variant in an in vivo model for sepsis correlates with 
decreased opsonophagocytic killing of opaque pneumococci in an in vitro phagocytosis assay 
(64). Finally, transparent variants have an increased capacity to cross the blood-brain barrier 
(95). The higher binding affinity of transparent pneumococci to the PAP receptor on 
microvascular endothelial cells is presumed to result in increased transcytosis of bacteria 
across these cells. 
The relationship behveen the expression of several previously identified cell surface 
components and phase variation has been investigated, The opaque phenotype of the 
pneumococcus is associated with larger amounts of capsular polysaccharide compared to the 
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transparent phenotype. This results in decreased opsonophagocytosis and a higher vimlence 
in an mouse model of systemic infections of the opaque variant (64, 65). In contrast, the 
transparent pneumococcal phenotype as compared to the opaque variant produces increased 
amounts of cell wall polysaccharides, i.e. phosphOlylcholine, which is thought to be 
responsible for the differences in adhesion between the two phenotypes (65, 117). The 
expression of four vimlcnce proteins has been examined in the pneumococcal phase variants. 
The expression of pneumolysin is similar in both variants (65). In contrast, the choline-
binding proteins LytA, PspA and CbpA have demonstrated differential expression. The 
opaque variants have decreased expression of autolysin and consequently undergo 
spontaneous lysis more slowly than transparent variants (119). PspA is expressed in greater 
amounts in the opaque variant than in transparent variants (65). CbpA is differentially 
expressed in pneumococcal phenotypic variants such that transparent variants express 
increased amounts (96). The ability of transparent variants to transcytose through 
microvascular endothelial cells, one of the cells lining the blood-brain barrier, was 
demonstrated to be dependent on CbpA expression (95). 
Nntural transformation 
Genetic plasticity plays a central role in the biology of S. pneutlloJliae. This naturally 
transfonnable microorganism has the ability to adapt to environmental changes by horizontal 
transfer of genetic material. Horizontal gene transfer enables the bacterium to evolve rapidly 
by the acquisition of novel determinants and has resulted, under the selective pressure from 
host defenses and because of antibiotic treatment, in a great variability of several vimlence 
factors and resistance detenninants (for review see references 25, 36, 70). 
One of the most elegant examples of horizontal gene transfer are the mosaic stmctures in the 
penicillin resistance genes. Low-affinity PBPs have arisen from interspecies recombination 
i.e., transformation and homologous recombination of DNA fl.-olll viridans streptococci. pbp 
genes of resistant isolates are composed of mosaic blocks that are either similar or identical to 
pbp genes from sensitive isolates and blocks that are similar or identical to genes from S. 
lIIitiS and S. oraUs (91). 
The pneumococcal polysaccharide capsule also exhibits a high-level of diversity. As many as 
90 different capsular types have been described (55). In addition, there are still capsular types 
that can not be determined by the 90 distinct capsular antisera (I2l). Several studies indicate 
frequent horizontal transfer of capsular genes in vivo (10, 2S, 29, 56, SO). The molecular 
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organization of the genes responsible for capsule biosynthesis has revealed a cassette-type 
organization with conserved regions flanking a cluster of genes that confer capsule specificity 
(42). Recombination events are therefore feasible to occur between the conserved flanking 
regions (29), 
Mosaic structures have also been identified in surface-exposed and secreted vimlcl1ce 
proteins, such as autolysin, neuraminidase A, IgA I protease and PspC. PspC, also designated 
as SpsA, CbpA and PbeA, has been described as a chimeric protein that has acquired 
domains from both intraspecies genetic exchanges with pspA of other pneumococcal strains 
and interspecies genetic exchanges with DNA from group B streptococci (20). lllterspecies 
genetic exchanges with strains of S. mitis have been described for the gene encoding IgAl 
protease (92) and the neuraminidase gene (36) of S. pJlelll1loniae. Although the autolysin 
encoding gene {ytA displays limited genetic variation, recombination between host {ytA and 
genes encoding cell wall lytic enzymes of pneumococcal bacteriophages (120) or {ytA from 
pathogenic viridans streptococci is highly suggestive (36), 
Host defense 
Host protection against pneumococcal infection is mainly mediated by phagocytosis (123). 
Pneumococci are cleared from the lung and the blood by phagocytosis and subsequent 
intracellular killing by neutrophils, alveolar macrophages and phagocytic cells (22), This 
mechanism depends on the presence of opsonins, i.e. immunoglobulins and complement. 
Pneumococci are able to activate the alternative complement pathway. Since the alternative 
complement pathway can be activated in the absencc of acquired specific antibodies, it is 
expected to be important for the naive host. Pneumococci are also activators of the classical 
complement pathway. In contrast, this requires the participation of specific antibodies. 
Therefore, the classical pathway is expected to play its protective role in the immune host. 
Activation of both thc classical and altcmative complement pathways results in the fixation 
of C3b to the pneumococcal surface, following cleavage of C3b to iC3b and C3d (123), 
Differences in cleavage patterns among pneumococcal serotypes help to explain serotype 
specific differences in susceptibility to phagocytosis and in capsular antigenicity. C3d is 
recognized by receptors on the B lymphocyte, but not by those on the phagocyte. In contrast, 
iC3b readily serves as a ligand for complement receptor type 3 on the neutrophil, thereby 
enhancing phagocytosis and clearance. Pneumococcal surfaces that halt C3 cleavage at iC3b 
will not generate C3d. For example, capsular types 3 and 4 are highly resistant to 
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phagocytosis and yet potent immunogens. C3d is the most predominant C3 fragment found 
on these capsular types. In contrast, capsular types 6A and 14 display only the cleavage 
fragment iC3b, which protects them from interaction with B lymphocytes but allo\vs them to 
be easily phagocytosed (59, 60). S. pllel/lIlOlliae is not susceptible to the lytic action of 
complement (123). 
Pneumococcal vaccines 
The current vaccine consists of the 23 most prevalent pneumococcal serotypes. The usc of 
this 23Rvalent vaccine has eliminated only a small fraction of the morbidity and mortality 
associated with this organism. The first and most important explanation is the 
undemtilization of this vaccine (38). A second explanation is the relatively low (±60%) 
effectiveness in the elderly against bacteremic infections caused by the 23 capsular types 
included in the vaccine (103). In addition, vaccination does not elicit adequate antibody 
responses in children less than 2 years of age who are an important risk group (35). Finally, 
antibodies to cel1ain polysaccharide antigens, especially to capsular type 6B, are not 
protective (1). The current pneumococcal vaccine strategies focus on the use of conjugates, in 
which a limited numbcr of different capsular polysaccharides are linked to a carrier protein. 
The conjugated proteins are able to switch the immune response against the polysaccharides 
present in the vaccine from T-cell independent to TRcell dependent. This will result in an 
increased antibody response against the polysaccharides and will induce a memOlY response. 
Conjugate vaccines are more immunogenic in young children than polysaccharide vaccines 
(23,33). However, the number of different capsular polysaccharide types that can be included 
in these vaccines is restricted (90). In this respect, the ability of pneumococci to change 
capsular type is of obvious imp011ance in relation to the development of pneumococcal 
conjugate vaccines. The apparent case by which capsular types change through 
recombination suggests that pneumococcal conjugate vaccines may in 10ng-tell1l be less 
effective to prevent disease. Indeed, current studies show that vaccination results in a shift in 
serotype distribution towards those pneumococcal capsular polysaccharides that are not 
present in the vaccines (32, 71). The selective pressurc for this shift is presumed to be fOl1ned 
by the human immune response that, after vaccination, selects for isolates with nonRvaccine 
capsular types and for recombination of capsular genes encoding the biosynthesis of capsular 
polysaccharides that are not present in the vaccine. A major tIueat is the acquisition of 11on-
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vaccine capsular types by antibiotic~resjstant pneumococci. Recently, the Kaiser Pennanente 
Vaccine Study Center Group has reported the results of a large double blind trial of a novel 
heptavalent conjugate vaccine in healthy children. They have demonstrated that the vaccine 
was highly effective in preventing invasive disease in young children, They also did not find 
any evidence for an increase of invasive disease by nOI1 M VaCcillc serotypes (17), However, the 
effectiveness in preventing otitis media was not as good as the effectiveness in preventing 
invasive disease .. Molecular epidemiological shldies will need to be performed in order to 
investigate the long-tenn effects oflarge-scale vaccination. 
Over the last few years, much attention has been foclIsed on the role of pneumococcal 
proteins in pathogenesis and protection. Proteins that are involved in the pathogenesis of 
infections by S. pneullloniae are considered interesting components for future conjugate and 
protein vaccines. Such proteins should ideally provide protection against colonization and 
infection with S. plleumolliae strains irrespective of their capsular type. Immunization with 
the pneumococcal cytoplasmic protein pneumolysin can protect mice against pneumococcal 
infection (87). This protection is probably due to neutralization of free toxin released from 
the pneumococcus during autolysis. Antiwpneumolysin antibodies are not expected to 
promote phagocytosis. A nontoxic variant of pneumolysin may be a good component for 
future pneumococcal protein and/or conjugate vaccines. PspA is a protectiollweliciting surface 
protein found on all pneumococci. Although the primmy stmcture of PspA is highly variable 
(30, 113), the protein is able to elicit cross-protection (73). Therefore, PspA is presumed to be 
a good vaccine candidate. Inununization with autolysin (11), neuraminidase (68) and PsaA 
(108) also clearly confer protection in animal models. Hmvever, since PsaA might be 
involved in triggering autolysin, loss of function of this protein may promote penicillin 
tolerance (83). To date, no protection could be demonstrated using purified hyaluronidase as 
an immunogen. Fmihennore, the pneumococcal IgA 1 protease has shown to be antigenic ally 
diverse making it a less attractive vaccine candidate (69). Due to the genetic plasticity of the 
pneumococcus, the optimal protein-based vaccine is proposed to contain multiple protein 
antigens. 
Scope of this thesis 
This thesis focuses on molecular epidemiological aspects of infection by S. pnellmoniae and 
the identification of pneumococcal proteins involved in the pathogenesis of infections. 
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The epidemiological dynamics of penicillin-nonsusceptible S. pneuf110niae isolates from 16 
different countries were investigated (Chapter 2). In addition, nation-wide molecular 
epidemiological surveys of penicillin-non susceptible pneumococci from Poland and Thailand 
were perfonned (Chapters 3 & 4). The molecular mechanisms of penicillin resistance in The 
Netherlands were studied in detail by sequence analysis of pbp fragments (Chapter 5). A 
molecular epidemiological survey was also perfonned on penicillin-susceptible invasive S. 
pneullIoniae isolates from The Netherlands. In the latter study, the genetic relatedness \vithin 
serotypes was investigated, and in addition, the international molecular epidemiological 
characteristics of serotype 3 isolates were identified (Chapter 6). The effect of immune-
protective antibodies raised against large-scale vaccination on natural competence of S. 
jJneullIoniae was investigated, and the consequences for the long-term efficacy of current 
vaccination strategies are discllssed (Chapter 7). To gain insight into the pathogenesis of 
pneumococcal disease, the molecular changes that occur during phase variation were 
investigated. To this purpose, protein expression pattellls of pneumococcal phenotypic 
variants were compared, and differentially expressed proteins were identified and 
characterized (Chapter 8). Interestingly, one of these proteins, pyruvate oxidase, was also 
demonstrated to playa role in the inhibition of other respiratory tract pathogens (Chapter 9). 
A second protein, the putative proteinase maturation protein A, PpmA, was also 
independently identified in another study as a conserved surface-exposed virulence factor 
with potential to elicit protective immune responses (Chapter 10). 
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SUMMARY 
An intematiollal study was undcI1akcn to investigate the epidemiological dynamics of 
penicillin~resistant pneumococci. We compared the molecular epidemiological characteristics 
of 316 penicillin-resistant isolates, originating from The Netherlands, Thailand, the United 
States, Spain, Greece, Poland, Cuba, Germany, Finland, United Kingdom, Iceland, South 
Africa, Hungary, Portugal, Croatia and the Czech Republic. A total of 132 distinct restriction 
fragment end labeling (RFEL) types were obselved. Thirty-six genetic types were shared by 
hvo Of more strains (clusters). Seven RFEL clusters consisted of strains originating from 
different countries, demonstrating international dissemination of penicillin-resistant 
pneumococci. The two most predominant RFEL types corresponded with the pandemic 
clones 23F and 9V, and were found in 10 and six different countries, respectively, This 
clearly demonstrates the pandemic behavior of these two clones, Fifteen out of the 36 RFEL 
clusters contained two or more serotypes, This finding indicates frequent horizontal transfer 
of capsular genes. Within distinct RFEL types identical penicillin-binding protein (PBP) 
genotypes were often observed, demonstrating a high frequency of horizontal DNA transfer 
of penicillin resistance genes. The most predominant PBP type comprised 40% of the entire 
collection. This PBP type was found in 20 distinct RFEL types and was observed in II 
countries, The vast majority of the strains belonging to the pandemic clones 23F and 9V 
shared this predominant PBP type. We hypothesize that the clones 23F and 9V are 
responsible for the worldwide increase of penicillin resistance, since they serve as an 
important genetic reservoir for susceptible pneumococci to acquire penicillin resistance. 
INTRODUCTION 
Sh'eplococclIS pneu11Ioniae (pneumococcus) continues to be a common cause of serious and 
Iife~threatening infections such as pneumonia, bacteremia and meningitis, and of noninvasive 
infections such as otitis media and sinusitis, In the late 1970s and 1980s, the incidence of 
penicillill~resistant pneumococci has increased in Westem countries, patticularly in Spain, 
reaching levels up to 50% (6, 12, 14,22). An epidemiological study in the United Statcs in 
1995 has demonstrated that 25% of invasive pneumococci were intennediate~level or high-
level resistant to penicillin (11), The emergence of high~level resistance to penicillin! 
patticularly in combination with other resistance determinants, possesses serious problems for 
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the instihltion of adequate antimicrobial therapy. 
The high incidence of infections caused by pneumococci and the emergence of drug~resistant 
isolates form major objectives for molecular epidemiological surveillance. Tn order to obtain 
meaningful epidemiological information, genetic markers are needed that reflect an adequate 
rate of genetic rean'angements over time. Various pheno- and genotypical methods have been 
developed to assist in epidemiological investigations. These methods include serotyping, 
multilocus enzyme electrophoresis, pneumococcal surfilce protein A typing, penicillin-
binding protein (PBP) typing, and DNA fingerprint methods such as pulsed-field gel 
electrophoresis, ribotyping and DNA fingerprinting of the PBP gencs. We havc recently 
investigated the usefulness of various DNA fingerprint methods to Shldy the molecular 
epidemiology of pneumococcal infections. The potentials of (i) ribotyping, (ii) BOX 
fingerprinting using the BOX repetitive sequence of S. pneumolliae as a DNA probe, (iii) 
polymerase chain reaction fingerprinting using a primer homologous to the enterobacterial 
repetitive intergenic consensus sequence or homologous to the pneumococcal BOX repetitive 
sequence, (iv) pulsed-field gel electrophoresis of large-size DNA fragments, and (v) 
restriction fragment end labeling (RFEL) to detect restriction fragment length polymorphism 
of small-size DNA fragments have been compared (10, 30). Although the discriminatOlY 
power of the DNA fingerprint techniques differs significantly, the deduced genetic clustering 
of the pneumococcal strains is comparable. The ease to perfonn computerized analysis and 
the potential to create reliable fingerprint libraries also differs significantly. Ribotyping, BOX 
fingerprinting and RFEL analysis are velY suitable for computerized analysis of the 
fingerprints. RFEL analysis, a technique that has also proved to be relatively stable over time 
(24), is currently routinely used in our laboratOlY to generate a data libnuy of pneumococcal 
DNA fingerprints (10). 
Several examples of international spread of resistant pneumococcal clones have been 
reported: (i) Soares et al. have documented the spread of a multiresistant clone of serotype 6B 
from Spain to Iceland in the late 1980s (28). This has resulted in an epidemic of this clone, 
which was isolated with a frequency up to 12% already in 1992 (13). (ii) In 1991, Munoz and 
colleagues have reported evidence for the intercontinental spread of a multiresistant clone of 
S. jJneullloniae serotype 23F from Spain to the United States (16). This clone has 
subsequently disseminatcd through the United States (15). (iii) Gasc ct al. have reported in 
1995 the spread of a penicillitH'csistant pneumococcal clone of serogroup 9 from Spain to 
France (5). The latter clone has also recently been observed ill Germany (19). Besides the 
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intemational spread of the clones 6B, 23F and 9V, novel penicillin~resistant and multiresistant 
clones have been rcpolted in fonner Czechoslovakia, Spain, Japan and South Africa that tend to 
spread in an epidemic manner within these countries (2, 21, 26, 32). 
In the present study, we investigated the international epidemiological dynamics of penicilliuM 
resistant pneumococci. For this purpose, we compared the molecular epidemiological 
characteristics of 316 penicillin-resistant isolates, originating from 16 distinct countries 
including The Netherlands, Thailand, the United States, Spain, Greece, Poland, Cuba, 
Gcnnany, Finland, United Kingdom, Iceland, South Africa, Hungary, POltugal, Croatia and 
the Czech RepUblic. 
MATERIALS AND METHODS 
Bacterial isolates. Penicillin-resistant pneumococcal isolates (11 = 316) \vere collected in 16 
different countries. A total of 188 penicillin-resistant isolates [minimum inhibitory 
concentration (MIC) :0>0.1 mg/L] were collected in The Netherlands. Thitty-nine Dutcll 
medical microbiology laboratories pm1icipated in this study, and sent all pcnicillitH'csistant 
pneumococci isolated between March 1995 and March 1997 to our laboratory. These 39 
laboratories offer microbiological services to the majority of the Dutch hospitals. The 
pmiicipating hospitals provide mediutn-, high- and intensive-care facilities, and arc 
distributed all over The Netherlands, The laboratories performed susceptibility testing on all 
pneumococcal isolates, and all penicillin-resistant pneumococci were included in the study. 
Duplicate isolates from patients were excluded. The clinical origin of the Dutch isolates was: 
sputum (1/ ~ 126), nasopharym (1/ ~ 21), nose (1/ ~ 19), blood (/I ~ 7), cerebrospinal fluid (n ~ 
3), pus (/1 ~ 3), bronchial secretion fluid (/I ~ 3), ear (1/ ~ 2), vagina (1/ ~ I), hypophatynx (/I ~ 
1) and conjunctiva (/1 = I). One pneumococcal isolate was of unknown clinical origin. 
Fifty-three penicillin-resistant isolates from Thailand were collected between Februmy 1993 
and May 1994 in six hospitals located in five distinct regions of the country. The isolates all 
originated from the nasophalynx of single individuals under the age of five with acute 
respiratOl)' infections. 
Nine penicilliIH·esistant isolates were collected between Febmary 1994 and September 1995 
in Kyriakou Children1s Hospital in Athens, Greece. These strains originated from patients 
under the age of 14 years (mean age 2.75 years), suffering frolll otitis media (n = 5), rhinitis 
(/I ~ 2), bronchiolitis (/I ~ \) or bacteremia (/I ~ \). 
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Five penicillilH'esistant isolates were collected in Cuba. The isolates all originated from the 
nasophmynx of single individuals under the age of five \vith respiratory infections. 
We fmiher received five penicillin-resistant pneumococci from Poland, which were isolated 
in three distinct hospitals from children suffering fi'om otitis media (11 = J») sinusitis (11 = I) or 
pharyngitis (11 ~ 3), 
In order to expand our pneumococcal collection with DNA fingerprints frol11 penicillin-
resistant strains, we asked various colleagues to provide us with clinical isolates. These 
strains originated fromthc United States [/I ~ 10, R, R, Facklam (8); /I ~ 9, H. Faden (25); 11 ~ 
4, A, Tomasz; /I ~ I, F, Tenover), Spain [/I ~ 3, R, Hakenbeck (19); /I ~ 10, J. Casal), 
Germany [/I ~ 4, R, Hakcnbeck (19)), Finland [/I ~ 3, R, Hakenbeck (23»), United Kingdom 
[/I ~ 3, L. M, C, Hall (7)), Iceland (/I ~ 3, K, Kristinsson), South Africa [11 ~ 2, R, Hakenbeck 
(23)], Hungary [/I ~ I, R, Hakenbeck (19»), Portugal (/I ~ I, A. Tomasz), Croatia (/I ~ I, A, 
Tomasz), and the Czech Republic [/I ~ I, R, Hakenbeck (19)). 
Biochemical characterization, serotyping and susceptibility testing. Species identification 
of the S. pneullloniae isolates was performed using optochine susceptibility and bile solubility 
testing (l7). Pneumococci were serotyped on the basis of capsular swelling (Quellung 
reaction) observed microscopically after suspension in antisera prepared at Statens Serum 
Institut) Copenhagen, Denmark (4). 
The MICs of the pneulllococcal strains were determined by agar dilution. The MIC was 
defined as the lowest concentration of the antimicrobial agent preventing visible growth. For 
this purpose) serial 210g concentrations of antibiotics were prepared in IsoSensitest agar 
(Oxoid, Unipath Ltd" Basingstoke, United Kingdom), supplemented with 5% horse blood, 
The pneumococcal isolates were removed from storage at -70°C, and sub-cultured at 37°C on 
Columbia agar (Oxoid) supplcmented with 5% sheep blood using 5% C02. Bacterial 
suspensions were prepared in 0.9% NaCI from 24-h agar cultures) and adjusted to a 
McFarkmd turbidity of 0.5. Suspcnsions were fmiher diluted (I: 10) in saline. The inocula 
were applied on the test plates using a multipoint inoculator, resulting in about 104 colony 
fonning units per spot. I\lIC values were read after 24 h of incubation at 37DC using 5% COl. 
The antimicrobial agents tested were: penicillin G (Sigma Chemical Co., st. Louis, MO), 
elythromycin (Abbott Lab, Ltd, Queenborough, Kent, United Kingdom), doxycycline (Pfizer 
S.A., Brussels, Belgium), vancomycin (Eli Lilly Indianapolis, In.), rifampicin (Sigma), 
cotrimoxazolc, Le., the combination (l: 19) of trimethoprim (Sigma) and sulphamethoxazole 
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(Sigma), and ciprofloxacin (Bayer, Wuppertal, Germany). Breakpoints of the antibiotics to 
discriminate between sllsceptible and non susceptible strains were used according to the 
NCCLS guidelines for susceptibility testing (IS). 
RFEL analysis. Typing of pneumococcal strains by RFEL was performed as described by 
Van Stecnbergen et a!. (31), and adapted by Hennans et a!. (10). Briefly, purified 
pneumococcal DNA was digested by the restriction enzyme EcoRJ. The DNA restriction 
fragments were end-labeled at n'c with [a-32PjdATP using Taq DNA polymerase (Goldstar, 
Eurogentec, Seraing, Belgium). The radiolaheled fragments were denatured, and separated 
eiectrophoretically on a 6% polyaclyJamide sequencing gel containing 8 M urea. 
Subsequently, the gel was transfcrred onto filter paper, vacuum-dried (HBI, Saddlebrook, 
Ny), and exposed for variable periods at room temperature to EeL Hyperfihns (Amcrsham, 
Bucks, United Kingdom). 
PBP-genot},ping. Genetic polymorphism of the PBP genes pbpJa, pbp2b and pbp2x was 
investigated by RFLP analysis. For this purpose) we amplified the genes by peR, and 
analyzed the digested DNA products by agarose gel electrophoresis. PCR-amplification of the 
PBP genes was performed in a 50-~tI peR buffer system containing 75 mM Tris-HCI pH 9.0, 
20 mM (NH4),S04, 0.01% (w/v) of Tween 20, 1.5 mM MgCb, 0.2 mM dNTP, 10 pmol of the 
individual primers, 0.5 units of DNA polymerase (Eurogeutec) and 10 ngi!ll of purified 
chromosomal DNA. Cycling was performed in a PTC-IOO Programmable Thermal ControHer 
(M] Research, \Vateliown, MA), and consisted of the following steps: pre-denaturation at 
94"oC for I min, 30 cycles of 1 min 94°C, 1 min S2°e, 2 min 72DC, and final extension at 
72°C for 3 min. The primers used to amplify the PBP la, 2b and 2x genes were described 
previously (I, 3, 16). The amplification products (5 !tl) were digested by restriction 
endonuclease Hil~fJ, and separated by electrophoresis in 2.5% agarose gels containing 0.5 x 
TBE and 0. 1 ~lg/llll of ethidium bromide (5 mill thick; Agarose "NIP, Boehringer Mannheim, 
Atmere, The Netherlands). Gels were nlll in 0.5 x TBE containing 0.1 ~lg/ml of ethidium 
bromide at a constant current of 20 mA for 4 h. Prior to electrophoresis, samples were mixed 
with a 5 x concentrated layer mix consisting of 50% glycerol in \vater and 0.8 mg bromo 
phenol blue per 1111. Gels were photographed \vith a Polaroid rvlP4 Landcamera and Polaroid 
667 films. The different PBP genotypes are represented by a three-number code (i.e., 06-05-19), 
refening at the RFLP pattenlS of the PBP genes I a (6), 2b (5) and 2x (19), respectively. 
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Computer-assisted analysis of the DNA fiugerprints. The RFEL types were analyzed using 
the Windows version of the Ge1compar software version 4 (Applied Maths, KOlirijk, 
Belgium) after scanning the RFEL autoradiograms using the Image Master DTS (Phannacia 
Biotech, Uppsala, Sweden). For this purpose, the DNA fragments in the molecular weight 
range of 160 to 400 base pairs were explored. The fingerprints were nOllllalized using 
pneumococcus-specific bands present in the RFEL banding patterns of all strains. 
Comparison of the fingerprints ,vas performed by unweighted pair group method using 
arithmetic averages (UPGMA) (20). and using the Jaccard similarity coefficient applicd to 
peaks (27). Computer-assisted analysis, and methods and algorithms used ill this study were 
carried out according to the instmctions of the manufacturer of Gelcompar. A tolerance of 
1.5% in band positions was applied during comparison of the fingelvrint patterns. Identical 
DNA types were arbitrarily defined as RFEL homologies higher than 95%. A genetic cluster 
was defined being a genotype (RFEL or PBP type) that was shared by two or more 
pneumococcal strains. The degree of genetic clustering was defined as the percentage of 
strains displaying genotypes (RFEL or PBP types) that were observed twice or more. 
RESULTS AND DISCUSSION 
All 316 penicillin-resistant pneumococcal strains were analyzed by serotyping, RFEL and 
PBP genotyping, and the resistance pattems were determined. The results are summarized in 
Fig. I. One hundred and thirty-two distinct RFEL types were observed, representing 36 
genetic clusters (RFEL types shared by two or more strains) and 96 unique RFEL types. Thc 
largest collections of strains originated from The Netherlands (/I ~ 188) and Thailand (/I ~ 
53), and demonstrated 76% and 68% of genetic clustering, respectively. The degree of 
clustering was much higher among the penicillin-resistant strains from both countries 
compared with a group of 153 penicillin-susceptible strains isolated in The Netherlands in 
1994. which displayed only 33% of genetic clustering (9). These data clearly demonstrate that 
the transmission behavior of these strains is comparable in both countries. \Ve have recently 
investigated in a onc-year survey the epidemiological characteristics of penicillin-resistant 
pneumococci in The Netherlands. The data obtained from this study have demonstrated that 
multiple clones of penicillin-resistant pneumococci arc frequently introduced in this Iow-
prevalence country. Some of these isolates are able to spread among the population in and 
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outside hospitals, in particular in sub·populations with a high risk for pneumococcal 
infections and a high consumption of antibiotics (9). 
Among the 316 penicillin-resistant pneumococci, 236 strains (75%) were intermediately 
resistant to penicillin and 77 (24%) displayed high-level resistance. Forty-seven percent of the 
penicillin-resistant strains were co-resistant to ctythromyciu, 56% to doxycycline and 87% to 
cotrimoxazole. All isolates were in vitro susceptible to vancomycin and ciprofloxacin. The 
resistance patterns of the penicillin-resistant pneumococci originating from The Netherlands 
afC summarized in Table 1. Comparison of the pneumococci with penicillin MIC values < 1 
~Ig/ml and those with MIC values ;;::1 J-lg/ml clearly demonstrated that the penicillin-resistant 
pneumococci with MIC values ;?:i ~tg/ml ,vere more frequently multiply resistant to four 
antibiotics (resistance pattcrn PCDE). In addition, the degree of genctic clustcring using both 
RFEL typing and PBP typing is also higher among the pcnicil1in~resistant isolates displaying 
MICs ;?:I ~lg/ml. These data suggest that the epidemic behavior of the penicilliIH-esistant 
strains is enhanced by increasing levels of penicillin resistance. Moreover, 've hypothesize 
that horizontal co-transfer of antibiotic resistance genes other than PBP genes occurs 
frequently among pneumococci with high~level resistance to penicillin. 
Table 1. Resistance pattems of penicillin-resistant pneumococci in The Netherlands (ll 
188). 
MIC for penicillin (Ug/ml) 
0.1 - 1 > 1 
genetic clustering (%) genetic clustering (%) 
Resistance Number of RFEL PBP Number of RFEL PBP 
pattem strains strains 
P 16 25 56 1 
pe 18 0 39 45 87 91 
PD 2 0 0 0 
PE 0 6 100 100 
peD 10 0 30 11 91 91 
peE 0 6 83 83 
PDE 1 1 
peDE 10 30 20 61 87 87 
P, penicillin G; C, cotrimoxazole; D, doxycycline; E, ef)1hromycin_ 
Sevcn out of thc 36 RFEL clusters consisted of strains originating from different countries 
(Table 2). The strains displaying the two predominant RFEL types 15 and 23 were found in 
to and six differcnt countries, respectively_ These data demonstrate the pandemic spread of 
these two genotypes. 
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Table 2, Genotypic and phenotypic propeliies of penicillin-resistant pneumococci sharing 
identical RFEL types. 
RFEL 
'!Ie' 
15 
23' 
19 
26 
140 
20 
142 
136 
141 
17 
36 
56 
143 
8 
4 
59 
63 
82 
Number Number of Serogroup 
of strains countries (number of strains) 
53 10 23 (37) 
19 (15) 
14 (I) 
32 6 09 (22) 
14 (10) 
27 15 (26) 
14 (I) 
10 14 (10) 
8 09 (4) 
14 (4) 
7 2 19 (5) 
15 (I) 
23 (I) 
7 14 (5) 
09 (2) 
5 23 (5) 
5 09 (5) 
4 2 19(2) 
14 (I) 
06 (I) 
4 23 (4) 
3 2 06(1) 
14 (I) 
23 (I) 
3 14 (2) 
09 (I) 
3 2 06 (3) 
3 I 23 (3) 
3 06 (3) 
3 06 (3) 
3 06 (3) 
RFEL Number 
typca of strains 
138 3 
6 2 
28 2 
38 2 
51 2 
68 2 
69 2 
60 2 
5 2 
14 2 
35 2 
44 2 
45 2 
65 2 
66 2 
67 2 
70 2 
144 2 
Number of Serogroup 
countries (number of strains) 
14 (3) 
06 (I) 
15 (I) 
19 (I) 
23 (I) 
06 (I) 
23 (I) 
06 (I) 
14 (I) 
06 (I) 
19 (I) 
14 (I) 
19 (I) 
2 06 (2) 
23 (2) 
14 (2) 
15 (2) 
23 (2) 
23 (2) 
06 (2) 
06 (2) 
06 (2) 
06 (2) 
14 (2) 
~ RFEL types displayed by 2 or more strains (RFEL clusters) were exclusively included. 
b RFEL type 15 represents pandemic clone 23F (16). 
C RFEL type 23 represents pandemic clone 9V (5). 
Fifteen oul of the 36 RFEL clusters harbored two or more serogroups (Table 2). This 
indicates frequent horizontal transfer of capsular genes among pneumococci. The high 
fi'equency of capsular transfer may have consequences with regard to the outcome of current 
vaccine strategies, which focus entirely on the use of capsular polysaccharides representing a 
restricted number of capsular types. The use of multivalent conjugate vaccines may shift the 
capsular distribution towards capsular types that are not present in these vaccines, Such a shift 
might be enhanced by the frequent horizontal exchange of capsular genes. 
All 316 penicillin-resistant pneumococci were analyzed by PBP genotyping, Ninety-two 
distinct PBP Iypes were observed, representing 22 PBP clusters (PBP genotypes shared by 
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two or more strains) and 70 unique PBP types (Fig. 1, Table 3). No overlap \vas seen behvecn 
the PBP types of the penicillinRresistant pneumococci and more than 200 susceptible isolates 
(data not shown), Within distinct RFEL types) identical PBP types were often observed. FOlty 
percent of the collection of 316 penicillin-resistant pneumococci displayed PBP type 01-01-
01. This predominant PBP type \vas observed in 11 countries and displayed by 20 distinct 
RFEL types (Table 3). This observation suggests frequent horizontal cxchange ofPBP genes, 
which has resulted in the spread ofPBP type 01-01-01 alllong various pneumococcal RFEL 
types. 
Within the group of316 penicillin-resistant strains, the previously described pandemic clones 
23F (16), 9V (5) and 6B (28) were also included (Fig. I). The predominant RFEL type 15, 
observed in 10 countries, was identical with the RFEL type of the pandemic clone 23F, 
whereas RFEL type 23, observed in six countries, was displayed by the pandemic clone 9V, 
respectively. Interestingly, all isolates from Greeec (/I ~ 9) matched either with clone 23F (/I ~ 
6) or with clone 9V (11 = 3), indicating the signif1cance of both clones in this country (Fig, 1), 
In addition, the vast majority of the strains belonging to the pandemic clones 23F and 9V 
shared thc predominant PBP type 01-01-0 I (Table 3). We hypothesize that the predominant 
pandemic clones 23F and 9V afe primarily responsible for the increase ofpenicilIin-resistance 
worldwide, because they arc an impOitant penicillin resistance reservoir for susceptible 
pneumococci, 
The previously identified pandemic 6B-type strains which displayed genetically related 
mliltilocus enzyme electrophoresis patterns (19), only shared 79% of the RFEL DNA bands. 
Interestingly, the two RFEL types belonged to a genctic family that branched at 75% genetic 
relatedness (Fig. I). Within this genetic family, scrogrollp 6 was displayed by 82% of the 
members, Only 27% of the serogroup 6 strains did not match within this family, These data 
indicate that most of the serogroup 6 strains arc c10nally related, and linked within a single 
genetic family, Genetic polymorphism observed by PBP typing was also restricted \vithin this 
family, and pbp2x type 13 was predominantly (68%) and almost exclusively present among 
the family members (Fig. I). 
This study aimed to identify the clones of peniciIlilH'esistant pneumococci that are currently 
displaying pandemic behavior, Our data clearly show the importance of the pandemic clones 
23F and 9V, as they were detected in IO and six out of the 16 countries, respectively, In 
addition, serogroup 6 strains were also frequently observed, However, the genetic 
homogeneity of these strains is reduced, This finding is consistent with the observations of 
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Table 3. Genotypic and phenotypic properties of penicillin-resistant pneumococci sharing 
identical PBP types. 
PBP type3 Number of strains Number of RFEL type Serogroup 
(l1l-2b-2,'~ countries (number of strains) (number of strains) 
01·01-01 127 11 15 (51) 23 (44) 
23(31) 09 (36) 
140 (8) 19 (16) 
142 (7) 14 (29) 
136 (5) 06 (I) 
141 (5) 15 (I) 
26 (4) 
28 (2) 
138 (2) 
143 (2) 
25 (I) 
29 (I) 
38 (I) 
46 (I) 
47 (I) 
48 (I) 
81 (I) 
137 (I) 
139 (I) 
144(1) 
03-03-04 27 19 (27) 15 (26) 
14 (I) 
01-10-13 13 4 59 (2) 06(13) 
66 (2) 
70 (2) 
17 (I) 
51 (I) 
62 (I) 
63 (I) 
65 (1) 
67 (I) 
112 (I) 
01-03-13 12 3 06 (2) 06 (10) 
68 (2) 15 (1) 
08 (I) 19 (1) 
59 (I) 
63 (1) 
64 (I) 
67 (1) 
77 (I) 
110 (I) 
III (I) 
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Table 3. Genotypic and phenotypic prope11ies ofpenicilliuRresistant pneumococci sharing 
identical PBP types (cont' d). 
PBP type3 Number of strains Number of RFEL type Serogroup 
(la-lb-2.\) countries (number of strains) (number of strains) 
05-05-06 9 2 04 (3) 23 (9) 
05 (2) 
54 (I) 
131 (1) 
132 (1) 
133 (1) 
01-06-13 7 2 39 (1) 06 (7) 
60 (1) 
65 (1) 
74 (1) 
75 (1) 
76 (1) 
78 (I) 
07-02-20 7 20 (2) 14 (3) 
13 (1) 19 (3) 
22 (I) 07 (1) 
27 (I) 
120 (I) 
134 (1) 
20-19-57 5 57 (1) 15 (5) 
ll8 (I) 
122 (1) 
123 (I) 
124 (1) 
01-01-58 4 26 (2) 14 (4) 
138 (1) 
144 (1) 
18-ll-09 4 36 (3) 23 (4) 
37 (1) 
01-01-13 3 2 07 (I) 06 (2) 
61 (1) 09 (1) 
125 (1) 
06-14-01 3 44 (I) 23 (3) 
45 (2) 
01-01-08 3 26 (3) 14 (3) 
02-04-41 2 20 (1) 15 (2) 
35 (1) 
02-15-14 2 87 (1) 14 (2) 
88 (1) 
07-02-01 2 20 (2) 19 (1) 
23 (1) 
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Table 3. Genotypic and phenotypic properties of penicillin-resistant pneumococci sharing 
identical PBP types (cont'd). 
PBP typea Number of strains Number of RFEL type Serogroup 
(1a-2b-2x) countries (number of strains) (number of strains) 
07-05-01 2 56 (2) 06 (I) 
23 (I) 
15-02-39 2 40 (I) 14 (2) 
79 (I) 
16-01-13 2 51 (I) 06 (2) 
52 (I) 
02-05-36 2 2 51 (2) 14 (2) 
07-02-63 2 20 (2) 19 (2) 
09-02-20 2 14 (2) 14(2) 
a RFEL types displayed by 2 or more strains (RFEL clusters) were exclusiyely included. 
b Includes the \'ast majority of the strains belonging to the pandemic clones 23F (16) and 9V (5). 
Harakeh et al. (8) who have demonstrated genetic heterogcneity within serotype 6B 
pneumococci isolated in the United States. Using a genetic relatedness 275%, serogroup 6 
strains were observed in seven countries. These observations suggest that the introduction and 
subsequent pandemic spread of clone 6B has occurred earlier in the antibiotic era compared 
with the international clones 23F and 9V. The contribution of clone 6B to the global 
increasing prevalence of penicillin-resistant pneumococci is at present overruled by the 
rapidly spreading clones 23F and 9V. 
Detection and reduction of transmission of alanuing drug-resistant pneumococci that are 
currently spreading all over the world is an important goal in the battle against pneumococcal 
disease. Obviously, restrictive use of antibiotics remains the major defense against the 
epidemic dissemination of such strains. In addition, the emergence of multidmg-resistant 
pneumococci increases the need for vaccination of patients at risk for pneumococcal disease 
such as the elderly, and the importance to improve conjugate vaccines to efficiently protect 
young children. Detailed studies on the epidemiology and epidemic behavior of 
(multi)resistant pneumococci will assist to identify emerging clones. To this respect, close 
collaboration behveen the laboratories sharing interests in pneumococcal molecular 
epidemiology is of utmost importance. Extensive collaboration can be facilitated by the 
establishment of a freely accessible electronic network. Such nehvork can be used to 
exchange information on teclmical aspects of DNA fingerprinting, aimed to standardize the 
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methodological procedures. Tn addition, the network can be used to COllstmet and distribute 
an international data library containing DNA fingerprints of (multi)resistant pneumococcal 
strains. Such approach will facilitate adequate worldwide monitoring of the epidemiology of 
emerging (multi)resislant pneumococcal strains. 
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SUMMARY 
Penicillin resistance among StreptocoCCIiS pneullloniae isolates has rapidly emerged in 
Poland during the last decade and has reached prevalence levels of up to 14.4% in 1997. Tn 
order to investigate the nahlre of this increase, a molecular epidemiological analysis of 
penicillin-nonsusccptiblc multi drug-resistant pneumococci isolated in 1995 and 1996 was 
conducted. Thirty-seven patients who suffered mainly from upper respiratory tract infections 
and pneumococcal pneulllonia were enrolled in this study. The medical centers to ,vhich the 
patients were admitted were located in 16 Polish towns across the country. Eight distinct 
BOX peR types \vere observed, representing 14 subtypes. Restriction fragment end labeling 
(RFEL) analysis divided the pneumococcal strains into 16 distinct types. By combining the 
BOX PCR and RFEL data, four genetically distinct clusters of strains were identified. Two 
clusters represented the genetic clones 23F and 9V, which have recently emerged all over the 
world. The two other genetic clusters, which represented serotypes 23F and 6B, clearly 
predominated in the analyzed collection of Polish penicillin-nonsusceptible pneumococcal 
strains. Since the latter clusters did not match any of the 133 RFEL types of penicillin-
nonsusceptible pneumococci collected in 15 other countries, their Polish clonal origin is most 
likely. 
INTRODUCTION 
StreptocoCCIIS pneumolliae (pneumococcus) continues to be a common cause of serious and 
life-threatening infections, such as pneumonia, bacteremia, and meningitis, and of non-
invasive infections, such as otitis media and sinusitis (3). In addition, pneumococci are often 
part of the normal nasopharyngeal flora. Especially in young children, pneumococcal 
colonization often occurs. Colonization is an important risk factor: children colonized with S. 
pnel/moniae more often develop acute otitis media than children who are not colonized (9, 
18,33,43). 
Until the 1960s, pneumococci were considered unifollllly susceptible to penicillin, and 
sensitivity tests were hardly ever perfollned. In 1967, the first isolation ofpenicillin-rcsistant 
pneumococci was reported in Australia (12). Subsequently, penicillin-resistant pneumococci 
have been isolated in Papua New Guinea and South Africa (20, 22, 31). In the late 1970s and 
19808, rates of resistance, including multiple resistance, have increased in \Vestern countries, 
particularly in Spain, with resistance levels of up to 50% (11, 20, 22, 31). A recent 
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epidemiological study perfonned in the United States has demonstrated that 25% of invasive 
pneumococci are penicillin-nonsusceptible (17). The emergence of high-level resistance to 
penicillin, palticularly in combination ,vilh other resistance detenllinants, is a serious threat 
for current treatment strategies. 
Several investigators have reported the international spread of multiply-resistant 
pneumococcal clones. Soares and coworkers have reported the spread of a dmg-resistant 
clone of serotype 6B from Spain to Iceland in the late 1980s (37). This has resllited in an 
epidemic of this clone, which was isolated with frequencies of lip to 12% in 1992 (21). In 
1991 J Munoz and colleagues reported evidence for the intercontinental spread of a multiply 
resistant clone of S. pneu1110niae serotype 23F from Spain to the United States (24). This 
clone has subsequently disseminated through the United States (23). Finally, in 1995 Gasc 
and colleagues repOtted the spread of a multiply-resistant pneumococcal clone of serogroup 9 
from Spain to France (10). The international clones 23F and 9V have been identified in many 
countries in different pat1s of the world (14, 28). Besides the international spread of the 
clones 6B, 23F, and 9V, novel penicillin-resistant and multiply-resistant clones that tend to 
spread in an epidemic manner have been observed in the fonner Czechoslovakia, Spain, 
Japan, and South Africa (4, 30,34, 42). 
Penicillin resistance among pneumococcal isolates has rapidly emerged in Poland during the 
last decade. The percentage of penicillin-nonsusceptible strains has increased fcom 0 to 3% in 
1990 to 1993 (I, 19) to 14.3% in 1996 (39) and 14.4% in 1997 (38). In order to identify the 
nahlre of the increase in the prevalence of pcnicillin-nonsusceptible pneumococci in Poland, 
a molecular epidemiological study was conducted. To this end, strains were isolated in 1995 
and 1996 from 37 patients who suffered mainly from upper rcspiratOlY tract infections and 
pneumococcal pneumonia and who were diagnosed in 19 different clinical centers located in 
16 towns across the counhy. The pneumococcal isolates were characterized by BOX peR 
typing, restriction fragment end labeling (RFEL) analysis, penicillin-binding protein (PBP) 
genotyping, serotyping, and drug susceptibility testing. 
MATERIALS AND METHODS 
Bacterial isolates. Penicillin-nonsusceptible S. pneull10niae strains were isolated from 37 
Polish patients in 1995 and 1996. A single pneumococcal isolate per patient per infection was 
analyzed. Bacteriological diagnosis ,vas carried out in 19 distinct medical centers. These 
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centers were located in 16 Polish towns across the countly (Fig. 1). The clinical, 
bacteriological, and demographic parameters are listed ill Table 1, 
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Fig. I. Map of Poland. The medical centers collaborating in this study are as follows: 1, Mother and Child 
Institute, Warsaw; 2, Health Care Center Praga-Polnoc, Warsaw; 3, Nieklallska Street Hospital, Warsaw; 4, 
Sienna Street Hospital, Warsaw; 5, Health Care Center, Kolobrzeg; 6, Regional Hospital, Gdansk; 7, Health 
Care Center, Tczew; 8, Health Care Center, Bralliewo; 9, Regional Children Hospital, Olsztyn; to, Regional 
Hospital, Suwalki; 11, Medical University, Bydgoszcz; 12, Health Care Center, Garzaw Wielkopolski; 13, 
Health Care Center, Czestochowa; 14, Health Care Center, Kedzierzyn Kozle; 15, Jan Bobcr Center for 
Microbiology and Autovaccines, Krakow; 16, Health Care Center, Myslcniee; 17, Health Care Center, Mielee; 
18, Health Care Center, Sanok; and (19), Regional Hospital, Lomza, 
Biochemical characterization, sel'ot)'ping, and susceptibility testing. The isolates were 
determined to be S. plleumoniae by investigating their optochin susceptibility and bile 
solubility (25), All pucumococci were serotyped iu the Sera and Vaccines Central Research 
Laboratory in Warsaw on the basis of capsular swelling (Quellllng reaction) observed 
microscopically after suspension in antisera prepared at Statens Semll1 Institllt, Copenhagen, 
Denmark (8), 
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The susceptibilities of pneumococcal strains were detennined in the Sera and Vaccines 
Central Research Laboratory in Warsaw according to the guidelines of the National 
Committee for Clinical LaboratDlY Standards (26) by the broth microdilution method in 
cation-adjusted Mueller-Hinton II broth (Beckton Dickinson, Oxford, United Kingdom) 
supplemented ,vith 5% lysed horse blood, The following panel of antimicrobial agents was 
tested: penicillin (Polfa, Poznan, Poland), amoxicillin (SmithKline Beecham, Brentford, 
United Kingdom), cefotaxime (Roussel, Paris, France), doxycycline (pol fa), chloramphenicol 
(pol fa), erythromycin (Pol fa), lincomycin (Upjohn, Kalamazoo, Mich.), vancomycin (Eli 
Lilly, Indianapolis, Ind,), rih1mpin (Polfa), ofloxacin (Hoechst-Roussel, Kansas City, Kans,), 
sparfloxacin (Rhone-Poulenc, Courbcvoie cedex, France), and cotrimoxazole (trimethoprim 
with sulfamethoxazole) (Polfa), For doxycycline, lincomycin, and sparfloxacin susceptibility 
testing. French interpretative critcria were applied (6). The microdilution panels were 
prcpared by a single senior technician. The quality control strains S, pneumolliae ATCC 
49619 and Staphylococcus aUl'ellS ATCC 29213 were included in each 11m. 
RFEL analysis and BOX peR typing. Typing of pneumococcal strains by RFEL analysis 
was performed as described by Van Steenbergen et a!. (41) and adapted by Hennans et a!. 
(16). Briefly, purified pneumococcal DNA was digested with the restriction enzyme EcoRT. 
The DNA restriction fragments were end labeled at 72°C with [a-32 P] dATP by using DNA 
polymerase (Goldstar; Eurogentec, Seraing, Belgium). The radiolaheled fragmcnts were 
denahtred and separated electrophoretically on a 6% polyaclylamide sequencing gel 
containing 8 M urea, Subsequently, the gel was transfelTed onto filter paper, vacuum dried 
(HBI, Saddlebrook, N.Y.), and exposed for variable lengths of time at room temperature to 
ECL Hyperfilms (Amersham, Bucks, United Kingdom). 
BOX PCR typing was carried out in a single laboratory as described before (40). Briefly, 50 
ng of pneumococcal DNA was amplified by PCR (4 min at 94°C [predenaturation]; 40 cycles 
of I min at 94°C; 1 min at 60°C; and 2 min at 74°C; and 2 min at 74°C [extension)), using 
primer BOX-A (5'ATACTCTTCGAAAATCTCTTCAAAC), which was designed from the 
primary stmcture of the BOX repeat motif, The amplified products were separated on a 1,5% 
agarose gel. Gels were stained with ethidium bromide, after which the banding patterns were 
evaluated visually. BOX peR patterns showing a single band difference were defined as 
nonidentical types (e.g., 1) 2, and 3). Identical banding patterns varying in the intensity of one 
or more bands were defined as subtypes (e.g., 7, 7.1, and 7.2). 
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PBP gcnot),ping. Genetic polYIllOlphism of the penicillin resistance genes pbpJa,pbp2b, and 
pbp2.\" was investigated by restriction fragment length polymorphism (RFLP) analysis. To 
this end, we amplified the genes by peR and analyzed the digested DNA products by agarose 
gel electrophoresis. peR amplification of the PBP-encoding genes was performed in a 50-I .. !! 
PCR buffer system containing 75mM Tris-HCI (pH 9.0), 20 mM (NH4),S04, 0.01% (wt/vol) 
Tween 20, 1.5mM MgCI" 0.2 111M deoxynucleoside triphosphates, 10 pmol of the individual 
primers, 0.5 U of DNA polymerase (Eurogentec), and 10 ng of purified chromosomal DNA. 
Cycling was perfonned in a PTC-IOO Programmable Thermal Controller (M] Research, 
\\'atertowll, Mass.) and consisted of the following steps: prcdenaturation at 94°C for 1 min; 
30 cycles of 1 min at 94°C; I min at S2°e; and 2 min at 72°C; and a final extension at 72°C 
for 3 min. The primers used to amplify the genes pbpJa, pbp2b, and pbp2x were described 
previously (5,7,24). 
The amplification products (5 ~II) were digested with the restriction endonuclease Hinfl and 
separated by electrophoresis in 2,5% agarose gels containing 0.5 x Tris-borate-BOTA and 0. I 
gg of ethidiul11 bromide per 1111 (5 mill thick) (Agarose MP; Boehringer Manuheim, Almcre, 
The Netherlands). Gels were 11111 in 0.5 x Tris-borate-EDTA containing 0.1 ~lg of ethidiul11 
bromide per 1111 at 20 mA for 4 h, Prior to electrophoresis, samples werc mixed with a 5 x 
concentrated layer mix consisting of 50% glycerol in water and 0.8 mg of bromophenol blue 
per 1111. Gels were photographed with a Polaroid MP4 Landcamcra and Polaroid 667 films. 
The different PBP genotypes are represented by a three-number code (c.g., 06- 14-43, 
referring to the RFLP patterns of the genes pbp I a [pattern 6], pbp2b [pattem 14], and pbp2.\" 
[pattern 43], respectively. 
Computer-assisted analysis of the DNA banding patterns. The RFEL types were analyzed 
by using the Windows version of the Gelcompar software version 4 (Applied Maths, Kortrijk, 
Belgium) after imaging the RFEL autoradiograms with the Image Master DTS (Phannacia 
Biotech, UppsaJa, Sweden). To this end, the DNA fragments in the molecular size range of 
160 to 400 bp were explored. The DNA banding patterns were nonnalized by using 
pneumococcus-specific bands present in the RFEL banding patterns of all strains. 
Comparison of the banding pattems was perfonned by the ull\veighted pair group method 
with arithmetic averages (29) and with the Jaccard similarity coefficient applied to peaks 
(36). Computer-assisted analysis and the methods and algorithms used in this study were 
according to the instructions of the manufachlrer of Gelcompar. A tolerance of 1.5% in band 
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positions was applied during comparison of the DNA patterns. Identical DNA types were 
arbitrarily defined as those with RFEL homologies higher than 95%. Cluster codes I to IV 
refer to clusters of pneumococcal strains displaying RFEL types ,vith homologies higher than 
80% that were confinued to be genetically related by using BOX PCR typing (identical BOX 
PCR types or subtypes). 
RESULTS 
The molecular epidemiology of penicilljn~nonsusceptible l11ultidlllg-resistant pneumococci in 
Poland was investigated. Thirty-seven patients who suffered mainly from upper and lower 
respiratory tract infections (11 = 20 and 13, respectively) ,vere enrolled in this study. In 
addition, threc patients suffered from otitis media, a brain abscess, and conjunctivitis, 
respectively. The clinical diagnosis of one patient was unknown. The medical centers to 
which the patients were refen'ed were located in 16 Polish towns across the countly (Fig. I). 
The clinical and demographic parameters are listed in Table I. 
The 37 penicillilHlonsllsceptible pneumococcal strains were characterized by RFEL analysis 
and BOX PCR typing. RFEL analysis divided the 37 pneumococcal strains into 16 distinct 
types (Fig. 2, Tablc I). Eight distinct BOX PCR types were observed, representing 14 
snbtypes (Fig. 3, Table 1). When RFEL and BOX PCR analyses were combined, four 
genetically distinct clusters of strains (designated I, II, Ill, and IV) were identified. Within 
these clusters, genetic relatedness of the strains was demonstrated by both RFEL analysis and 
BOX PCR (sub)typing. Clusters I, II, Ill, and IV consisted of 12, 3, 11, and 7 strains, 
respectively. Each cluster \vas represented by strains that originated from different centers 
(Tablc I). The remaining four strains did not fulfill the cluster criteria. 
Comparison of the Polish RFEL types \vith 133 genotypes present in the intemationai RFEL 
data libraty representing 15 other cOllntries (13, 14) revealed that the genetic clusters II and 
IV matched the Spanish pandemic clone 23F (RFEL type 15) and the Spanish-French 
intemational clone 9V (RFEL type 23), respectively (data not shown). The remaining 14 
Polish RFEL types did not match any of the 133 non-Polish types present in the international 
library. The 37 penicillin-nonsllsceptible pneumococci from Poland represented seven 
distinct serotypes (Table I). The most predominant serotypes were 23F (/I ~ 15), 6B (/I ~ 12), 
and 9V (/I ~ 6). Serotypes 6A, 14, and 19A were all obselyed once in the Polish collection. 
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Patient Pneumococcal strain w 
Age Sex Clinical Centei Strain Clinical Penicillin Resistance Serotype BOX RFEL PBP 
(years) diagnosis number origin MIC 3 PCR 4 profile type genotype 
(J.'g1ml) type (cluster) 5 
<1 female URTII 7 39 nose 4.0 PAXCDELT 23F 106 (I) 6-2-53 
<1 male URTI 7 40 nose 4.0 PAXCDELT 23F 106 (I) 6-1-53 
child 
-' URTI 6 32 nose 4.0 PAXCDELT 23F 106(1) 6-1-53 
1 male URTI 7 26 nose 4.0 PAXCDELT 23F 105 (I) 6-18-53 
child male URTI 17 29 nose 4.0 PAXCDELT 23F 105 (I) 6-18-56 
male LRTII 1 6 throath 8.0 PAXCDET 23F 105 (I) 16-3-1 
<1 male LRTI 7 9 blood 4.0 PAXCDELT 23F 105(1) 6-18-53 
1 male URTI 14 22 nose 2.0 PAXCDELT 23F 145 (I) 6-14-43 
6 male otitis media 4 151 ear 4.0 PA*CDE** 23F 44(1) 6-14-43 
4 female URTI 3 178 nose 8.0 PA*CDE** 23F 44 (I) 6-14-1 
4 male URTI 4 233 throat 8.0 PA*CDE** 23F 1 45 (I) 6-14-1 
5 female URTI 4 234 throat 8.0 PA*CDE** 23F 1 45 (I) 6-14-1 
adult female .LRTI 2 4 sputum 2.0 PAXCDET 23F 2 15 (II) 1-1-1 
13 female LRTI 18 16 BALI 2.0 PAXDET 23F 2.1 15 (II) 1-1-1 
3 male URTI 16 33 throath 2.0 PAXCDET 23F 2 15 (II) 1-18-1 
57 male brain abscess 12 8 CSFI 0.5 PCDELT 19A 3 104 7-17-52 
55 male LRTI 10 2 BAL 1.0 PCT 6A 4 97 2-5-51 
8 31 1.0 PD rough 5 148 07_2_54 
3 female URTI 7 36 nose 1.0 PCDELT 6B 6 147 0-1-54 
14 male LRTI 9 12 sputum 0.12 PCDELT 6B 7 98 (III) 2-2-9 
7 male LRTI 9 13 sputum 0.12 PCDELT 6B 7 98 (III) 2-2-9 
3 female LRTI 9 14 blood 0.12 PCDELT 6B 7.1 98 (III) 2-2-9 
1 male URTI 13 35 nose 0.12 PCDELT 6B 7.2 98 (Ill) 2-18-9 
6 male URTI 16 34 nose 0.12 PCDELT 6B 7.1 98 (III) 2-18-9 
V> 
V> 
Table L Microbiological parameters of37 penicillin-resistant pnewnococcal isolates, and clinical and demographic data of the patients 
(cont'd). 
Patient Pneumococcal strain 
Age Sex Clinical Center2 Strain Clinieal Penicillin Resistance Serotype BOX RFEL PBP 
(years) diagnosis origin 3 PCR 4 number M1C profile type genotype 
(flglml) type (cluster) 5 
adult LRTI II 17 sputum 0.12 PCDELT 6B 73 102 (lII) 2-2-9 
2 male URTI 14 23 nose 0.12 PDE 6B 7.3 102 (lII) 2-2-9 
child male conjunctivitis 2 30 eye 0.12 PDEL 6B 7.1 102 (lII) 2-2-9 
12 male LRTI 9 IS female 0.12 PDEL 6B 7.2 101 (lII) 2-2-9 
<I LRTI 2 5 tbroath 0.12 PDEL 6B 7.3 99 (lII) 2-2-9 
5 male URTI 17 27 nose 0.12 PCDET 6B 7.4 99 (lII) 2-2-9 
child female URTI 7 24 nose 1.0 PACDT 9V 8 23 (IV) 1-1-1 
adult male URTI 17 38 nose 1.0 PAXCDET 9V 8.1 23 (IV) 1-2-1 
adult female LRTI 6 I pleural fluid 1.0 PAXCDET 9V 8.1 23 (IV) 1-1-1 
child male URTI 5 10 nose 1.0 PAXCDET 9V 8 23 (IV) 1-5-1 
adult LRTI 15 II sputum 2.0 PAXCDELT 14 8 23 (IV) 1-5-1 
child female URTI 3 37 throath 0.5 PXCDT 9V 8.1 23 (IV) 1-2-1 
10 female URTI 19 181 throath 1.0 PA*C"'* 9V 8.1 140 (IV) 1-1-1 
lURTI, upper respiratory tract infection; LRTI, lower respiratory tract infection; BAL, broncheo-alveolar lavage; eSF, cerebra-spinal fluid. 
2Codes refer to geographical areas depicted in Figure l. 
3p. penicillin G; A, amoxicillin; X, cefotaxime, C, chloramphenicol; D, doxycycline; E, erythromycin; L, lincomycin; T, trimethoprim- sulfamethoxazole 
(cotrimoxazole). "'Susceptibility to cefotaxime, lincomycin and cotrimoxazole was not tested. 
~e arbitrary cut-off value for an identical RFEL type is 95%; RFEL codes exclusively refer to the genetic distances calculated using the entire collection of 
147 pneumococcal RFEL types, in which the Polish genotypes were included (see materials and methods section) (13, 14). 
~oman numbers refer to cluster codes depicted in Figure 2. 
6- ,data not available. 
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Strain 31 displayed a rough phenotype and could not be serotyped. Serotypes 23F, 6B, and 9V 
included 6,5, and 2 RFEL types, respectively, whereas the remaining three scrotypes (6A, 14, 
and 19A) were restricted to single RFEL types. The clusters I, II (pandemic clone 23F), and 
III displayed the serotypes 23F, 23F, and 6B, respectively. Genetic cluster IV (pandemic 
clone 9V) harbored both serotypes 9V (/I ~ 6) and 14 (/I ~ I), indicating horizontal transfer of 
capsular genes within this cluster. 
50 60 70 80 90 100 
) , ! ! ! ! 
II 
II 
II 
II 
II 
II 
II 
II 
II 
III 
III 
Iii 
III 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
III 
II III II 
II 1111 II 
II III II 
II III II 
II III II 
II III II 
II II II 
II II II 
1111 1111 II 
II 11111 II 
II 11111 III 
II 1111111111 
II 111111111 
II II III 
II II III 
II II HI 
II II Iii 
II II 1111 
II 1111 
II 11111111 
II 111111 II 1111 
II 111111 II 1111 
II 111111 II 1111 
II 111111 II 1111 
II 111111 II II 
II 1'11'1 II 1111 
II 11111 II 1111 
II illl II 1111 
II iii II 1111 
II 111'111 II II 
II IIlnl II II 
II 1111 III II 
II 1111 II II 
II 1111 III II 
II 1111 III II 
II 1111 III II 
II 1111 III II 
II 111111 III II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II 
II II 
II II 
II II 
I II 
I II 
I II 
II II 
It 
II 
III 
tl 
II 
II 
II 
:11 
II 
III 
iii 
U 
In 
II 
II 
II 
III 
III 
IIlifl 
1111111 
IIii'I 
IIRm 
IIIL] 
111111 
111:11 
IIIlii 
1111 
IIlliI 
11111 
11111 
11m 
I I 
I I 
I I 
I I 
I I 
I I 
I III 
I I H 
I III 
I III 
I III 
I III 
I III 
I III 
I I II 
I III 
I III 
I III 
I II 
I II 
I II 
II II 
1111 
III 
I I 
1111 
1111 
1111 
UII 
1111 
1111 
1111 
1111 
1111 
1111 
1111 
II 
II 
II 
II 
II 
II 
II 
III 1111 39 
III I III 10 
III I III I 32 
III 1111 I 26 
III t II I 29 
III I II I 6 
III I III I 9 
III 1111 22 
III I II 151 
1111111 176 
11111111233 
III 1111 1234 
I 
III 1111 14 
III I I I 16 ] II 
III I I I 33 
III I I I 8 III I II I 2 
1111 I U I I ~! 
1111 I II I I 
111111111'2 
1111 11111 I i! 
1111 11111 I " 
1111 11111 I 34 
1111 111111 17 
IIIII III 23 
1111 I II I 30 
1111 11111 I 15 
1111 I II I 5 
III I I 38 
III 
III I l' IV 
\\\' III\':;~ ] 
III I I 10 
III I I 11 
III I I 37 
III I I 181 
Fig. 2. Genetic relatedness of 37 Polish penicillin-llollsusccptible pneumococcal strains based on the RFEL 
banding patterns of the isolates. The RFEL fingerprints, their relatedness (dendrogram), strain numbers, and 
genetic cluster codes (Roman numerals) arc depicted. Clustcr codes I to tV rcfer to c1ustcrs ofpncumococcal 
strains displaying RFEL types with homologies higher than 80% that are confirmed to be genetically related by 
BOX PCR typing (identical BOX PCR types or subtypes). 
The penicillin MICs of Ihe pneumococcal slrains varied from 0.12 to 8.0 ~lg/m1. Within the 
genetic clusters, various resistance profiles were observed, ranging from lack of susceptibility 
to penicillin and doxycycline only to multidl1lg resistance against penicillin, cefotaximc, 
cotrimoxazole, doxycycline, chloramphcnicol, crythromycin, and lincomycin. Genetic cluster 
I had the highest penicillin MICs (up to 8 ~Ig/ml), as well as the greatest multidmg resistance 
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(Table I). The lowest penicillin MICs were obselved for isolates of genetic cluster III. The 
resistance patterns of these strains demonstrated the irrelative sllsceptibilities to the 
antimicrobial agents tested. Nevertheless, all members of cluster III were multidmg-resistant, 
i.e., resistant to three or more antibiotics. None of the isolates were resistant to vancomycin, 
rifampin, and fluoroquinolones. 
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Fig. 3. DNA fingerprint patterns of the 14 distinct BOX peR (sub)types represented by the 37 Polish 
penicillin-nonsusceptiblc pneumococcal strains. Lane numbers indicate BOX peR type codes. Numbers at the 
left indicate the sizes of standard DNA fragments in base pairs. 
The penicillin resistance profiles of the pneumococcal strains were investigated in fmiher 
detail by PBP genotyping. To this end, the penicillin resistance genes pbpJa, pbp2b, and 
pbp2x were subjected to RFLP analysis (Fig. 4). The genetic clusters II (pandemic clone 23F) 
and IV (pandemic clone 9V) included two and three distinct PBP genotypes, respectively 
(Table I). The polymorphism was restricted to pbp2b. Similar results were obscrved for 
cluster III: there wcre two distinct PBP gcnotypes that differed only in the pbp2b gene. For 
cluster I, seVen distinct PBP genotypes were observed; in contrast to the case for the other 
three genetic clusters, genetic POlYll1OlVhism was demonstrated in pbpJa (two types), pbp2b 
(five types), and pbp2x (four types). Except for clusters II and IV, representing pandemic 
clones 23F and 9V, respectively, no overlap was observed between the PBP genotypes of the 
four clusters. Similarly, the four genotypes that were observed only once in the Polish 
collection also displayed unique PBP genotypes. The polymorphism of the PBP-encoding 
genes within clusters II and IV was remarkable, as the majority of the pandemic 23F and 9V 
isolates that are now present in the international data library (51 23F strains from 10 countries 
[96%] and 31 9V strains from 5 countries [97%]) display PBP genotype 1-1-1 (13, 14). 
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Fig. 4. DNA t1ngerprinl patterns of the pbpla (II = 5), pbp2h (1/ = 7), and pbp2x (1/ = 8) genotypes represented 
by the 37 Polish penicillin-nonsusceptible pneumococcal strains. Lane numbers indicate PBP genotype codes. 
Numbers <lIthe left indicate the sizes of standard DNA fragments in base pairs. 
Comparison of the PBP genotypes of the individual genes pbpJ a, pbp2b, and pbp2x between 
the Polish penicillin-non susceptible strains and 185 Dutch penicillin-susceptible 
pneumococcal meningitis isolates (15, 32) revealed the exclusive presence of penicillin-
susceptible pbp I a and pbp2b genotypes among the Polish clusters I, III, and IV, Two strains 
of cluster IV (pandemic clone 9V; strains 37 and 38 with penicillin MICs of 0,5 and 1.0 
flg/ml, respectively) displayed the predominant penicillin-susceptible pbp2b genotype 2 (Fig, 
4, Table I), In addition, the majority of thc strains belonging to cluster III displayed the 
predominant penicillin-susceptible pbp I a-pbp2b genotype 2-2 (penicillin MIC of 0,12 
flg/ml), Finally, the majority of clustcr I displayed the penicillin-susceptible pbpla genotype 
6 (penicillin MICs ranging from 2,0 to 8,0 flg/ml); this genotype was observed only once in 
the collection of 185 Dutch penicillin-susceptible pneumococci. 
Among the pbpJa, pbp2b, and pbp2x genotypes that are restricted to penicillin-
nOll susceptible pneumococci (13,14), the presence ofpbpla genotype 1 was observed among 
clusters II (clone 23F) and IV (clonc 9V) (Table 1), In addition, the pbp2b genotypes I and 
18 and the pbp2x genotype 1 were observed in three genetic clusters. These data indicate 
horizontal exchange of penicillin resistance genes between pneumococcal strains of the 
different Polish clusters. 
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DISCUSSION 
Penicillin resistance among pneumococcal isolates has rapidly emerged in Poland during the 
last decade. The percentage ofpenicilliIHlonsusceptible strains has increased from 0 to 3% in 
1990 to 1993 (I, 19) to 14.3% in 1996 (39) and 14.4% in 1997 (38). In order to identify the 
nature of the increase in the prevalence of penicillill-nonsusccptible pneumococci in Poland, 
a molecular epidemiological Shldy ,vas conducted. The emergence of four genetically distinct 
penicillin-non susceptible muItidmg-resistant pneumococcal clusters was clearly 
demonstrated. Clusters 11 and IV represented the genetic clones 23F (24) and 9V (II), 
respectively, which have recently emerged all over the world (13, 14). In addition, the two 
other clusters, I and III, predominated in the collection of penicillin-nonsusceptible 
pncumococci from Poland. Since these clusters did not match any of the 133 RFEL types of 
penicillin-nonstlsceptible pneumococci collected in 15 other countries and present in the 
international data librmy ofRFEL types (13,14), their Polish origin is most likely. 
Various researchers have repOlied horizontal transfer of capsular genes (2, l3-15). The high 
frequency of capsular transfer may have consequences for the outcome of cUlTent vaccine 
strategies, which focus on the usc of a restricted number of distinct capsular polysaccharides. 
The use of multivalent conjugate vaccines may shift the capsular distribution towards 
capsular types that arc not present in these vaccines, Such a shift might be enhanced by the 
frequent horizontal exchange of capsular genes, Genetic cluster IV (pandemic clone 9V) 
harbored both scrotypcs 9V (/I ~ 6) and 14 (/I ~ I). These serotypes are known to occur in this 
international clone (13,14). The Polish strains that were genetically related to the pandemic 
clone 23F (cluster II), which harbors serotypes 23F, 19F, 14, 9N, 19A, and 3 (13, 14,27), 
displayed only the ancestral serotype 23F. 
Within the four genetic clusters, RFLP of the PBP-encoding genes was often observed, in 
pmiicular in pbp2b, This finding indicates frequent horizontal transfer of the penicillin 
resistance genes. PBP genotype 01-01-0 I was observed in clusters II (pandemic clone 23F) 
and IV (pandemic clone 9V). In a recent study by Hermans and coworkers (13), the vast 
majority of isolates of the pandemic clones 23F and 9V also displayed the PBP genotype 01-
01-01. In that study, PBP genotype 01-01-01 was displayed by 41 % of the strains collected in 
15 other countries and represented 20 of the 133 distinct RFEL types. In addition, genetic 
polymorphism in the penicillin resistance genes of the pandemic clones 9V and 23F was 
rarely observed. However, in five of the 10 Polish strains that were related to the pandemic 
clones 9V and 23F, differences in the PBP genotypes ,vere observed, suggesting that in 
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Poland horizontal transfcr of penicillin resistance genes, in particular pbp2b, occurs more 
frequently in these clones than in those present in the other countries. The pbp2h genotypes 
18 (observed only in Poland so far) and I and the pbp2x genotype I were observed in three of 
the four genetic clusters. These data suggest that these PBP genotypes have spread in the 
Polish population of penicillin-non susceptible pneumococci by horizontal gene transfer. 
The strains belonging to cluster III invariably displayed low penicillin MICs of 0.12 ~tg/ml. 
In addition, the majority of these strains displayed the penicillin-susceptible pbpla-pbp2b 
genotype 2-2. Although the predictive value of PBP genotyping for pneumococcal penicillin 
resistance can be debated for methodological reasons, this observation is in concordance with 
data from Smith and cO\vorkers (35), who have demonstrated that in pneumococci vlith low 
penicillin MICs,pbp2b is usually not affected by mutations. 
In sUlnmmy, penicillin resistance has rapidly emerged in Poland over the last decade. 
Although the pandemic clones 9V and 23F are present in this counily, the nationwide 
emergence of two novel muitidlllg-resistant pneumococcal clones that are presumably of 
Polish origin has clearly contributed to the increase in the prevalence of penicillin-
nonsusceplible pneumococci in Poland. 
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SUMMARY 
The prevalence of penicillin-resistant StreptococCllS plleul1Ioniae ill Thailand has dramatically 
increased over the last decade. During a national survey, which \vas conducted from 1992 to 
1994, 37.2% of the pneumococci isolated from the nasophatyngcs of children with acute 
respiratory tract infections \vere penicillin-resistant (MIC, ;:::0.1 pg/ml). In order to investigate 
the prevalence and clonal relatedness of nasopharyngeal catTiage of penicillin-resistant S. 
jJneufIlol/;ae in Tlutiland, a molecular epidemiological survey was undertaken. To this end, 53 
penicillin-resistant pneumococcal isolates from children who suffered from acute respiratOlY 
tract infections and who originated from five distinct regions of the counhy were 
characterized in detail. DNA fingel1Jrint analysis demonstrated 13 clusters) i.e., genotypes 
shared by two or more strains, and 14 unique genotypes. The cluster size varied from 2 (nine 
clusters) to 11 strains (one cluster). Six of the 13 restriction fragment end labeling clusters 
consisted of nyo or more distinct serotypes, indicating frequent horizontal transfer of capsular 
genes. Geographical distribution of the genotypes among the five regions of Thailand 
demonstrated that only four genetic clusters were restricted to single arcas of the country, 
whereas the other nine clusters represented isolates collected in two or more districts. These 
observations demonstrate that the majority of the genetic clusters are sprcad throughout the 
counhy. The most predominant genetic cluster, representing 21% of the isolates, was 
identical to the Spanish pandemic clone 23F. In addition, the second largcst cluster matched 
the Spanish-French international clone 9V. These data indicate that the genetic clones 23F 
and 9V, which are \yidely spread throughout the world, are the most predominant Illultidrug-
resistant pneumococcal clones in Thailand. Therefore, we conclude that these pandemic 
clones are primarily responsible for the increase in the prevalence of pneumococcal penicillin 
rcsistance in Thailand. 
INTIWDUCTION 
Streptococcus pneulI/oniae is one of the leading bacterial pathogens causing illness and death 
among young children) the elderly, and persons with underlying medical conditions, such as 
immullocompromised patients (5). Pneumococcal infection is usually preceded by 
colonization of the human nasophalynx. This is an important step toward infection. 
Consequently, pneumococcal colonization is an impOliant risk factor for developing disease. 
64 
Penicilli/H'esislmlf S. pnellll10niae in Thailand 
For instance, young children who are frequently colonized \vith pneumococci more often 
develop acute otitis media than do children who are not or less frequently colonized (12, 19, 
33,43). 
The prevalence of penicillin resistance among pneumococci, both high-level resistHllce (MIC 
of >1 J.lglml) and intermediate-level resistance (MIC of 0.1 to I J.lglml), is alanningly 
increasing worldwide (4, 8, 14, 21-24, 42), International spread of a restricted number of 
multiresistant pncumococcal clones has significantly contributed to this increase, Soares and 
co-workers have documcnted the spread of a multiresistant clone of serotype 6B from Spain 
to Iceland in the late 1980s (35). This has resulted in an epidemic of this clone, which was 
isolated with a frequency of up to 12% as early as 1992 (22). In 1991, Munoz and colleagues 
repOlied evidence for the intercontinental spread of a multiresistant clone of S. pneu1110lliae 
serotypc 23F from Spain to the United States (26). This clone has subsequently disseminated 
throughout the United States (25). Finally, Gasc and colleagues in 1995 repOIied the spread 
of a multiresistant pneumococcal clone of serogroup 9 from Spain to France (13). The 
intemational clones 23F and 9V have been identified in many countries all over the world 
(16, 30). Besides the international spread of the clones 6B, 23F, and 9V, novel penicillin-
resistant and multiresistant clones in the fanner Czechoslovakia, Spain, Japan, and South 
Africa that tend to spread in an epidemic manner within these countries have been repOlied 
(6,30,31,34,41). 
In Thailand, a national survey conducted from 1992 to 1994 demonstrated a prevalence of 
penicillin-resistant pneumococci (MIC of ;'0.1 ~tglml) as high as 37.2% (I, 29, 37). This 
figure was much higher than those in the sUlveys in 1978 (6.7%) (36) and in 1987 (10.6%) 
(20). In order to identify the nature of the increase in the prevalence of penicillin-resistant 
pneumococci in Thailand, a molecular epidemiological study was undetiaken. To this end, 
strains isolated from the nasopluuynges of 53 pediatric patients, who suffered from acute 
respiratOlY tract infections and who originated from different regions across the counhy, were 
examined, The pneumococcal isolates were characterized by restriction fragment end labeling 
(RFEL) analysis, BOX PCR typing, penicillin-binding protein (PBP) genotyping, serotyping, 
ancl drug susceptibility testing. 
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MATERIALS AND METHODS 
Bacterial strains. In the survey conducted in 1978, susceptibility testing was performed with 
446 isolates, One hundred seventeen isolates were collected in Bangkok from patients who 
were admitted to three university hospitals (Siriraj Hospital, Chulalongkorn Hospital, and 
Ramathibodi Hospital) and a private hospital (Seventh Day Adventist Hospital). These 
pneumococci were collected mainly from blood (26%), throat swab (23%), sputum (17%), 
cerebrospinal fluid (10%), and pus (7%) samples. In addition, 329 isolates were obtained 
from healthy carriers (ranging from 3 to 45 years of age) in Bangkok (80%) and 
Samutprakarn (20%), a province near Bangkok. The survey conducted in 1986 comprised 95 
pneumococcal isolates from patients who were admitted to the Siriraj University Hospital in 
Bangkok. The isolates were collected mainly from blood (57%), sputum (20%), pus (12%), 
cerebrospinal fluid (4%), and pleural fluid (4%) samples. 
During a national survey of antimicrobial resistance in Thailand from 1992 to 1994 (1, 29, 
37), nasophmyngeal swabs were taken from 1,783 children under the age of 5 years with 
acute respiratOlY infections. The children were hospitalized in six hospitals representing five 
regions of Thailand (Fig. I): Children's Hospital Bangkok (central region), Cholburi Hospital 
(eastern region), Khonkaen Hospital and Maharaj Nakorn Ratchasima Hospital (nOltheastern 
region), Phra Buddha Chinaraj Hospital (northelll region), and Hatyai Hospital (southel1l 
region). S. pnellmolliae species identification was determined by optochin sensitivity and bile 
solubility testing (27). In this survey, 615 pueumococci were isolated (isolation rate, 34.5%). 
All 615 strains were referred to our laboratOlY, and 530 strains were viable at the time of 
arrival. The antibiotic resistance profile of these 530 strains was determined (see below). The 
collection represented 197 penicillitH'esistant pneumococcal isolates (MIC of ~O.l ~(g/I11I). 
Twenty-six of 36 high-level penicillin-resistant pneumococcal isolates (MIC of> l.0 flg/mI) 
and 27 of 161 intermediate-level-resistant pneumococci (MIC of 0.1 to 1 flg/ml) were 
randomly selected for this study (Table I). 
Thc MICs for the pneumococcal strains were determined by agar dilution. The MIC was 
defined as the lowest concentration of the antimicrobial agent preventing visible growth. To 
this end, serial 210g concentrations of antibiotics were prepared in IsoSensitest agar (Oxoid, 
Unipath Ltd., Basingstoke, United Kingdom), supplemented with 5% horse blood. The 
pneumococcal isolates were removed from storage at -70°C and subcultured at 37°C on 
Columbia agar (Oxoid) supplemented with 5% sheep blood with 5% CO2. Bacterial 
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4 
.. 
Thailand 
Fig, 1. Geographical map of Thailand. The medical ccntcrs collaborating in tItis study are indicated by 
numbers: I, Childrcn's Hospital Bangkok (central rcgion); 2, Cholburi HospHal (eastem region); 3, 
Khonkaen Hospital (northeastem region); 4, Muhanlj Nakron Ratchasimu Hospital (northeastem 
region); 5, Phra Buddha Chinaraj HospHaJ (northern region); 6, Hatyai Hospital (southem region), The 
geographical regions seryiced by the medical centers are depicted by opcn circles. 
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suspensions were prepared in 0.9% NnCI from 24-h agar culhlfCS and adjusted to a 
McFarland turbidity standard of 0.5. Suspensions were further diluted (1:10) in saline. The 
inocula were applied on the test plates with a multipoint inoculator, resulting in about 104 
CFU per spot. MICs were read after 24 h of incubation at 37°C with 5% CO2• 
The antimicrobial agents tested were penicillin G (Sigma Chemical Co., St. Louis, Mo.). 
erythromycin (Abbott Laboratories, Ltd" Queenborough, Kent, United Kingdom), 
doxycycline (Pfizer S. A., Bmssels, Belgium), vancomycin (Eli Lilly & Co., Indianapolis, 
Ind.), rifampin (Sigma), cotrimoxazole, the combination (1:19) oftrimcthoprim (Sigma) Hnd 
sulfamethoxazole (Sigma), and ciprotloxacin (Bayer, Wuppertai, Germany). Breakpoints of 
the antibiotics to discriminate between susceptible and nonsusccptible strains were used 
according to the National Committee for Clinical Laboratory Standards guidelines for 
susceptibility testing (28). 
Bacterial typing. (i) SCl'otyping. Pneumococci were serotyped on the basis of capsular 
swelling (quellung reaction) observed microscopically after suspension in antisera prepared at 
Statens SenUll Jnstitut, Copenhagen, Denmark (11). 
(ii) RFEL analysis. Typing of pneumococcal strains by RFEL was performed as described 
by Van Steenbergen et ai. (40) and adapted by Hermans et ai. (18). Briefly, purified 
pneumococcal DNA was digested by the restriction enzyme EcoRl. The DNA restriction 
fragments were end labeled at noc with [a-32 P) dATP with Taq DNA polymerase 
(Goldstar; Eurogentec, Seraing, Belgium). The radiolabeled fragments \vere denatured and 
separated electrophoretically on a 6% polyacrylamide sequencing gel containing 8 M urea. 
Sllbsequently, the gel \vas transferred onto filter paper, vacuum dried (Hanke Buchler 
Instruments Inc., Saddlcbrook, N.Y.), and exposed for v(Hying periods at room temperature to 
ECL Hyperfilms (Amersham, Little Chalfont, Buckinghamshire, United Kingdom). 
The RFEL types were analyzed with the \Vindows version of the Gelcompar software version 
4 (Applied Malhs, Kortrijk, Belgium) after the RFEL autoradiognulls were scanned with 
Image Master DTS (Pharmacia Biotech, Uppsnla, Sweden). For this purpose, the DNA 
fragments in the molecular size range of 160 to 400 bp were examined. The fingerprints were 
normalized with pneumococcus-specific bands present in the RFEL banding pattems of all 
strains. Comparison of the fingerprints was performed by the ullweighted pair group method 
llsing arithmetic averages and by using the Jaccard similarity cocmcient applied to peaks. 
Computer-assisted analysis, methods~ and algorithms used in this study were carried out or 
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used according to the instmctions of the manufacturer of Gelcompar. A tolerance of I.S% in 
band positions was applied during comparison of the fingerprint patterns. Identical DNA 
types were arbitrarily defined as RFEL homologies higher than 9S%. A genetic cluster was 
defined as a genotype (RFEL or PBP type) that was shared by two or more pneumococcal 
strains. The degree of genetic clustering was defined as the percentage of strains displaying 
genotypes (RFEL or PBP types) that were observed twice or more. 
(iii) BOX peR typing. BOX PCR typing was carried out as described before (39). Briefly, 
50 ng of pneumococcal DNA was amplified by PCR (4 min at 94°C [predenaturation]; 40 
cycles of 1 min at 94°C, I min at 60°C, and 2 min at 74°C; and 2 min at 74°C [extension]), 
with primer BOX-A, designed on the prinuuy structure of the BOX repeat motif. The 
amplified products were separated on a 1.S% agarose gel. Gels were stained with ethidiul1l 
bromide, after which the banding patterns were evaluated visually. BOX peR patterns 
shO\ving a single band difference were defined (IS nonidentical types. BOX PCR Wt!S used as 
a confinnatOlY method to verify genetic clustering observed by RFEL analysis. 
(iv) PBP genotyping. Genetic polymorphism ofthe penicillin resistance genes pbpJa, php2b, 
and pbp2:r was investigated by restriction fragment length polymorphism analysis. To this 
end, we amplified the genes by PCR and analyzed the digested DNA products by agarase gel 
electrophoresis. PCR amplification of the PBP-encoding genes was performed in a SO-~tl 
PCR buffer system containing 75 mM Tris-HCI (pH 9.0), 20 mM (NH4),S04, 0.01% (wt/vol) 
Tween 20, 1.5 mM MgCI" 0.2 mM deoxynucleoside triphosphate, 10 pmol of the individual 
primers, 0.5 U of Golds tar Taq DNA polymerase (Eurogentec, Liege, Belgium), and 10 llg of 
purified chromosomal DNA. Cycling was performed in a PTC~ 100 programmable thermal 
controller (MJ Research, \Vatertowll, Mass.) and consisted of the following steps: 
prcdenaturation at 94°C for I min; 30 cycles of I min at 94°C, I min at S2°e, and 2 min at 
72°C; and final extension at 72°C tor 3 min. The primers used to amplify the genes pbpJa, 
pbplh, and php2x were described previously (7, 10, 26). The amplification prodncts (5 ~tl) 
were digested by restriction endonuclease Hilla <lnd separated by electrophoresis in 2.S% 
agarose gels (S mill thick; Agarosc "[vfP; Boehringer Mannheim, Almere, The Netherlands) 
containing O.S x Tris-borate-EDTA ancl 0.1 ~tg of ethidium bromide per 1111. Gels were run in 
O.S x Tris-boratc-EDTA containing 0.1 pg of cthidium bromide per ml at a constant current 
of 20 mA tor 4 h. Prior to electrophoresis, samples were mixed with a 5 x concentrated layer 
mix consisting of SO% glycerol in watcr and 0.8 mg of bromophenol blue per ml. Gels were 
photographed with a Polaroid MP4 Landcamera and Polaroid 667 films. The different PBP 
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genotypes arc represented by a three-number code (e.g., 01-06-13), ref cITing to the restriction 
fragment length polymorphism patterns of the genes pbpJ a (pattern I), pbp2b (pattern 6), and 
pbp2x (pattern 13), respectively. 
RESULTS 
From 1992 to 1994, the prevalence of penicillin-resistant pneumococci in Thailand was 
detennined during a national antimicrobial resistance survey. This study showed a 
countrywide penicillin resistance rate (MIC of ;'0.1 ~g/ml) of 37.2%; 6.8% of the 
pneumococcal isolates showed high-level resistance to penicillin, whereas 30.4% of the 
isolates were intermediate-level resistant (Table 1). The resistance rates varied from region to 
region, ranging from 17.1% in Hatyai Hospital (southern region) to 59.2% in Phra Buddha 
Chinaraj Hospital (northem region). The latter region had the highest prevalence of high-
level pneumococcal penicillin resistance (28.6%), followed by the Children's Hospital 
Bangkok (central region; 6.9%). Twenty-three of the 26 randomly selected high-level 
penicillin-resistant isolates and 14 of the 27 intermediate-level penicillin-resistant isolates 
were resistant to more than three antibiotics with resistance profile penicillill-trimethoprim-
sulfal11ethoxazole-doxycycline-elythrol11ycin---chloramphenicol, peniciUin-trimethoprim-
sulfamethoxazole-doxycycline--erythromycin, or penicillin-tril11ethoprim-sulfamethoxazole-
doxycyclinc---chloramphenicol. None of the isolates were resistant to vancomycin, rifampin, 
or ciprofloxacin. 
All 53 penicillin-resistant pneumococcal isolates were analyzed by RFEL. This DNA 
fingerprint method divided the strains into 27 distinct types (Fig. 2, Table I). These RFEL 
types represented 13 clusters, i.e., types shared by nyo or more strains, and 14 unique types. 
Thirty-nine strains shared RFEL types with at least one other strain (74%). The cluster size 
varied from two (nine clusters) to 11 strains (one cluster). In addition, two clusters of three 
strains nnd one cluster of four strains were observed. For lO RFEL clusters) genetic identity 
was confirmed by BOX PCR typing. Within the remaining three RFEL clusters, strong 
genetic relatedness was observed by BOX peR typing (data not shown). Although the degree 
of genetic clustering, i.e.) the percentage of strains sharing their RFEL types with one or 1110rc 
other strains, \vas comparable between the groups of high-level and intennediate-level peni-
cillin-resistant strains (high-level, 50%; intennediate-level, 48%), a reduced number of RFEL 
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types was observed among the high-level penicillin-resistant isolates (15 high-level penieillin 
resistance RFEL types and 20 intermediate-level penicillin resistanee RFEL types [Fig. 2]). 
Table I. Prevalence of penicillin-resistant pneumococci among 1,783 ehildren with acute 
respiratOIY tract infectionsa• 
HPRP IPRP 
Hospital No. of No. % No. of randomly No. % No. of randomly % HPRP 
isolates selected for this selected for this phIs IPRP 
study study 
B 216 15 6.9 7 82 38.0 16 44.9 
C 44 2 4.5 2 16 36.4 4 40.9 
K 53 I 1.9 10 18.9 3 20.8 
N 86 3 3.5 2 25 29.1 2 32.6 
P 49 14 28.6 13 15 30.6 2 59.2 
S 82 I 1.2 13 15.9 0 17.1 
Total 530 36 6.8 26 161 30.4 27 37.2 
aData were collccted during the Nntiollal Pncumococcal Antimicrobial Resistance Suryeillance bctwcen 1992 
and 1994. From this collection, 26 high-level and 27 intemlediate-Ievel penicillin-resistant isolates were 
randomly selected for detailed molccular epidemiological analysis. Abbreviations: B, Children's Hospital 
Bangkok; C, Cholburi Hospital; K, Khonkaen Hospital; N, Maharaj Nakom Ratchasima Hospital; P, Phra 
Buddha Chinaraj Hospital; S, Hatyai Hospital; HPRP, high-Ieyel pcnicillin-resistant pneumococci; IPRP, 
intennediatc-Ic\'el penicillin-resistant pneumococci. 
Comparison of the 27 Thai RFEL types with 107 additional types present in the international 
RFEL data Iibraty and representing 15 other countries (15, 16) revealed that the most 
predominant cluster matched the Spanish pandemic clone 23F (RFEL type 15), whereas 
RFEL cluster 23, representing four 9V strains, was identical to the Spanish-French 
international e10ne 9V, respectively. Strain P390, displaying RFEL type 17, was genetically 
identical to a penicillin-resistant pneumococcal strain isolated in The Netherlands. In 
addition, the remaining 24 Thai RFEL types did nolmatch any of the 107 types present in the 
intelllationailibrary. 
The 53 pneumococcal isolates comprised eight distinct serotypes. Tn addition) one strain 
displayed a nontypeable capsular type. The capsular types of the high-level resistant isolates 
were restricted to 6A, 6B, 9V, 19F, and 23F. The intermediate-level penicillin-resistant 
pneumoeocei harbored the serotypes 6A, 6B, 9V, 14, 15B, 15C, 19F, and 23F (Table 2). Six 
of the 13 RFEL clusters consisted of two or more distinct serotypes. The most predominant 
RFEL e1uster, 15, eonsisting of II strains, harbored three distinct serotypes, 23F, 19F, and 14 
(Table 2). Based on the serotype distribution of the 53 penicillin-resistant pneumococci, 89% 
of the strains display capsular types that are covered by the 7-valent conjugate vaccine in 
which the serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F are represented. 
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Fig. 2. Genetic relatedness of 53 penicillin-resistant pneumococcal isolates from Thailand. The RFEL t1ngcrprint 
pattems of the strains (designated by numbers) and their genetic relatedness (denclrograph) are depicted (for 
details, see lex!). High-Ieyel penicillin-resistant isolates are marked in boldface. 
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The 53 penicillin-resistant pneumococcal strains were collected in six hospitals representing 
five regions of the countly: Children's Hospital Bangkok (central region; 11 = 23), Cholburi 
Hospital (eastem region; 11 = 6), Khonkaen Hospital and Maharaj Nakorn Ratchasima 
Hospital (northeastem region; 1/ = 4 and 4, respectively), Phm Buddha Chinaraj Hospital 
(n0l1hern region; 1/ ~ IS), and Hatyai Hospital (southern region; 1/ ~ I). The RFEL clusters 66 
(1/ ~ 2), 67 (1/ ~ 2), 68 (1/ ~ 2), and 70 (1/ ~ 2) were observed in single regions of the counlty, 
whereas the other nine clusters represented isolates collected in two or more regions (Table 
2). 
All strains were analyzed by PBP genotyping. Sixteen distinct PBP genotypes were observed. 
The representative types are summarized in Fig. 3. The PBP types 01-01-01 and 01-10-13 
were the most predominant penicillin resistance types and represented 16 and 10 strains, 
respectively. PBP type 01-01-0 I was obselved in four distinct RFEL types representing five 
distinct regions, whereas PBP type 0 I-I 0-13 was displayed by seven different RFEL types 
representing three distinct regions. F01ll1een PBP type 01-01-01 strains (88%) and four PBP 
type 01-10-13 strains (40%) were high-level penicillin resistant (Table 2). The PBP types 01-
01-01 and 01-10-13 were observed in II and 4 of the 16 countries that are currently 
represented in the international database (15). Twelve of the 16 PBP genotypes were 
Thailand specific, as they were not observed so far in any of the other countries representing 
80 distinct PBP genotypes (15). The pbp2x type 13 was observed in 23 strains isolated in four 
distinct regions of the country and represented 17 RFEL types (Table 2). The vast m'\iority of 
the 23 pbp2x type 13 strains displayed serotype 6B (1/ ~ 20). Comparison of the PBP 
genotypes of the individual genes pbp/a, pbp2b, and pbp2x between the 53 Thai penicillin-
resistant strains and 185 Dutch and 10 Thai penicillin-susceptible pneumococcal isolates (17, 
32) did not demonstrate any overlap (data not shown). 
DISCUSSION 
In Thailand, a national survey conducted from 1992 to 1994 demonstrated a prevalence of 
penicillin-resistant pneumococci of37.2% (1, 29, 37). This figure was mllch higher than that 
demonstrated in the surveys in 1978 (6.7%) (36) and in 1987 (10.6%) (20) (details of the 
1978 and 1987 surveys are available in Materials and Methods). In order to identify the 
nature of the increase in the prevalence of penicillin-resistant pneumococci in Thailand, a 
molecular epidemiological shldy in which 53 penicillin-resistant pneumococcal isolates 
collected from 1992 to 1994 were analyzed in detail was conducted. 
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Table 2. Microbiological parameters of 53 penicillin-resistant pneumococcal isolates and 
demographic data of the patients. 
Strain Hospitala RFEL PDP genotype Serotype Penicillin l>.lId Resistance profilcfi 
type In 2b 2x 
P410 P 39 01 06 13 6B 2.000 PTDEC 
P550 C 39 02 04 41 15B 0.500 P 
P320 B 38 16 01 13 6B 1.000 PTOE 
P386 P 38 01 01 01 23F 2.000 PTDEC 
P042 P 42 02 02 34 19F 0.125 PTDEC 
P519 B 42 11 02 30 19F 0.250 POE 
P390 B 17 01 10 13 6B 1.000 PTOEC 
P276 C 40 14 02 38 14 0.250 POC 
P146 C 41 16 01 13 6B 2.000 PTDE 
P318 B 92 15 02 39 14 0.125 PT 
P218 N 35 02 04 13 15C 0.250 PC 
P520 B 35 02 04 41 15B 0.250 PTDE 
P471 B 50 00 12 01 23F 1.000 PTDE 
P179 K 51 02 05 36 14 0.250 P 
P356 B 51 01 10 13 6B 1.000 PTC 
P246 P 51 02 05 36 14 0.250 P 
P034 C 58 12 09 01 NT' 0.500 PTDC 
P349 N 15 14 02 38 14 0.125 POC 
P077 P 15 01 01 01 23F 2.000 PTDEC 
P053 P 15 01 01 01 23F 2.000 PTDEC 
P176 B 15 01 01 01 19F 2.000 PTDEC 
P193 S 15 01 01 01 23F 2.000 PTDEC 
P462 B 15 01 01 01 19F 2.000 PTOEC 
PIn P 15 01 01 01 23F 2.000 PTOEC 
P210 P 15 01 01 01 23F 2.000 PTDEC 
P469 B 15 01 01 01 19F 2.000 PTDC 
N77 B 15 01 01 01 23F 2.000 PTOEC 
P386 P 15 01 01 01 23F 2.000 PTDEC 
P537 B 48 01 01 01 9V 1.000 PTDE 
N76 B 68 01 03 13 6B 1.000 PTOEC 
P499 B 68 01 03 13 6B 1.000 PTOEC 
P403 C 70 01 10 13 6A 1.000 PTOEC 
P404 C 70 01 10 13 6A 2.000 PTDEC 
P329 B 69 17 03 40 19F 0.500 PDE 
P385 K 69 02 06 36 14 0.125 PT 
N41 B 67 01 03 13 6B 1.000 PTDEC 
P375 B 67 01 10 13 6B 2.000 PTDEC 
P174 B 66 01 10 13 6B 2.000 PTDEC 
P458 B 59 01 10 13 6B 1.000 PTDEC 
P086 P 59 01 03 13 6B 2.000 PTDEC 
P228 B 59 01 10 13 6B 1.000 PTDEC 
P122 B 62 01 10 13 6B 0.060 PTDEC 
P216 N 78 01 10 13 6B 2.000 PTDEC 
P244 P 78 01 06 13 6B 2.000 PTDEC 
P397 B 79 15 02 39 14 0.250 PT 
Nil P 74 01 06 13 6B 2.000 PTOEC 
P543 P 75 01 06 13 6B 2.000 PTOEC 
P409 P 76 01 06 13 6B 2.000 PTOEC 
P304 B 77 01 03 13 6B 2.000 PTOEC 
P165 P 23 01 01 01 9V 2.000 PT 
P353 N 23 01 01 01 9V 2.000 PT 
P1l7 K 23 01 01 01 9V 1.000 PT 
P384 K 23 01 01 01 9V 2.000 PT 
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'B, Children's Hospital Bangkok; C, Cholburi Hospital; K, Khonkacn Hospital; N, Maharaj Nakom Ratchasima 
Hospital; P, Phra Buddha Cbinaraj Hospital; S, Hatyai Hospital. 
~esjstancc profile: P, penicillin; T, trimethoprim-sulfamethoxazole; D, doxycycline; E, erythromycine; C, 
chlorampllenicol. 
<NT, Ilontypeable 
d1HCs are illl11icrograms per milliliter 
RFEL analysis of 53 penicillin-resistant pneumococcal isolates that were collected from 
children with acute respiratOlY tract infections in five distinct regions divided the strains into 
27 distinct types, These RFEL types represented 13 clusters, i.e" types shared by two or more 
strains, and 14 unique types. Thirty-nine strains shared RFEL types with at least one other 
strain (74%). The degree of clustering among the penicillin-resistant isolates was comparable 
with that of data obtained in The Netherlands (17), a country with a velY low prevalence of 
penicillin resistance «1%). These data clearly demonstrate that the transmission behavior of 
these strains is comparable in both countries. The cluster size varied from two (nine clusters) 
to II strains (one cluster). The most predominant RFEL cluster, representing 21% of the 
isolates, was identical to the Spanish pandemic clone 23F (RFEL type 15) (26), In addition, 
the second largest RFEL cluster (RFEL type 23; four isolates) matched the Spanish-French 
intemational clone 9V (13), These data indicate that the pandemic clones 23F and 9V, which 
are widely spread throughout the world (15, 16, 38), are the 1110st predominant 111ultidrug-
resistant pneumococcal clones in Thailand. 
Although the five regions were not equally represented by pneumococcal isolates, 
geographical distribution of the genotypes among the five Thai regions demonstrated that 
only the RFEL clusters 66 (/I ~ 2), 67 (/I ~ 2), 68 (/I ~ 2), and 70 (/I ~ 2) were observed in 
single areas of the country, whereas the other nine clusters represented isolates collected in 
two or more districts. These data clearly suggest the national spread of the majority of the 
RFEL clusters, The majority of the RFEL types (24 of 27 types) were Thailand specific, as 
they did not match with any of the 107 RFEL types representing 15 other countries, In 
addition, the PBP genotypes also suggest a Thailand-specific origin: the majority of the PBP 
types (12 of 16 types) were not observed in the intemational collection. Nevertheless, since 
the pandemic clones 23F and 9V are Illost predominantly present in Thailand, we conclude 
that these imported clones are primarily responsible for the high prevalence of pneumococcal 
penicillin resistance in this countty. 
The increasing rate of antibiotic resistance in S. pnellnlolliae complicates the elimination of 
pneumococci by therapy and strongly supports the application of new vaccine strategies. 
Conjugate capsular vaccines contain a limited number of capsular serotypes, linked to a 
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pbpla 
1 2 11 1214 1516 17 
1018 -
506 -
344 -
220 -
154 -
pbp2b pbp2x 
1 2 3 4 5 6 9 10 12 113 30 34 36 38 39 40 41 
Fig. 3. DNA fingerprint pattems of the pbp/a (n = 8), pbp2h (1/ = 9), and pbp2x (1/ = 9) genotypes 
represented by the 53 Thai penicillin-resistant pneumococcal strains. Lime numbers indicate PBP genotype 
codes. Numbers at the left indicate the sizes ofslundard DNA fragments in base pairs. 
carrier protein (3, 9). Although the results of early trials \vitlt these vaccines look promising, 
care should be taken since several investigators have observed horizontal transfer of capsular 
genes (2, 15-17). Horizontal transfer of capsular genes may interfere with vaccination 
programs in the long run if (antibiotic-resistant) strains with a vaccine-type capsule switch to 
nonvaccine capsular types, In Thailand, horizontal transfer of capsular genes appears to occur 
frequently. Six of the 13 RFEL clusters consisted of hvo or more distinct serotypes. The 
pandemic clone 23F (RFEL cluster 15; II strains), harbored three distinct serotypes, 23F, 
19F, and 14. Based on the serotype distribution of the 53 pellicillin~resistant pneumococci, 
89% of the strains display capsular types that are covered by the 7~valent conjugate vaccine. 
However, it is imp0l1ant to notice that in the collection investigated in this study the number 
of high-level penicillin-resistant isolates is over represented. Since the number of non-vaccine 
serotypes is highcr in the group of intermediate-level resistant isolates, vaccine coverage of 
penicillin-resistant pneulllococci (M1C of <:0.1 ~tg/llll) is therefore expected to be lower than 
calculated. 
The emergence of resistant strains and the rapid sprcad of resistant clones raise the need for 
an effective global surveillance system. Detailed studies on the epidemiology and epidemic 
behavior of (multi)resistant pneumococci will assist in identifying emerging clones. To this 
respect, close collaboration behvecn the laboratories sharing interests in pneumococcal 
molecular epidemiology is of utmost importance. Extensive collaboration can be facilitated 
by the establishment of a freely accessible electronic network. Such a network can be used to 
exchange epidemiological information. Consequently, this network can be used to constlllct 
and distribute an international data library containing DNA fingerprints of (multi)resistant 
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pneumococcal strains. This approach will facilitate adequate worldwide monitoring of the 
epidemiology of emerging (multi)resistant pncumococcal strains. 
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SUMMARY 
Recently, a nation-wide molecular epidemiologic survey of pcnicillill-llonsusceptiblc 
Streptococcus pnellmolliae has been perfonned jn The Netherlands. In the cun'ent study, we 
analyzed the pbp genes from these clinical isolates in detail. The pneumococcal strains ,vere 
selected on the basis of differences in restriction fragment length polymorphism (RFLP) 
pattenlS of the complete genes pbp/a, pbp2b and pbp2x, representing 8, 7 and 10 distinct 
pattems, respectively. We characterized specific gene parts of pbp/a (nucleotide position 
1741 to 2229),pbp2b (nucleotide position 1211 to 1714) andpbp2x (nucleotide position 1241 
to 1786). Classification based upon sequence analysis of these pbp fragments correlated well 
with the classification according to RFLP analysis. Sequence analysis of pbp2h enables a 
refinement of the classification based on RFLP analysis. However, sequence analysis of 
pbp I a and php2x was less discriminatory compared to RFLP analysis. The mutations in the 
pbp sequences of the Dutch isolates invariably matched with the mutations described in pbp 
sequences of penicillin-nonsusceptible pneumococci isolated in other countries. This 
observation supports the hypothesis that multiple clones of penicillin-resistant pneumococci 
have been imp0l1ed and spread in The Netherlands. Interestingly, novel combinations of 
mosaic stmctures were also identified indicating horizontal exchange of pbp gene parts 
among penicillin-nonsusceptible pneumococci. 
INTRODUCTION 
Streptococcus pneumoll;ae is a common cause of serious and life-threatening infections, such 
as pneumonia, bacteremia and of noninvasive infections such as otitis media and sinusitis. 
Ever since the beginning of the antibiotic era, penicillin has been the first choice dntg against 
pneumococcal infections. However, in the last 20 years, increasing numbers of penicillin-
nonsusceptible pneumococcal clinical isolates with rising MIC values have been isolated 
(II). 
Penicillin resistance in S. pneu1I1onz'ae has emerged through the development of altered 
penicillin-binding proteins (PBPs), ,,,hich show a decreased affinity for penicillin and other 
p-Iactam antibiotics. PBPs are membrane-bound D,D-peptidases, which catalyze the 
transpeptidation reaction that cross-links the peptidoglycan of the bacterial cell wall. The p-
lactam antibiotics interact with the PBPs and fonn a covalent pellicilloyl complex via the 
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active-site serine resulting in an inactivated enzyme. In penicillin-susceptible pneumococci, 
this interaction results in cellular lysis (4, 11). S. plleulJlol1iae contains six PBPs: the high 
molecular weight proteins PBPla, PBPlb, PBP2a, PBP2b and PBP2x, and the low molecular 
weight protein PBP3. In clinical isolates, altered PBP2b and PBP2x are the primary 
resistance determinants, i.e. they confer low-level resistance when introduced into sensitive 
strains, whereas alterations in PBPla contribute to an increase in resistance levels (10, 13). 
The alterations in the PBPs are due to the fonllation of a mosaic structure of the genes, 
presumably as a result of horizontal gene transfer. The pbp genes of nonsusceptible isolates 
are composed of mosaic blocks that share identity with pbp genes from sensitive isolates and 
blocks that are identical to pbp genes from Streptococcus mitis, Streptococcus sanguis and 
Streptococcus araUs (23). It is therefore suggested that the mosaic pbp gencs are the result of 
intcrspecies recombination. Some mosaic pbp genes are composed of a single block from 
viridans streptococci, whereas others are the result of complex multiple recombination events 
involving several donors (6). The presence of an enonnous diversity of mosaic pbp genes 
suggests that resistance to penicillin has arisen on many indepcndent occasions. These 
recombination events have resulted in multiple amino acid substitutions in the PBPs. Several 
amino acids are essential for the interaction of the PBPs with J3-lactam antibiotics. 
Substitutions of these amino acids often result in a reduction of affinity and consequently in 
reduced penicillin susceptibility. Most mutations which confer resistance occur close to the 
motifs SXN or KT/SG, or close to the active-site serine \vhich is part of the conserved STMK 
motif (II, 12). 
\Ve have recently investigated the epidemiologic characteristics of penicillin-nonsusceptible 
pneumococci in The Netherlands in a nation-wide survey (16). The penicillin-nonsusceptible 
clinical isolates have been analyzed by restriction fragment length polymorphism (RFLP) 
analysis of the genes pbpJa, pbp2b and pbp2x. In this Shldy, we sequenced gene parts of 
pbpJa, pbp2b and pbp2x representing distinct RFLP patterns. These data were used to 
investigate the correlation between pbp RFLP analysis and pbp sequence analysis, and to 
identify the molecular nahlre of pneumococcal penicillin resistance in The Netherlands. 
MATERIALS AND METHODS 
Bacterial strains, growth conditions and growth medium. PenicillitHlonsusceptible 
pneumococcal strains were isolated from patients in The Netherlands between March 1995 
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and March 1996. Their epidemiological characteristics have been described previously (16). 
The majority of the strains were isolates from patients with pneumococcal pneumonia. 
Clinical isolates representing distinct restriction fragment length polymorphism patte01s of 
pbpJa, pbp2h and pbp2x, respectively, were used for nucleotide sequence analysis of their 
pbp genes. The pneumococcal strains repOIied in this study arc listed in Fig. 1 to 3. The 
penicillin MICs of these strains ranged from 0.12 to 2 ~lg/ll11. Bacteria were culhlred at 37°C 
on Columbia agar supplemented with 5% sheep blood (Oxoid, Basil1gstoke, United 
Kingdom) in an atmosphere of increased C02. Bacterial colonies were inoculated in Todd~ 
Hewitt broth (Difco laboratories, Detroit, USA) supplemented with 0.5% ycast extract (Difco 
laboratories; THY broth) and grown at 37'C. 
PDP gcnotyping. Genetic polymorphisms of the penicillin resistance genes pbp/a, pbp2b, 
and pbp2x wcre investigated by restriction fragment length polymorphism (RFLP) analysis as 
described previously (16). Briefly, chromosomal DNA was extracted with cetyl 
trimethylammonium bromide (26). PCR amplification of the PBP~encoding genes \vas 
performed in 50 ~ll reactions containing 75 mM Tris-HCI (pH 9.0), 20 mM (NH4),S04, 
0.01% (\\1Ivol) Tween 20, 1.5 111M MgCI" 0.2 mM deoxynucleoside triphosphates, 10 pmol 
of the individual primers, 0.5 U of DNA polymcrase (Eurogentec, Liege, Belgium), and 10 
ng of purified chromosomal DNA. Cycling was perfonued in a PTC-IOO Programmable 
Thermal Controller (MJ Research, \Vatertowll, USA) and consisted of thc following steps: 
prcdcnaturation at 94°C for 1 min, 30 cycles of I min at 94°e, 1 min at S2°e, 2 min at 72°e, 
and a final extension at 72°C for 3 min. The primcrs used to amplify the genes pbpJa, pbp2b, 
and pbp2x were described previously (scc Table I). The amplification products (5 ~ll) were 
digested with the restriction endonuclease Hh!tI and separated by electrophoresis in 2.5% 
agarosc gels, Gels were scanned and printed with thc Geldoc 2000 systcm (Biorad, 
Veenendaal, The Netherlands). The ditTerent PBP genotypes are represented by a three-
number code (e.g., 06-14-43), referring to the RFLP patterns of the genes pbpla (pattern 6), 
pbp2b (pattern 14), and pbp2x (pattern 43), respectively. The PBP RFLP codcs used in this 
study refer to those described previously (16). 
Nucleotide sequence analysis. Nucleotide sequencing \vas performed on parts of the 
penicillin~binding domain of pbpJa, of pbp2b, and of pbp2x, respectively, from the 
pneumococcal strains mentioned in Fig. 1 to 3. The primer pairs Pbpla.fw/Pbpla.rev, 
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Pbp2b.fw/Pbp2b.rev and Pbp2x.fwlPbp2x.rev were used to amplify nucleotides 1723 to 2350 
of pbpla. nucleotides 1199 to 1734 of pbp2b, and nucleotides 1217 to 1796 of php2x, 
respectively (Table I). The numbering is based on published data for strain R6 [phpla (20), 
pbp2b (9), pbp2x (18)]. PCR-amplification was performed as described above in 100 fli 
reactions with 50 ng of purified pneumococcal chromosomal DNA. The PCR products 'vere 
separated by electrophoresis in 1% agarose gels, cut from gel and puritied ''lith the QIAquick 
Gel Extraction kit (Qiagcn, \Vcstburg, Leusden, The Netherlands). Purified templates were 
sequenced with the Prism Ready Reaction Sequence Kit (Perkin Elmer, Roosendaal, The 
Nctherlands) and 50 pmol of the primers Ml3.fw and MI3.rev (Table 1). Sequencing was 
performed on an Applied Biosystems Prism 377 (PE Applied Biosyslems, Nieuwerkerk, The 
Netherlands). The nucleotide and deduced amino acid sequences were compared to the 
published sequence of php 1 a (20). php2h (9) and pbp2x (18) from the penicillin-susceptible 
strain R6 with BioEdit Sequence Alignment Editor (15). With the BLAST algorithm (I), the 
nucleotide sequences were analyzed for similarity to sequences deposited in the April 2000 
version of the nucleotide database at the National Center for Biotechnology Infonnation 
(Washinton D.C., USA). 
Table 1. Primers used in this study. The underlined sequence patis of the primers Pbpla.fw, 
Pbpla.rev, Pbp2b.fw, Pbp2b.rev, Pbp2x.fw, Pbp2x.rev represent M13-based sequences. 
primer name 
PnlAup 
PnlAdown 
Pn2Bup 
Pn2Bdown 
Pn2Xup 
Pn2Xdown 
Pbpla.fw 
Pbpla.rev 
Pbp2b.fw 
Pbp2b.rev 
Pbp2x.f\v 
Pbp2x.rev 
MI3.f\v 
Ml3.rev 
primer sequence 
CGGCATTCGA TTTGATTCGCTTCT 
CTGAGAAGATGTCTTCTCAGG 
GATCCTCTAAATGATTCTCAGGTGG 
CAATTAGCTTAGCAATAGGTGTTGG 
CGTGGGACTATTTATGACCGAAATGG 
AATTCCAGCACTGATGGAAATAAACATATTA 
TGTAAAACGACGGCCAGTCAAAGTCTCAAATCAGCAAG 
CAGGAAACAGCTATGACCGTTGTGTTACTTGAAATGGC 
TGT AAAACGACGGCCAGTCTGAAAAGTTATTTCAA TTC 
CAGGAAACAGCTATGACCAA WCCAGTWGA YTCATCTGG 
TGTAAAACGACGGCCAGTAAAATGGGAGATGCTAC 
CAGGAAACAGCTATGACCTGGATACCTGAATAATG 
TGTAAAACGACGGCCAGT 
CAGGAAACAGCTATGACC 
reference 
(5) 
(5) 
(8) 
(8) 
(22) 
(22) 
this study 
this study 
this study 
this study 
this study 
this study 
Nucleotide sequence accession numbers. The pbpJa sequence data for the following 
clinical isolates were submitted to the EMBL/GenBank databases under the indicated 
aecessionnlllllbers (acc. nos.): isolate 950225, AJ403974; isolate 960036, AJ403975; isolate 
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950710, AJ403976; isolate 950421, AJ403977; isolate 950423, AJ403978; isolate 950473, 
AJ403979; isolate 960027, AJ403980 and isolate 950035, AJ403981. The pbp2b sequence 
data for the following clinical isolates have been submitted to the EMBL/GenBank databases 
under the indicated ace. nos.: isolate 950279, AJ278222; isolate 950961, AJ278223; isolate 
950901, AJ278224; isolate 950138, AJ278225; isolate 960118, AJ278226; isolate 960035, 
AJ278227; isolate 960036, AJ278228; isolate 960030, AJ278229; isolate 954073, AJ278230 
and isolate 960097, AJ278231. The pbp2x sequence data for the following clinical isolates 
have been submitted to the EMBL/GenBank databases under the indicated acc. nos.: isolate 
950181, AJ278232; isolate 950138, AJ278233; isolate 950423, AJ278234; isolate 960036, 
AJ278235; isolate 950454, AJ278236; isolate 950961, AJ278237; isolate 950637, AJ278238; 
isolate 950925, AJ278239, isolate 960097, AJ278240; and isolate 960165, AJ278241. 
RESULTS 
Sequence heterogeneity in pbpJ a of penicillin-II 011 susceptible pneumococcal isolates. We 
sequenced nucleotides l741 to 2229 ofpbp/a from 44 Dutch clinical pneumococcal isolates 
representing eight distinct pbpJa RFLP types. The pbpJa nucleotide sequences from strains 
representing identical pbpJa RFLP types were invariably identical (data not shown). A 
representative strain of each pbpJa RFLP type was chosen for sequence comparison. Fig. 1 
provides a schematic illustration of the rnosaic stlllchlres of pbp J a. 
The nucleotide sequences and deduced amino acid sequences of pbp J a obtained from the 
RFLP type I and 10 strains were identical (Fig. I). Nucleotides 1741 to 1789 difTered from 
the penicillinMsusceptibJe strain R6 by one synonymous substihltion, nucleotides 1790 to 
2039 were identical to pbp/a from S. lIIitis strain B6 (ace. no. AJ002290) (14), and 
nucleotides 2040 to 2229 differed from strain R6 by II synonymous substitutions and II 
nonsynonymous substihltions resulting in eight amino acid changes (Thr371Ala, Leu382T1e, 
Glu388Asp, Ile393Met, His395Asn, Glu397Ile, Asn405Ser, Gly414Ala) (Fig. I). The pbpJa 
sequences ofRFLP types I and 10 matched with the pbpJa sequence of S. pnellllloniae strain 
D isolated in Spain (21) and S. p"eulllo"iae strains #51H31 and # 17/246 isolated in Japan (3). 
Patt ofpbp/a of the RFLP type 3 strain (nucleotides 1880 to 2229) and part ofpbpJa of the 
RFLP type 6 strain [nucleotides 1920 to 2229 except for five synonymous substitutions and 
one nonsynonymous substitution (Ala371 Thr)] were identical to pbp / a of RFLP type I and 
10 strains (Fig. I). The pbpJa regions of the RFLP type 2 and 5 strains were identical and 
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differed from strain R6 by two synonymous substitutions and a single nonSYllonymous 
substitution (Glu388Asp) (Fig. 1). Interestingly, this substitution occurred in the deduced 
amino acid sequences from all isolates analyzed in this study. The pbpJa sequences ofRFLP 
type 2 and 5 strains were identical to S. jJnellfllolliae strain C, a penicillin-susceptible strain 
isolated in South Africa (21). The pbpJ a sequence of the RFLP type 4 strain differed in seven 
additional synonymous substihltions and one additional nonsynonymous substihltion 
(Asn405Asp) (Fig. I). pbp J a of RFLP type 2, 4, and 5 strains were highly homologous to 
pbpJa of S. plleulIlolliae strain #23/HSB21 isolated in Japan (3). The pbpJa nucleotide and 
deduced amino acid sequence of the RFLP type 7 strain differed significantly from the 
previous sequences, and differed from stmin R6 by 52 synonymous substihltions and 13 
nonsynonymous substihltions resulting in 12 amino acid changes (Ala347Ser, Thr371Ala, 
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Gly385Asp, Va1386Ile, Glu388Asp, Thr392Ser, Glu397Val, Asn405Asp, Va1408Leu, 
Arg413Lys, Gly414Val, Leu42 I lie) (Fig. I). The partialpbpJa sequence of the RFLP type 7 
was homologous to S. pneu1110niae strain #14/Z42 isolated in Japan (3). Interestingly, the 
amino acid substitution Thr371 Ala was found in all high-level penicillin-resistant strains. 
Sequence heterogeneity ill pbp2b of pcnicillin-nonsusceptiblc isolates. \Ve sequenced 
nueleotides 1211 to 1714 of pbp2b from 57 Dutch clinical pneumococcal isolates 
representing seven distinct pbp2b RFLP types. The pbp2h sequences from strains 
representing identical pbp2b RFLP types were identical for RFLP types 2, 4 and 5, 
respectively (data not shown). In contrast, the pbp2b nucleotide sequences from stmins 
representing RFLP type I could be divided into two sequence types designated type IA and 
I B. In addition, the pbp2h nucleotide sequenccs from strains representing RFLP type 3 could 
be divided into three sequence types designated type 3A, 3B and 3C. RFLP types 7 and 8 
were represented by one strain each. A representative strain of each RFLP type and scquence-
type, respectively, was chosen for sequence comparison (Fig. 2). 
The pbp2b sequence of the RFLP type I A strain was identical to pbp2b from the penieillin-
resistant S. sanguis strain 1907 (ace. no. M32226), except for one synonymous substitution 
(Fig. 2). In addition, this pbp2b fragment was identical to pbp2b of S. pnellflloniae strains 
SPI470 isolated in France (acc. no. AF210766), MI5 isolated in the United Kingdom (acc. 
no. AJ243054), 577 isolated in the United Kingdom (ace. no. AJ243053) and 56762 isolated 
in South Africa (ace. no. U20080).pbp2b of the RFLP type IB strain was in Pali identical to 
the pbp2b sequence of the RFLP type 3A strain (nucleotides 1211 to 1402) and in part to the 
pbp2b sequence of the RFLP type IA strain (nucleotides 1403 to 1714) (Fig. 2). The pbp2h 
fragment of the RFLP type 3A strain was identical to php2b of S. //litis strain 86 (ace. no. 
AJ002289), except for one nonsynonymous mutation (Ile382Val) (Fig. 2). In addition, this 
pbp2h fragment was identical to penicillitH'esistant S. oralis strain 5296 (acc. no. M32228), 
except for one synonymous mutation and onc nonsynonymous mutation (I1e382Val). The S. 
pneufIlolliae strain 52328 isolated in South Africa (acc. no. U20073) also contained the same 
pbp2b sequence, except for two synonymous mutations. The pbp2b fragment of the 
pneumococcal RFLP type 3B strain was identical to that of the RFLP type 3A strain, with the 
exception of the fragment formed by nucleotides 1227 to 1279, which was identical to that in 
the penicillin-susceptible strain R6 (Fig. 2). pbp2b of the RFLP type 3C strain was in part 
homologous to the R6 sequence (nucleotides 1211 to 1391) differing in 6 synonymous 
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mutations and one llonsynonymous mutation (Glu368Asp). and in part identical to pbp2b of 
RFLP type 3A and 3B strains, except for one synonymous mutation (Fig. 2). pbp2b of the 
RFLP type 2 strain contained 26 synonymous substitutions and 9 nonsynonymous 
(Glu332Gly, Gln426Ala, Ala427Phe, Tyr428Ser, Gly429Arg, Ser430Pro, Phe43lMet, 
Thr445Ala, Glu475Gly) substitutions compared to the R6 sequence. The pbp2h fragment of 
this strain was identical to S. p"eu11Ioniae strains DN87/669 isolated in the United Kingdom 
(acc. no. M25521) and 8249 isolated in South Africa (acc. no. M25520), except for one 
synonymous substitution (7). The pbp2b fragment of the RFLP type 4 strain contained 22 
synonymous substitutions and three nonsynonymous (Ser4 II Pro, Tlu445Ala, Glu475Gly) 
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substitutions compared to the R6 sequence and was not identical to any of the published 
sequences present in databases (Fig. 2). The pbp2b fragment of the RFLP type 5 strain 
differed in 49 synonymous mutations and 11 nonsynonymous mutations resulting in 10 
amino acid changcs (Ser41IPro, Gln437Glu, Thr445Ala, Leu454Ile, Gly466Leu, Ser468Asn, 
Glu475Gly, Gly482Ala, Thr488Ala, Ala489Ser) from pbp2b of strain R6 and was identical to 
pbp2b of S. pneumoniae strain SP 1513 isolated in France (acc. no. AF210762) (Fig. 2). Part 
of the pbp2b fragment of the RFLP type 5 strain (nucleotides 1460 to 1714) was homologous 
to pbp2b of S. mitis strain NCTC 11189 (acc. no. Z22183). In this fragment, we obscrvcd II 
synonymous mutations and 4 amino acid substitutions (Thr445Ala, Gly466Leu, Ser468AsIl, 
Ala480Ser) compared to the S. mitis sequence, while 40 synonymous mutations and the 11 
nonsynonymous mutations (Sel"411 Pro, Gln437Glu, Thr445Ala, Leu454Ile, Gly466Leu, 
Ser468Asn, Glu475Gly, Gly482Ala, Thr488Ala, Ala489Ser) were observed compared to the 
R6 sequence (Fig. 2). pbp2b of the RFLP type 7 and 8 strains were in part identical to php2b 
from the RFLP type 5 strain (Fig. 2). The pbp2b sequence of the RFLP type 7 strain differed 
in llllcleotidcs 1211 to 1455 from the R6 sequence by eight synonymous substitutions and 
two non synonymous substitutions (Glu332Gly, Jle360Leu), was identical to pbp2b of the 
RFLP type 8 strain for nucleotides 1456 to 1714, and, except for two synonymous mutations, 
was identical to pbp2b of the RFLP type 5 strain for nucleotides 1528 to 1714 (Fig. 2). pbp2b 
of thc RFLP type 8 strain was identical to pbp2b of R6 for nueleotides 1211 to 1455 and to 
pbp2b of the RFLP type 7 strain for nueleotides 1456 to 1714 (Fig. 2). The Thr445Ala 
substitution was found in all penicillin-nonsusceptible strains we investigated. In addition, the 
Glu475Gly substitution was found in all pbp2b sequence types of our strain collection. Six 
consecutive substitutions at residues 426 to 431 were found in pbp2b RFLP type 2 only. 
Sequence heterogeneity in pbp2x of penicillin-nonsusceptiblc strnins. \Ve sequenced 
nueleotides 1241 to 1786 of pbp2x from 53 Dutch clinical pneumococcal isolates 
representing 10 distinct RFLP types. The pbp2x nucleotide sequences from strains 
representing identical php2x RFLP types were identical as far as RFLP type 1,4, 6, 8, and 20 
was concerned, except for two or less synonymous point mutations observed in RFLP type 1. 
The RFLP typcs 7, 13,22,25 and 31 were represented by single strains. A representative 
strain for each pbp2x RFLP type was chosen for sequence comparison (Fig. 3). 
The pbp2x DNA ti'agments of the RFLP type 1,8 and 13 strains were identical in nucleotide 
and deduced amino acid sequence (Fig. 3). This sequence type shared identity with pbl'2x of 
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S. oratis strain U5 (acc. no. YI0536), andpbp2x of S. mitis strains 476 (ace. no. YI0534) and 
197 (acc. no. YI0533). In addition, the pbp2x sequence ofRFLP type 1,8 and 13 strains was 
identical to pbp2x of S. p"e"lllo"iae strain 577 isolated in the United Kingdom (19) and S. 
pneumoniae strains 341H31 and 31IKU5 isolated in Japan (2), The pbp2x fragment from the 
RFLP type 4 strain was identical for the nucleotides 1319 to 1786 with pbp2x from RFLP 
type I, 8 and 13 strains. The 5' part of the sequence (nucleotides 1211 to 1318) differed from 
pbp2x of strain R6 by 14 synonymous mutations and one nonSYllonymous mutation 
(Ala434Ser) (Fig. 3). The pbp2x fragment of the RFLP type 6 strain was highly homologous 
to pbp2x of S. lIIilis strain 10712 (ace. no. X78216), and differed in 10 synonymous 
substitutions and 5 nonsynonymous substitutions (Asp488Asn, Lys493Arg, Ser509Gly, 
Gln552Glu, Tyr568Asn) (Fig. 3). The pbp2x fragment of the RFLP type 6 strain was 
identical to pbp2x of S. pl1clmlOn;ae strain FI isolated in France (ace. no. AJ238581), except 
91 
Chapter 5 
for two synonymous substihltions. pbp2x of the RFLP type 31 strain was identical to pbp2x 
RFLP type 6 sequences, except for five synonymous substitutions (Fig, 3), The pbp2x 
sequence of the RFLP type 25 strain differed from pbp2x of the R6 sequence in 56 
synonymous substitutions and 6 llonsynonymous substihltions (Va1456Ala, LenSIOOln, 
Asn514His, Leu565Thr, Asp567 ASIl, Ser576Asn) (Fig, 3), The pbp2x sequence of the RFLP 
type 25 strain was identical to pbp2x of S. pllell11loniae strain 53139172 isolated in Papua New 
Guinea (19), pbp2x of the RFLP type 7 strain wos in Palt homologous to pbp2x of the RFLP 
type 25 strain, in part to pbp2x ofRG, and in part to pbp2x of the RFLP type 6 and 31 strains 
(Fig, 3): nucleotides 1241 to 1345 of pbp2x of the RFLP type 7 strain were identical to p/)p2x 
of the RFLP type 25 strain except for two synonymous mutations, nucleotides 1346 to 1650 
were identical to pbp2x of strain R6 except for nvo synonymous lllutations, and nucleotides 
1651 to 1786 were identical to pbp2x of strains representing RFLP types 6 except for two 
synonymous mutations. The pbp2x sequence of the RFLP type 20 strain differed from R6 in 
60 synonymous substihltions and 12 nOllsynonymous substitutions (Gln447Met, Ser449Ala, 
lle462Leu, Tle483Leu, Va151611e, Gln552G1u, Leu565Ser, Asp567 Asn, Tyr568Asn, 
Ala572Val, Ser574Ala, Ser576Asn) (Fig, 3), The pbp2x RFLP type 20 sequence was 
identical to pbp2x of S. pnetlf1loniae strains SP1258 isolated in France (ace. no. AF210756) 
and 669 isolated in the United Kingdom (ace, no, X65133) (19), The sequenced pbp2x 
fragment of the RFLP type 22 strain was homologous to php2x of S, lIIitis strain 10712 (ace, 
no, X78216) although 32 synonymous and 5 nonsynonymous substitutions (VaI423I1e, 
Asp488Asn, Thr490Ser, Gln552Glu, Tyr568Asn) were present. pbp2x of the RFLP type 22 
strain was identical to pbp2x of S. plleulllolliae slrain SPl513 isolated in France (acc. no. 
AF210754), except for one nonsynonymous substitution (AsIl567His). 
IJISCUSSION 
Pncumococcal isolates express six PBPs. iVfany penicillin-nonsusccptible isolates arc 
modified in PBPla, PBP2b and PBP2x only (12). If one or more amino acids change in Ihe 
conserved amino acid motifs SXXK (with active site serine), SXN and K(H)T(S)G or 
adjacent amino acids, penicillin and other p-Iactam antibiotics are otten unable to binel 
efficiently 10 PBPs, which results in resistance. 
RFLP analysis has previously been performed to clmracterize pbpJa, pbp2b and pbp2x from 
penicillin-nonsusceptible strains isolated in The Netherlands that displayed a wide range of 
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MIC levels (0.12 to 2 Itg/m!) (16). In this study, we characterized parts of thc DNA 
sequences ofpbpJa, pbp2b and pbp2x of these clinicnl isolntes. The classification based on 
sequence analysis of the pbp fragments correlated well with the clnssitlcation according to 
pbp RFLP analysis. Sequence analysis of the pbp2b fragment (nucleotides 1211 to 1714) 
enables a refinement of the clnssification based on RFLP analysis of the complete pbp2b 
gene. The pbp2b RFLP types 1 and 3 were divided into sequence types lA and IB, and 3A, 
3B and 3C, respectivcly. However, the classification ofthe pbp2b RFLP types 2, 4, 5, 7 and 8 
was maintained after sequence nnalysis. \Ve were unable to differentiate within the pbpJa 
RFLP types by pbpJa sequence analysis ofnucleotides 1741 to 2229. Moreover, strains with 
pbpJa RFLP types I and 10, and strains with RFLP types 2 and 5 were classified to the same 
sequence type, respectively, In addition, we were not able to subdivide pbp2x RFLP types by 
sequence analysis of pbp2x nucleotides 1241 to 1786 and strains with pbp2x RFLP type I, 8 
and 13 were classified to the same sequence type. 
Most of the pbp sequences characterized in this study matched with pbp sequences from 
strains isolated in other countries, Martin et al. described pbpJa sequence parts of eight 
resistant isolntes (21) and Asnhi et a!. classified pbpJa and pbp2x sequences from clinical 
isolates into live sequence types (I to V) cach (2, 3). All pbpJa sequence types identified in 
this study could be matched with pbp/a sequences described by both research groups, The 
pbp2x sequences of RFLP type 1,8 and 13 strains were identical to pbp2x sequence types IV 
lind V (2). In addition, the pbp2x sequences or the RFLP type 20 and 25 strains matched with 
sequences described by Laible et a!. (19). Dowson and colleagues have divided pbp2b li'om 
penieillitH'esistant isolntes in two classes, A and B (7), pbp2h RFLP type IA was similar to 
class B pbp2b, and pbp2b RFLP type 2 belongs to class A pbp2b. All other pbp2b RFLP 
types described in this study did not match any of the classes A or B, pointing to the 
limitations of Dow son IS classification, 
Interestingly, penicillin-llo11s11sccptible strains with php sequences tlwt were highly 
homologous to pbpJa sequences from susceptible strains were intennediately resistant. In 
contrast, penicillin-noll susceptible strains with a high degree of heterogeneity in their pbp 
sequences compared to sllsceptible strains have oneil MIC levels of21 pg/ml. The difference 
in penicillin susceptibility between strains belonging to the sallle sequence type lllay be due 
to <Imino acid alterations in non-sequenced parts oflhc pellicillill~binding domain and in other 
pbp genes. 
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All prominent PBPla amino acid substitutions in penicillin-nonsusceptible isolates described 
by Smith el al. (24) were also obselved in this study. The amino acid change Asn405Asp was 
previously identified as being one of the prominent amino acid substitutions in pbpJa of 
resistant isolates (24). In addition, we confirmed that the Thr371Ala substitution in PBP1a 
was impOliant for high-level resistance (3), since all high-level penicillin-resistant strains 
contained this substitution. The PBPla amino acid substitution Glu388Asp, which has been 
identified in all pcnicillin-nollsusceptible isolates in this study, also occurs in susceptible 
strains. This substitution is probably not able to confer penicillin resistance (24). The amino 
acid substitutions found in PBP2b in strains of our collection confinned the previously 
described amino acid substitutions in penicillin-resistant isolates (8, 25, 27). The Thr445Ala 
substitution was found in all penicillitHl0nsusceptibie strains adjacent to the Ser443-Ser-Asn 
motif, and its importance has previously been noted by Dowson and cmvorkers (8). The ASH 
residue of this motif has been proposed to form a hydrogen bond with the carbonyl group of 
the RI side chain of penicillin, and the Thr445Ala substitution presumably dismpts this 
hydrogen bond (8). The signifieance of Glu475Gly has been noted by Smith and Klugman 
(25), and was found in all pbp2h sequence types of our strain collection. In addition, the six 
consecutive residues at amino acid position 426 to 431 found in pbp2h RFLP type 2 were 
previously described (25). Since these residues do not occur in other sequence types, they are 
presumably not critical to resistance developmcnt. j\10st of the PBP2x amino aeid 
substitntions found in this study were also described previously (2, 17, 19). The amino acid 
substitution Leu546Vai proceeding the KSG motif found in PBP2x of RFLP type 4 and 
RFLP types 1, 8 and 13 strains is presumed to be involved in eefotaxime resistance (2). All 
strains with this amino acid substitution had a reduced susceptibility for cefotaxime (MIC 
range 0.5 to I ~lg/ml; unpublished observations), confirming the importance of the 
Leu546Vai substitution for cefotaxime resistance. Although the amino acid substitution 
Gln552Glu has also been observed in cefotaxime resistant isolates, the impact on resistance is 
unknown (17). Strains with the Gln552G1u substitution (RFLP types 6 and 31, RFLP type 7, 
RFLP type 20, and RFLP type 22) were all cefotaxime-susceptible (cefotaxime level: <0.016 
to 0.032 ~tgiml; unpublished observations), suggesting that the Gln552G1u does not playa 
role in ccfotaxime resistance. 
The pbp sequences identified in this study confirmed the acquisition of resistance by DNA 
transfer between non-pneumococcal species and pneumococci. Sequence blocks within 
pbpJa,pbp2b andpbp2x were identical to DNA from S. mitis, S. OJ'alis and S. sal1guis. Intra-
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species horizontal transfer events among different genetic lineages of pneumococci have 
probably occurred as ,veil, and this is especially suggested between strains withpbpJa RFLP 
types 1,3,6 and 10 and between strains withpbp2b RFLP types 5, 7 and 8, A recurrence of 
the recombination with viridans streptococci may have also taken place giving rise to a 
smalier section of the mosaic and is highly suggestive for pbp2b of the RFLP type I Band 3C 
strains and for pbp2x RFLP type 4 and 7, 
In conclusion, mutations in pbp sequences of most Dutch isolates were similar to those 
described in pbp sequences of strains isolated in other countries. This supports the hypothesis 
that multiple clones of penicillin-resistant pneumococci have been introduced and 
subsequently spread in The Netherlands as repolied by Hermans et al. (16). However, novel 
combinations of sequence blocks in pbp/a, pbp2b and pbp2x were also identified, and 
suggests horizontal transfer of DNA between pbp genes of penicillin-resistant pneumococci 
previously described and pbp genes of susceptible strains. 
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SUMMARY 
The molecular epidemiological characteristics of all Streptococcus plleumoniae strains 
isolated in a nation-wide manner frol11 patients with meningitis in The Netherlands in 1994 
were investigated. Restriction fragment end labeling analysis demonstrated 52% genetic 
clustering among these penicillin-susceptible strains, which is substantially lower than the 
percentage of clustering among Dutch penicillitHlonsllsceptible isolates, Different serotypes 
were found within eight of the 28 genetic clusters, suggesting that horizontal transfer of 
capsular genes is common among the penicillin-susceptible strains, The degree of genetic 
clustering was much higher among serotype 3, 7F, 9V and 14 isolates than among isolates of 
other serotypes i.e. 6A, 6B, 18C, 19F and 23F. We further studied the molecular 
epidemiological characteristics of serotype 3 pneumococci, which arc considered the most 
vim lent serotype and is commonly associated with invasive disease in adults. Fifty 
epidemiologically unrelated penicil1in~susceptible serotype 3 invasive isolates originating 
from the United States (1/ ~ 27), Thailand (1/ ~ 9), The Netherlands (1/ ~ 8) and Denmark (1/ ~ 
6) were analyzed. The vast majority of the serotype 3 strains (76%) belonged to two 
genetically distinct clades that were observed in the United States, Denmark and The 
Netherlands. This indicates that two serotype 3 clones have independently disseminated in an 
intemational manner. Six serotype 3 strains were less than 85% genetically related to the 
other serotype 3 isolates. Our observations suggest that the latter isolates originate from 
horizontal transfer of the capsular type 3 gene locus to other pneumococcal genotypes. In 
conclusion, epidemiologically unrelated serotype 3 isolates were genetically more related 
than those of other serotypes. This observation suggests that serotype 3 has evolved only 
recently or has remained unchanged over large periods. 
INTRODUCTION 
StreptocoCClIS plleu11Ioniae continues to be a common cause of serious and life-threatening 
infections stich as pneumonia, bacteremia and meningitis in both adults and children (I). 
Pneumococci can be classified according to differences in capsular polysaccharide stmch1l'e. 
As many as 90 ditferent capsular types can be divided by serotyping (II). The distribution of 
serotypes varies in different populations and different geographic areas, and celiain 
pneumococcal serotypes are known to be more virulent than others (25, 29). Pneumococcal 
serotype 3 isolates are considered to represent the most vim lent serotype. These isolates are 
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often responsible for invasive disease (18, 21), particularly in adults (16, 20). Bacteremia 
caused by this organism is considered to have the highest mOliality rate as compared to the 
other serotypes (16, 21). To date, the frequency of penicillin resistance among serotype 3 
isolates has remained low (17). 
Serotyping as a tool for epidemiological studies has several disadvantages. S. plleuflloniae is 
a naturally transformable species and frequent exchange of capsular genes occur (2-4, 14, 
24). In addition, serotyping determines the variation in a single genetic locus, i.e. the cps 
locus. Therefore, several other typing methods have been developed to assist the 
identification of the relatedness between strains and their cellular stmctures. These methods 
include multilocus enzyme electrophoresis (MLEE) (10), penicillin-binding protein profile 
analysis (22, 23), pneumococcal surface protein A typing (23) and DNA fingerprint methods 
such as pulsed-field gel electrophoresis (PFGE), multi locus sequence typing (MLST) (8), 
ribotyping, restriction fragment end labeling (RFEL) analysis, BOX peR llngerprinting and 
DNA fingerprinting of the penicillin-binding protein (PBP) genes (15, 33). RFEL analysis 
provides a high degree of discriminatory power, and RFEL profiles are reproducible and 
suitable for computerized comparison (15). In addition, RFEL analysis provides a DNA 
fingeq)rint that represents multiple loci in the pneumococcal genome. This technique is 
routinely used in our laboratOly to generate a data library of pneumococcal DNA fingerprints. 
In this study, we investigated the molecular epidemiological characteristics of S. pnelllllolliae 
strains isolated in a nation-wide manner from patients with meningitis in The Netherlands in 
1994. The genetic relatedness within pneumococcal serotypes was determined. In addition, 
we studied the molecular epidemiological characteristics of epidemiologically unrelated 
serotype 3 pneumococci from four distinct countries. The isolates were characterized by 
serotyping, RFEL analysis and PBP genotyping. 
MATERIALS AND METHODS 
Bacterial isolates. We studied a collection of S. pneumoniae strains (11 = 153) isolated from 
Dutch patients suffering from meningitis in The Netherlands in 1994. These strains werc 
collected by the National Reference Center for Bacterial Meningitis in a nation-wide manner 
and represent all pneumococcalmcningitis isolates collected in a one-year period. In addition, 
these strains \vere penicillin-susceptible and arc prcsumed to be epidemiologically unrelated. 
In addition, 42 penicillin-susceptible invasive serotype 3 pneumococci were isolated from 
patients in the United States (n ~ 27), Thailand (n ~ 9) and Denmark (n ~ 6). The latter strains 
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were also presumed to he epidemiologically nonrelated, since they were isolated from various 
geographic regions within these countries and at different time-points ranging from 1960 to 
1962 and 1992 to 1998 (Table I). 
Serotyping. Pneumococci were serotyped on the basis of capsular swelling (quellung 
reaction) observed microscopically after suspension in antisera prepared at Stotens SenUll 
Institut Copenhagen, Denmark (9). 
RFEL analysis. Typing of pneumococcal strains by RFEL analysis was performed as 
described by Van Steenbergen et a!. (34) and adapted by Hermans et a!. (15). Briefly, purified 
pneumococcal DNA was digested with the restriction enzyme EcoRI. The DNA restriction 
fragments were end labeled at n'c with [0:-32 P] dATP by using Taq DNA polymerase 
(Goldstar; Eurogentec, Seraillg, Belgium). The radiolabeled fragments were denatured and 
separated electrophoretic ally on a 6% polyaclylamide sequencing gel containing 8 M urea. 
The gel was transferred onto filter paper) vacuum dried (HBI) Saddlebrook) the United 
States), and exposed to ECL Hyperfilms (Amersham, Bucks, Unitcd Kingdom). 
PBP genotyping. Genetic polymorphism of the penicillin resistance genes pbpJa, pbp2h, and 
pbp2x was investigated by restriction fragment length polymorphism (RFLP) analysis. PCR 
amplification of the PBP-encoding genes was performed in a 50-~ll PCR buffer system 
containing 75 mM Tris-Hel (pH 9.0), 20 mM (NH4)zS04, 0.01% (wt/vol) Tween 20,1.5 mM 
MgCJ" 0.2 mM deoxynucleoside triphosphates, 10 pmol of the individual primers, 0.5 U of 
Taq DNA polymerase (Golds tar; Eurogentec), and lOng of purified chromosomal DNA. 
Cycling was performed in a PTC-IOO Progranunable Thermal Controller (MJ Research, 
Watertown) the United States) and consisted of the following steps: predenaturation at 94°C 
for I min; 30 cycles of I min at 94°C) I min at 52°C) and 2 min at 72°C; and a final 
extension at 72°C for 3 min. The primers used to amplify the genes pbpJa) pbp2b) and pbp2x 
were described previously (3, 6, 22). The amplification products (5 ~ll) were digested with the 
restriction endonuclease Hilltl and separated by electrophoresis in 2.5% agarose gels (28). 
Gels were scanned and printed with the Geldac 2000 system (Biarad, Veenendaal, The 
Netherlands). The different PBP genotypes are represented by a three-numbcr code (e.g., 06-
14-43), referring to the RFLP patterns of the genes pbpJa [pattern 6], pbp2b [pattern 14], and 
pbp2x [pattem 43], respectively. 
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Table 1. Geographic origin and isolation date of the 50 penicillin-snsceptible serotype 3 
pneumococcal isolates. 
strain code original strain state, country isolation RFEL-type PBP type 
code date (phpl a-[!bp2h-ehr2x) 
DKOOI 3-4 #484/61 Denmark 1961 294 02-02-71 
DK002 3-7 Denmark 1961 294 02-02-71 
DKOO3 3-1 Denmark 1960 292 02-02-71 
DK004 785-91 Denmark 1991 167 02-02-71 
DK005 59-92 Denmark 1992 299 02-02-71 
DK006 3-6 #524/62 Denmark 1962 289 02-02-71 
NLIOO 940099 The Netherlands 1994 167 02-02-71 
NLlOI 940149 The Netherlands 1994 167 02-02-71 
NLl02 940275 The Netherlands 1994 167 02-02-71 
NL103 940148.1 The Netherlands 1994 393 02-02-71 
NL104 940723 The Netherlands 1994 300 02-02-71 
NL106 941656.1 The Netherlands 1994 291 02-02-71 
NLl07 940081 The Netherlands 1994 290 02-02-71 
NL108 941091 The Netherlands 1994 294 02-02-71 
THOOI 9 Thailand 1998 093 02-02-71 
TH002 EIO Thailand 1998 096 09-02-71 
TH003 15 Thailand 1998 122 02-02-03 
TH004 14 Thailand 1998 122 02-02-03 
TH005 E56 Thailand 1998 121 02-02-03 
TH006 22 Thailand 1998 123 02-02-03 
TH007 E89 Thailand 1998 165 02-02-71 
TH008 26 Thailand 1998 105 02-02-03 
TH009 59 Thailand 1998 242 02-02-71 
USOOI 3-2 #2 USA 1960 294 02-02-71 
US002 3-3 #Jersey USA 1960 294 02-02-71 
US003 4182-95 Alaska, USA 1995 295 02-02-71 
US004 0205-94 Colorado, USA 1993 167 02-02-71 
US005 0456-93 Califomia, USA 1992 167 02-02-71 
US006 0678-93 Alaska, USA 1993 167 02-02-71 
US007 0680-93 Alaska, USA 1993 167 02-02-71 
US008 0911-94 Alaska, USA 1993 167 02-02-71 
US009 1807-92 Wisconsin, USA 1992 167 02-02-71 
USOIO 1164-95 Pennsylyania, USA 1995 167 02-02-71 
USOll 1165-95 Pennsylvania, USA 1995 167 02-02-71 
US012 1440-95 Maryland, USA 1995 167 02-02-71 
US013 2197-93 Alaska, USA 1993 167 02-02-71 
US014 2208-96 Oklahoma, USA 1996 167 02-02-71 
USOl5 2280-93 Washington, USA 1993 167 02-02-71 
USOl6 2341-95 Washington, USA 1995 167 02-02-71 
USOl7 2564-93 Ohio, USA 1993 167 02-02-71 
US018 Al USA 1990s 167 02-02-71 
US019 A2 USA 1990s 167 02-02-71 
US020 A3 USA 1990s 167 02-02-71 
US021 A5 USA 1990s 167 02-02-71 
US022 A8 USA 1990s 167 02-02-71 
US023 2926-94 1vfaryland, USA 1994 297 02-02-71 
US024 A4 USA 1990s 297 02-02-71 
US025 0934-94 Caliromia, USA 1994 298 02-02-71 
US026 1603-92 Wisconsin, USA 1992 296 02-02-71 
US027 1139-96 Oklahoma, USA 1996 076 02-02-71 
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Computer-assisted analysis of the DNA banding patterns. The RFEL types were analyzed 
\vith the Windows version of the Gelcompar software version 4 (Applied Maths, Kortrijk, 
Belgium) aftcr imaging the RFEL autoradiograms \vHh the Image Master DTS (Pharmacia 
Biotech, Uppsala, Sweden). The DNA fi'agments in the molecular size range of 160 to 400 bp 
,,,ere documented, The DNA banding patterns were normalized with pneumococcus-specific 
bands present in the RFEL banding patterns of all strains. Comparison of the banding patterns 
was performed by the unwcighted pair group method with arithmetic averages (27) and with 
the Jaccard similarity coefficient applied to peaks (32). Computer-assisted analysis and the 
methods and algorithms used in this study were according to the instmctions of the 
manufacturer of Gelcompar. A tolerance of 1.2% in band positions was applied during 
comparison of the DNA patterns. For cvaluation of the genetic rclatedness of the isolates, we 
used the following definitions: (I) strains of a palticular RFEL type are 100% identical on the 
basis of RFEL analysis (2) an RFEL cluster represents a group of RFEL types that differs 
only onc band (approximately ~95% genetic relatedness; (3) an RFEL clade represents a 
group of RFEL types that differs in less than 4 bands (approximately ;:'85% genetic 
relatedness). The genetic heterogeneity is defined as the number of RFEL clades representing 
one or more strains divided by the total number of strains. 
RESULTS 
Epidemiology of invasive pneumococcal isolates in The Netherlands. Thc epidemiology 
of S. plleulJlolliae strains isolated in a nation~wide manner from patients suffering from 
meningitis in 1994 in The Netherlands was investigated. These strains (11 = 153) were all 
found to be penicillin-susceptible, and were analyzed by serotyping, PBP typing and RFEL 
typing. The results are shown in Fig. 1 and Table 1. The invasive isolates represented 31 
serotypes. The isolates represented the serotypes I (II ~ 3), 3 (II ~ 8), 4 (II ~ 3), 5 (II ~ 2), 6A 
(II ~ 7), 6B (II ~ 15), 7F (II ~ 7),8 (II ~ 4), 9N (II ~ 4), 9V (II ~ 7), IOF (II ~ 2), lOA (II ~ 4), 
llA(J/~2), 14(1I~ 12), 15A(II~ I), 15C(II~2), 16F(II~2), 18F(II~ I), 18B(II~2), 18C 
(II ~ 12), 19F (J/ ~ 18), 19A (II ~ 2), 22F (II ~ I), 23F (n ~ 16), 23A (II ~ I), 23B (J/ ~ 2), 24F 
(II ~ 3), 32A (II ~ I), 33F (II ~ 5), 34 (J/ ~ I) and 38 (II ~ 3). 
Seven distinct PBP genotypes were observed displaying variation in RFLP patterns of pbp2x 
only. The PBP types 02-02-03, 02-02-71, and 02-02-02 occurred Illost frequently. In addition, 
all serotype 8 strains displayed PBP genotype 02-02-14, both serotype 5 strains displayed 
102 
Genetic relatedness within S. plleumolliae serotypes 
PBP genotype 02-02-15, and the single serotype 32A strain represented PBP genotype 02-02-
16. Finally, three of the 18 serotype 19F strains displayed PBP genotype 02-02-05 (Table 2). 
Table 2, PBP genotypes of the 153 S. pnellmoniae strains isolated 
from patients with meningitis in 1994 in The Netherlands, 
PBP genotype number of strains serotype of the strains 
02-02-03 67 21 distinct serotypes 
02-02-71 54 14 distinct serotypes 
02-02-02 22 10 distinct serotypes 
02-02-14 4 serotype 8 
02-02-05 3 serotype 19F 
02-02-15 2 serotype 5 
02-02-16 serotype 32A 
RFEL analysis divided the 153 strains into 116 distinct RFEL types. These RFEL types 
represented 28 genetic clusters, Le. strains representing over 95% genetic relatedness, and 73 
RFEL types that were less than 95% related to other strains, RFEL clusters \vere represented 
by 80 strains (52%). The cluster size varied from two (19 clusters) to nine strains (2 clusters). 
In addition, four clusters of three strains and three clusters of four strains \vere observed. The 
RFEL types 28 and 101 were the most predominant types. They were each represented by 
nine isolates, Within genetic clusters, different serotypes were observed. Eight of the 28 
RFEL clusters displayed two or more serotypes (Table 3). The strain collection could be 
divided into 25 genetic clades, i.e, strains with more than 85% RFEL homology, The genetic 
clades varied in size from nvo to 23 strains (Fig, I). Comparison of the penicillill~susceptible 
invasive isolates with penicillin~nonsusceptible strains representing 193 distinct RFEL types 
present in the international data librmy and representing 16 countries (14), revealed no 
overlap in RFEL types between penicillin-susceptible strains and penicillin-nonsllsceptible 
strains, 
Genetic relatedness within scrotypes in The Netherlands. The genetic relatedness of 
strains within the nine most predominant scrotypes present in the collection was investigated, 
Thc genetic heterogeneity is defined as the number of RFEL clades representing onc or more 
strains divided by the total number of strains, The genetic heterogencity within each serotype 
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was as follows: serotype 3 (2/S), 6A (417), 6B (6115), 7F (1/7), 9V (1/7), 14 (3112), ISC 
(4112) 19F (IIIIS) and 23F (5116). All strains of serotype 7F (1/ ~ 7) belongcd to clade IX and 
all strains of serotype 9V (1/ ~ 7) belonged to clade VII. The strains of serotype 3 (1/ ~ S) 
belonged to two distinct genetic clades, I and VIII. Thc strains of serotype 14 (1/ ~ 12) 
reprcsented three distinct genetic clades, III, X and Xl. Strains of serotypes 6B, ISC and 23F 
were genetically more heterogeneous, respectively. However, most strains of serotypes 6B, 
ISC and 23F belonged to one clade. Eight of the 15 serotype 6B strains belongcd to clade V, 
nine of the 12 serotype 18C strains belonged to clade III and seven 7 of the 16 serotype 23F 
strains belonged to clade IV. Strains with the serotypcs 6A and 19F displayed most 
heterogeneity in this collection of S. pneulIIoniae isolates, as seven serotype 6A strains were 
represented by four genetic clades and IS serotype 19F strains were represented by II genetic 
clades (Fig. I). 
Table 3. RFEL clusters consisting of strains with different serotypes. 
RFEL-c1ustcr~ 
28 
101 
23 
328,330 
I t9, 342 
56,341 
321 
377 
serotype 
14 (II - 4), 15C (11- I), 19F (11- I), 24F(1I - 3) 
4(11 ~ I), 18B(1I ~ I), 18C(1I ~7) 
9V (II ~ 3), 19F (II ~ I) 
23F (II ~ 2), 23B (II ~ I) 
8 (II ~ 2), 33F (II ~ I) 
14 (II ~ I), 19F (II ~ 1) 
14 (II ~ I), 19F(1I ~ I) 
18F (II ~ I), 18C (II ~ I) 
a For definition ofRFEL cluster, see Materials and Methods section. 
Genetic relatedness \"ithin serotype 3 isolates of distinct geographic origin. We 
investigated the molecular epidemiology of serotype 3 strains from The Netherlands (1/ ~ S) 
and three additional countries: the United States (1/ ~ 27), Thailand (1/ ~ 9) and Denmark (1/ ~ 
6). These fifty epidemiologically unrelated serotype 3 isolates were characterized by RFEL 
Fig. 1. Genetic relatedness of 153 penicillin-susceptible invasive pneumococcal isolates based on the RFEL 
banding pattems of the isolates. The country code (NL, The Netherlands), strain codes, RFEL types and 
serotypes are depicted. Codes 1 to Xl refer to genetic clades of pneumococcal strains (for definition see 
materials and methods section). 
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analysis. Four distinct RFEL clades and six RFEL types that were less than 85% related to 
other serotype 3 strains ,vere observed among these strains (Fig. 2), The most predominant 
RFEL clade I represented 30 serotype 3 strains (60%). This RFEL clade was represented by 
23 isolates from the United States, nyc isolates from Dcmuark and five isolates from The 
Netherlands. RFEL cluster VIII was rcpresented by eight isolatcs (16%) and consisted of two 
American, three Danish and three Dutch strains. RFEL clade XII was represented by four 
Thai isolates. In addition, two Thai isolates formed a Thai~specific clade. Thus, 44 strains 
shared RFEL types with at least one other strain (88%). Six serotype 3 strains with RFEL 
types 295, 165, 105,289,76 and 242 did not match with the four genetic clades, and five of 
them did 110t match any of the 153 Dutch invasive isolates representing 116 RFEL types and 
31 serotypes. In contrast, the serotype 3 strain with RFEL type 105 was genetically related 
(90.9%) with a serotype 19F strain representing RFEL type 352. 
The serotype 3 collection was also analyzed by PBP typing. The PBP genotype 02-02-71 was 
invariably observed in the strains from the United States, Denmark and The Netherlands. The 
Thai strains displayed three distinct PBP genotypes: 02-02-03 (1/ ~ 5), 02-02-71 (1/ ~ 3), and 
09-02-71 (/I ~ I) (Tablc 1). 
DISCUSSION 
Few studies have documcuted genotype analysis of penicillin-susceptible strains (13, 30), and 
of serotype specific strains (10, 19). We investigated the epidemiological characteristics of 
153 penicillin-susceptible S. pneumoniae strains isolated fro111 patients with meningitis in The 
Netherlands in 1994. The isolates represented 31 serotypes. The most predominant serotypes 
were 19F, 23F, 6B, 18C, 14, 3, 6A, 7F and 9V. Various investigators have rep011ed the 
OCCUlTcncc of horizontal transfer of capsular genes (2, 12-14). In the Dutch pcnicillin-
susceptible isolates, horizontal transfer of capsular genes has occurred frequently. The high 
frequency of capsular exchange has been reported in molecular epidemiological studies of 
penicillin-resistant isolates from many countries (13, 14). This is the first Shldy suggesting 
frequent OCCUlTcncc of horizontal transfer of capsular genes among penicillin-susceptible 
strains. 
Fig. 2. Genetic relatedness of 50 penicillin-susceptible pneumococcal serotype 3 isolates based on the RFEL 
banding paltems of the isolates. The country codes (NL, The Netherlands; US, the United States; DK, Denmark; 
TH, Thailand), strain codes and RFEL types are depicted. Codes I, VIII and XII refer to genetic clades of 
pneumococcal strains (for definition sec Materials and Methods section). 
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70 80 90 100% 
,,'1. I " 
I I 1111 I II II I III III I I NL108 294 
I I I III I II II I III III I I US001 294 
I I 1111 I II II I II I III I I US002 294 
I I 1111 I II II I III III I I DK001 294 VIII 
I I I III I II II I II I III II DK002 294 
I I 1111 II II I II I III I I NL107 290 
I 1111 II II I III III I I DK003 292 
I I 1111 II III I I II III I I NL106 291 
I II I I I II II III III I II I TH001 093 ] XXVII 
I II I I I II II III III I I I TH002 096 
I I III II II II II III I II TH003 122 
] XII I I II I II II 1111 III I "TH004 
122 
I I II I II II III III I II TH005 121 
I I III II III II I III I III TH006 123 
I I 1111 II II I 1111 III I I II US003 295 
I I I II I I II I II 1111 III I 1111 NL100 167 
I I 1111 I II I II 1111 III I 1111 NL101 167 
I I 1111 I II III 1111 III I 1111 NL102 167 
I I I "I I 
" 
III 1111 III I 1111 US004 167 
I I 1111 I II I II 1111 1111 1111 US005 167 
I I I III I II III 1111 III I 1111 US006 167 
I I 1111 I II III 1111 III I 1111 US007 167 
I I 1111 I II III 1111 1111 1111 US008 167 
I I I III I II III 1111 1111 1111 US009 167 
I I II II I II III 1111 III I 1111 US010 167 
I I I III I II III 1111 III I 1111 US011 167 
I I 1111 I II III 1111 1111 "" US012 167 
I I 1111 I II III 1111 III I "" US013 167 
I I I I II I II III 1111 III I 1111 US014 167 
I I 1111 I II I II 1111 III I "" US015 167 
I I I III I 
" 
III 1111 III I 1111 US016 167 
I I I III I II III 1111 III I 1111 US017 167 
I I I III I II I II 1111 "I I 1111 DKOO4 167 
I I I III I 
" 
III 1111 III I 1111 US018 167 
I I I I II I II III 1111 1111 "" US019 167 
I I I III I II III 1111 III I IHI US020 167 
I I 1111 I 
" 
I II 1111 1111 1111 US021 167 
I I 1111 I II III 1111 III I 1111 US022 167 
I I I " I II II I II 1111 III I 1111 NL103 393 I I I III II II I II 1111 III I 1111 DK005 299 
I I 1111 I II I II III I" I 1111 US023 297 
I I I III I II III I II III I "II US024 297 
I I 1111 I II I I 1111 III I III NL104 300 
I I I III I II III I 1111 I" I "" US025 298 
I I I" I 
" 
III 1111 III III US026 296 
I I 1111 I II III I III III I 11111 THO 07 165 
I I II I I II I" III "I II "I TH008 105 I I II I 
" I I III "1111 I DK006 289 I I II I 1111 I III 1111 II US027 076 
I I I III I " I 11111111 II III III" TH009 242 
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RFEL analysis revealed that 52% of the strains belonged to genetic clusters, The genetic 
clustering ,vas substantially lower among the penicillin~susceptible isolates than among 
penicillin-nollsusceptiblc isolates in other studies (2, 5) 12-14, 26). Comparison of the 
penicillin-susceptible invasive isolates with 193 penicillitHlOIlStlSceptible strains representing 
193 distinct RFEL types present in the international data library and representing 16 countries 
revealed no overlap (13,14). 
The PBP genotypes 02-02-03, 02-02-71 and 02-02-02 were found most frequently. This 
observation corresponds with the PBP typing results of penicillin-susceptible pediatric 
carriage isolates in the American. population (31). Interestingly, four additional PBP 
genotypes (02-02-14, 02-02-15, 02-02-16 and 02-02-05) were identified which were prcsent 
in the serotypes 8, 5, 32A and 19F, respectively. The serotype-specificity of the latter PBP 
genotypes suggests divergence ofPBP genotypes before the origin of the capsular types 8, 5, 
32A and 19F. 
The genetic relatedness within the specific pneumococcal serotypes was highly variable, 
RFEL genotypes of serotype 6A and 19F strains displayed high levels of heterogeneity, i.e., 
strains of these serotypes represented many RFEL types that belong to many genctic clusters 
and genetic clades. In contrast, the RFEL genotypes within the serotype 7F, 9V, 14 and 3 
strains were found gcnetically related, Interestingly and consistent with our observations, 
Canadian penicillinRsusceptible isolates of serotype 3 and 7F were also more genetically 
related than isolates of other serotypes (19). Moreover, invasive penicillillRslisceptible 
serotype 3 isolates from the United Kingdom also tend to be mutually more closely related 
than to isolates of other serotypes (10). 
We focused on the molecular epidemiological characteristics of epidemiologically unrelated 
serotype 3 pneumococci and extended our serotype 3 collection with isolates from the United 
States, Thailand and Denmark. RFEL analysis demonstrated that serotype 3 strains isolated in 
these countries displayed a strong degree of genetic relatedness: the vast majority of the 
strains represented two distinct RFEL clades. Furtherlllore, both genetic clades harbored 
isolates from three countries: the United States, Denmark, and The Netherlands. These 
observations indicate that two serotype 3 clones have disseminated internationally, In 
addition, six Thai serotype 3 isolates belong to two RFEL clades (clade XII and XXVI). The 
data suggest strong genetic homogeneity within the serotype 3 pneumococci and SliPPOlt the 
observations in Canada and the United Kingdom (l0, 19). Interestingly, the Canadian 
serotype 3 strains displayed two distinct genetic types, and the majority of the 
epidemiologically non-related serotype 3 strains from the United Kingdom grouped within 
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two genotypes. Moreover, MLST analysis of serotype 3 strains isolated in six distinct 
countries identified two major genetic clusters (7). Since the strains have been characterized 
with distinct typing methods, i.e. PFGE, MLEE, MLST and RFEL analysis and since there is 
no overlap in characterized strains, the genetic relatedness between the latter serotype 3 
isolates and the strains characterized in this Shldy is currently unknown. The remaining six 
serotype 3 RFEL types occUlTed once in our collection. Our obscrvations suggest that these 
latter isolatcs have derived from horizontal transfer of the capsular type 3 gene locus to other 
pneumococcal genotypes. 
PBP genotyping of the serotype 3 strains demonstrated limited variation in the pbp I a, pbp2b 
and pbp2x genes. All serotype 3 strains from the United States, Denmark and The 
Netherlands display PBP genotype 02-02-71. However, variation was demonstrated in the 
Thai serotype 3 isolates. The PBP type 09-02-71 was represented by a single Thai isolate. 
This PBP type was also specific for the penicillin-susceptible phenotype as there was no 
overlap with penicillin-nonsusceptible isolates from 16 different countries (l4). 
In conclusion, pneumococcal strains belonging to serotype 3 display limited genetic 
heterogeneity despite the lack of epidemiological relatedness. We hypothesize that this 
serotype has recently evolved or has remained unchanged for a prolonged period. The few 
serotype 3 isolates not belonging to the main clusters are presumably derived from horizontal 
transfer of capsular genes. 
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SUMMARY 
Vle studied the effect of opsonisation of StreptococCllS pnell11/olliae \vith capsular 
antibodies 011 horizontal transfer of DNA, Opsonisation did not inhibit DNA uptake. This 
suggests that horizontal transfer of capsular genes, which is an important escape 
mechanism of the pathogen, remains a potential threat for the efficacy of conjugate 
vaccination. 
Streptococcus pllellf110niae is an important human pathogen, which causes high morbidity 
and tnOliaiity. Genetic plasticity plays a central role in the biology of the pneumococcus, 
Horizontal gene transfer enables the bacterium to evolve rapidly by the acquisition of 
novel detenninants and has resulted, under the selective pressure of host defense 
mechanisms and antibiotic treatment, in a great genetic variability of several vimlence 
factors and resistance detenninants (for revie,v see references 2, 5, 10), 
S, plleumolliae has the ability to express at least 90 unique capsular polysaccharide types 
(7, 19), Multidrug-resistant pneumococcal isolates are mostly associated with a limited 
number of serotypes (6). Pneumococci expressing the latter capsular types cOl11monly 
cause disease and, therefore, attention is focussed on prevention of infection caused by 
these pneumococcal types (13). The current pneumococcal vaccine strategies concentrate 
on the use of conjugate vaccines, in \vhich capsular polysaccharides are linked to a highly 
immunogenic canier protein thereby switching the immune response against 
polysaccharides from T-cell independent to T-cell depcndent. Consequently, the antibody 
response towards the polysaccharides is increased and a memOlY response is provided. 
HO\vever, the number of different capsular polysaccharide types that can be included in the 
vaccine is restricted (13), Several studies have shown that conjugate vaccination results in 
a change in serotype distribution of nasopharyngeal isolates from vaccine serotypes to 
non-vaccine serotypes (II; R Dagan, N. Givon, P,Yagupsky, N, Porat, 1. Janco, 1. Chang, 
A. Kimura, 1. Hackell, Abstr, 38th Intersci. Conf, Antimicrob. Agents Chemother. abstr. 
107-G, 1998), Such a shift may be enhanced by frequent horizontal exchange of capsular 
genes (1, 3, 4, 8, 12). Consequently, exchange of capsular genes in (multi)drug-resistant 
isolates from vaccine types to nonvaccille types is a potential threat to the efficacy of 
conjugate vaccines. 
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Increased expression of capsular polysaccharide results in a lower degree of competence 
(15, 18), whcrcby the capsule acts as a barrier that prevents competence factor from 
reaching its cellular target (20). Opsonisation may increase the steric hindrance by the 
capsule. In this study, we examined the effect of opsonisation with immune-protective 
capsular-type specific antibodies on pneumococcal competence. 
For this purpose, the genetically unrelatcd clinical isolates of serotype 14 (strain NCTC 
11902) and serotype 9V (strain 961729) were used, Bacteria were grown to an optical 
density at 600 n111 ~ 0, I at 37°C in Todd-Hewitt broth supplemented with 0,5% yeast 
extract (Difco laboratories, Detroit, USA) (THY broth) and for transformation 
experiments in THY broth with 0.16% bovine senUll albumin and 0.01% CaCh 
(competence broth). Bacterial pellets from I ml of culture \vere \vashed hvice (5 min, 
10,000 x g) with Iml of phosphate-buffered saline pH 7,5 (PBS), pre-heated at 37°C, The 
senllll concentration that resulted in maximum opsonisation was detenl1ined by incubating 
the pellet for 10 min at 37°C in the presence of 0, 1.25,2,5,5 and 10% of capsular type 14 
(batch HT95-0028 M091#7) and capsular type 9V (batch HT95-0022 M054#8) rabbit 
antisel11m (\Vyeth Lederle Vaccines, \Vest Henrietta, United States), respectively, in 20 ~ll 
final volume while shaking. After washing twice with pre-heated PBS, the bacteria were 
incubated for 10 min at room temperature with 20 ftl (1:5 dilution) of fluorescein-
conjugated goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, 
United States) while shaking. The bacteria \vere washcd twice and resuspended in 100 ~d 
of 0.5% paraformaldehyde in PBS. The samples were analyzed in a flow cytometer 
(FACScan, Becton Dickinson, Mountain View, USA). The concentration of 10% capsular 
type 14 nntiserum demonstrated the highest opsonic activity on type 14 pneumococci (Fig. 
I) and, therefore, this senun concentration was used for fmiher experiments. Similar data 
were observed with capsular type 9V antiserum and type 9V pneumococci (data not 
shown), 
To investigate the effect of opsonisation on pneumococcal viability, the bacterial 
suspensions were opsonized with 10% serum as described above, washed twice, diluted 
and plated onto THY-agar plates (15 g of agar per liter) and incubated at 37°C with 
increased CO2• The average number of viable type 14 and type 9V pneumococci before 
opsonisation was 4,37 x 10' ± 2,71 x 10' CFU/ml and 2,82 x 108 ± 4,37 x 10' CFU/ml, 
respectively, and after opsonisation with capsular-type specific antibodies 3.38 x 108 ± 
7.42 x 10' CFU/ml and 2,75x lOs ± 4,24 x 10' CFU/ml, respectively, Statistical analysis 
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Fig. I. The degree of pneumococcal serotype 14 opsonisatioll with increasing concentrations of illllTlunc-
protective capsular type 14 specitlc hyperinullune rabbit 311tisenUll as detennined by FACS analysis. Y axis: 
number of pneumococci analyzed. X axis: the degree of imlllullo-fluoresccnce. Numbers indicate bacterial 
autofluorescence (1), specific binding with 1.25% (2), 2.5% (3), 5% (4) and 10% (5) of capsular type 14 
antiscnllll. 
(Student's T-test) showed no significant difference in bacterial viability before and after 
opsonisation. 
In transformation experiments, pneumococci were opsonized with 10% scnUll, washed 
and resuspended in I 1111 of competence broth. The bacteria were transformed as described 
by Lacks (9) v-lith DNA from streptomycitH'esistant S. pnelllJloniae strain DP1617, which 
was the source for resistance marker DNA (16). The cells were incubated for 2.5 h \'lith 
0.4 and 1 fig of purified genomic DNA (17), respectively, and 300 ng of synthetic CSP-l 
(14), The frequency of transformation of opsonized and nonopsonized pneumococci, 
respectively, was determined by comparing the number of colonies in the presence and in 
the absence of streptomycin (100 Jlg/ml), Statistical analysis using the Anoya test 
demonstrated no differences in the uptake of marker DNA between pneumococci 
opsonized with immune-protective capsular-type specific antibodies and nonopsonizcd 
pneumococci for both pneumococcal clinical isolates (Fig. 2). In addition, different 
amounts of donor DNA (0.4 and I pg, respectively) did not affect transfol111ation 
frequency (data not shown). 
In this Shldy, in vitro DNA transfer experiments demonstrated that pneumococcal 
opsonisation with inullune-protective capsular-type specific antibodies did not affect the 
uptake of marker DNA. These data indicate that horizontal transfer of capsule loci is not 
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Fig. 2, Comparison of the genetic transfonllatiol1 frequencies of a type 14 and a type 9V clinical isolate, 
respectivcly, in the absence (opcn bars) and the presence (solid bars) of capsular-type specific antibodies. 
The Iransfonllation frequency (number of transfonlHlI1ts/total number of bactcria) with resistance marker 
DNA was detenllincd, Values are means of three independent detcnninations, Results are represenlali\'e for 
hvo independent experiments. 
inhibited in the presence of opsonizing antibodies and may provide an escape mechanism 
for pneumococci in vaccinated individuals. These recombination events have the potential 
to diminish the long-tenn effectiveness of CUlTent conjugate vaccination strategies, which 
contain a limited number of capsule types. Hence) molecular epidemiological studies are 
needed to monitor pneumococcal colonization and infection of individuals who will be 
vaccinated with conjugate vaccines. 
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SUMMARY 
Streptococcus pneu1110lliae undergoes spontaneous phase variation resulting in opaque and 
transparent colony forms. Differences in colony opacity correlate with differences in 
virulence: the transparent variants are more capable of colonizing the nasopharynx, whereas 
the opaque variants show increased virulence during systemic infections. To gain insight into 
the pathogenesis of pneumococcal disease at the molecular level, protein expression patterns 
of the phenotypic variants of two pneumococcal strains were compared by high-resolution 
two~dill1ensional protein electrophoresis. In comparison with transparent variants, the opaque 
variants reduced the expression of two proteins and overexpressed one protein. The proteins 
were identified by mass spectrometric analysis. The protein overexpressed in the opaque 
phenotype revealed significant homology to elongation factor Ts of Helicobacter pylori. One 
of the two proteins that were underexpressed in the opaque variants revealed significant 
homology to the proteinase maturation protein PrtM of Lactocobacillus paracasei, a member 
of the f..1mily of peptidyl-prolyl cis/trailS isomerases. A consensus lipoprotein signal sequence 
suggests that the putative proteinase maturation protein A, designated PpmA, is located at the 
surf..1ce of the pneumococcus and may playa role in the maturation of surface or secreted 
proteins. The second underexpressed protein was identified as pymvate oxidase, SpxB. The 
lower SpxB expression in opaque variants most probably explains the reduced production of 
hydrogen peroxide, a reaction product of SpxB, in this variant. Since a spxB-defective 
pneumococcal mutant has decreased ability to colonize the nasopharynx (B. Spellerberg, D. 
R. CundeJl, J. Sandras, B. J. Pearce, I. lndanpaan-Heikkila, C. Rosenow, and H. R. Masure. 
Mol. Microbiol. 19:803-813, 1996), our data suggest that SpxB plays an important role in 
enhancing the ability of transparent variants to efficiently colonize the nasophmynx. 
INTRODUCTION 
A critical process in the pathogenesis of infections caused by Streptococcus pnellf}Joniae is 
the ability of the pathogen to adapt to various ecological niches in the human host. The 
pneumococcus colonizes the human nasopharynx and may spread locally to cause upper and 
lower respiratOlY tract infection. In some cases, pneumococci are able to enter the 
bloodstream and cause bacteremia or cross the blood-brain barrier and cause meningitis. 
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As is the case for other respiratOlY tract pathogens that frequently cause invasive infection, 
the ability to survive in these different host environments requires the regulation of the 
synthesis of key surface structures (10, 31). In S. pnellmolliae, the reversible expression or 
phase variation in stmctures can be detected as spontaneous, reversible changes in colony 
morphology. Differences in surface molecules affect the arrangement of organisms within a 
colony, resulting in a change in colony appearance (32). The frequency of switching in 
colony morphology is highly variable from isolate to isolate and appears to be independent of 
in vitro growth conditions including pH, temperature and osmolarity (32). Genetic analysis 
has demonstrated that a stemwloopwfollning repetitive element, BOX Awe, located upstream 
of the glpF gene, increases the variation in opacity (23). 
Differences in colony morphology correlate with differences in in vitro and in vivo 
characteristics. In an infant rat model of nasopharyngeal carriage, only the transparent 
phenotype is able to establish dense and stable colonization of the mucosal surface of the 
nasophatynx (32). This can be explained by the enhanced binding of transparent 
pneumococci to buccal epithelial cells and their glycoconjugate receptors when compared to 
opaque pneumococci (5). Similarly, the adherence of transparent pneumococci to cytokine-
stimulated human type II lung cells and human vHscular endothelial cells is enhanced, as well 
as the receptors (N-acetyl-D-glucosamine and platelet-activating factor [PAFJ receptor) that 
appear on these cells after cytokine stimulation (5). On the other hand, the opaque variant is 
more vim lent in an animal model of systemic infection following intraperitoneal inoculation 
of adult mice (13). The higher vimlence of the opaque variant in an in vivo model of sepsis 
correlates with decreased opsonophagocytic killing of opaque pneumococci in the in vitro 
phagocytosis assay (12). Finally, the transparent variants have an increased capacity to cross 
the bloodwbrain balTier (20). The higher binding affinity of transparent pneumococci to the 
P AF receptor on microvascular endothelial cells is suggested to result in increased 
transcytosis of bacteria across these cells. 
To gain insight in the pathogenesis of pneumococcal disease at a molecular level, the 
relationship behveen several previously identified cell surface stmctures and opacity variation 
has been examined. The opaque phenotype is associated with larger amounts of capsular 
polysaccharide than is the transparent phenotype (12, 13). In contrast, the transparent 
phenotype produces increased amounts of teichoic acid, which contains phosphOlylcholine 
(13, 30). Phosphorylcholine forms an anchor for at least eight choline-binding proteins (21). 
This stmcture is also pali of PAF and is suggested to be impOIiant in the attachment to 
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cytokine-activated human cells via the PAF receptor by structuralmimicty (5). Differences in 
the amount of phosphorylcholine might explain the s\vitch between adherent and non adherent 
phenotypes. Phenotypic variation also cOll'elates with differential expression of cell surface 
proteins, including three choline binding proteins, LytA, PspA, and CbpA, Opaque variants 
undergo spontaneous lysis more slowly as a result of the decreased expression of the major 
amidase, LytA (33). In contrast to LytA, PspA is expressed in greater amounts in the opaque 
variant (13). PspA inhibits complement activation, thereby reducing the effectiveness of 
complement receptor-mediated patJ1\vays of clearance (27), In addition, PspA binds 
lactoferrin, an ironRsequestering glycoprotein that predominates in mucosal secretions, and 
may function in iron acquisition at mucosal surfaces (9). The differential expression of CbpA 
is similar to that of LytA, such that transparent variants exprcss increased amounts of this 
protein (21). CbpA mediates adherence to cytokilleRactivated human lung epithelial and 
endothelial cells, is involved in invasion through microvascular endothelial cells, and 
participates in pneumococcal colonization of the nasopharynx (20, 21). The expression levels 
of LytA, PspA, and CbpA are uulikely to detennine colony morphology directly, since 
mutants lacking each of the encoding genes still undergo variation in colony morphology (13, 
21,30). 
The purpose of this study was to identify additional proteins that are differentially expressed 
in the phenotypic variants of S. pneu11Ioniae to gain insight into the molecular changes that 
occur during phase variation. This information will contribute to an improved understanding 
of the molecular adaptation of phenotypic variants of pneumococci that result in changes in 
virulence and colony morphology, This paper reports on a comparison of expression pattems 
of the phenotypic variants of two pneumococcal strains by higlH'esolution twoRdimensional 
protein clectrophoresis and the identification of differentially expressed proteins by mass 
spectrometry. 
MATERIALS AND ~mTHODS 
Bacterial strains, growth conditions and growth medium. Bacteria were removed from 
storage at R 70°C and culhlred at 37°C on Columbia agar supplemented with 5% defibrinated 
sheep blood (Oxoid, Basingstokc, United Kingdom) in an atmosphere of increased C02, 
Bacterial colonies were inoculated in ToddRHe\vitt broth (Difeo Laboratories, Detroit, Mich,) 
supplemented with 0.5% yeast extract (Difco Laboratories) (THY broth) and grown at 37°C. 
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Broth cultures were plated onto THY agar plates (15 g of agar per liter) impregnated with 80 U 
catalase (\Vol1hington Biochemical, Freehold, N.J.) per cm2, and incubated at 37°C in an 
atmosphere of increased CO2 that was provided in a candle extinction jar. Colony morphology 
of all cultures was detenllined as described previously (32). The pneumococcal strains used in 
this study are the opaque and transparent variants of type 9V clinical isolate PI 0 (32) and the 
opaque and transparent variants of type 6B clinical isolate P314 (12). S. pneumoniae D39 (2) 
and a spxB-defective mutant (D39, spxB::pHRMI04, plIOA+; 26) were used as control strains 
used in the hydrogen peroxide assay. A ppmA-defective mutant (D39, ppmA::ermAM) (16a) 
was used as a control strain used for western blot analysis. 
Protein sample preparation. The bacteria were cultured ovelllight in 10 1111 of THY broth 
and subsequently to logarithmic growth phase (optical density at 550 lUll ~ 0.3) in 250 ml of 
THY broth. This culture was harvested by centrifugation (1,500 x g for 15 minutes), and 
washed twice with 250 ml of phosphate-buffered saline (pH 7.5) and once with 10 ml ofTris-
EDT A buffer (10 111M Tris-HCI, I 111M EDTA). The cells were dismpted by uln·asonic treatment 
(15 min with a microtip in a model 250 sonifier [Branson Ultrasonics, Danbuny, Conn.]) while 
being held at 5°C. Protein concentrations were detennined by the method of Bradford (3). 
Two-dimensional protein gel electrophoresis, staining and computerized comparison of 
the protein profiles. Isoelectric focusing (pi 4 to 7) was perfollned with a Multiphor II 
electrophoresis unit and Immobiline DlyStrips (phanllacia Biotech, Uppsala, Sweden) as 
recommended by the manUh'lcturers and includes the modifications desctibed by Rabilloud et al. 
(18). The proteins were separated in the second dimension by gradient (12 to 20% 
polyaclylamide) polyaclylamide gel electrophoresis. Bacterial Iysates containing 300 fIg of 
protein were analyzed in the individual expcrirnents. Polyaclylamide gels were stained ,vith 
Coomassie brilliant blue (CBB) (24). The software program PD Quest (PD!, New York, N.Y.) 
was used for the computerized analysis of two-dimensional protein profiles. The relative amount 
of a protein, represented in palis per million (ppm), was detennilled by dividing the spot 
quantity by the total density of all proteins in the gel, thereby normalizing the amount ofa single 
protein to the total amount of protein loaded. Significant differences in protein expression levels 
in the phenotypic Valiants were detcnnined by the Mmlll-Whitney test ,vith a set value of 
P:S;0.05. 
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Purification, tryptic digest and mass spectrometric analysis of the proteins. The protein 
gel spots of interest were excised from the gel. The gel fragments were sliced thinly and 
washed twice for 15 min in 5% trichloroacetic acid (CCbCOOH [Merck, Darmstadt, 
Germany]) and three times in distilled water. The gel fragments were equilibrated in sample 
buffer (pH 6.8) (0.1 % sodium dodecyl sulfate, 10% glycerol, 50 mM dithiothreitol, 12 mM 
Tris-HCI, 0.01% bromophenol blue indicator [Merck]) for I h at room temperature. The 
proteins were concentrated by an agarose electrophoresis (l % agarose type VIII [Sigma, st. 
Louis, Mo.]) method as described by Rider et al. (19) and Gevaeli et al. (7) on a model 150-A 
gel electrophoresis cell (Bio-Rad laboratories, Riclllllond, Calif.) with Pasteur pipettes. The 
agarose gel was stained with carconcarboxylic acid (Sigma), and the proteins were excised 
from the gel. The agarose fragments were washed with distilled water, and resuspended in 18 
Itl of digestion buffer (pH 8.0) (50 mM NH 4HCOJ, 5 mM CaC!,). The agarose was melted at 
85°C tor 1 min. After it was cooled to 37°C 0.05 Ilg of trypsin (hypsin modified sequencing 
grade [Promega, Madison, Wis.]) per I" was added for at least 15 h at 37°C to digest the 
proteins. Tlypsin was inactivated by adding I I" of 10% trifluoroacetie acid (CFJCOOH 
[Merck]), The tryptic digests were analyzed using a reversed phase microcapillmy COlUllll1 
switching highwpressure liquid chromatography system. (16, 28). Peptide sequencing was 
performed on an LCQ quadrupole ion trap Illass spectrometer (Finnigan "NIAT, San Jose, CA, 
Calif.), Tandem mass spectrometric data were collected in data dependent scan mode for 
sequence infolmation on single tryptic digest products. \Vith Peptide Search (14), the 
deduced (partial) amino acid sequences were analyzed for matching sequences in all possible 
translation products of the most current version of the unfinished pneumococcal genome 
released by The Institute for Genomic Research (TIGR) 
(http://wwlV.tigr.org/data/s_llIleumoniae/) to identify the proteins. With the BLAST algorithm 
(I), putative pneumococcal proteins were analyzed for similarity to sequences deposited in 
the November 1999 version of the nonredundant protein database at the National Center for 
Biotechnology Information (\Vashil1gton, D.C.). 
Hydrogen peroxide assny. Hydrogen peroxide production by pneumococci was determined 
by the method of Pick and Keisari (17) and modified by Duane et al. (6). Bactcria were 
grown to midMlog phase, washed, and then grown ill 250 ~tI of brain heart infusion broth 
(BBL Microbiology Systems, Cockeysville, Md.) in 96-well plates. Negative control wells 
contained 1000 U of catalase per Ill!. After I h of incubation at 37°C, the culhlres were 
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harvested and centrifuged at 10,000 x g for 2 min, and the supernatant was filtered through 
0.2-uun-pore-size filters. Phenol red and horseradish peroxidase were added to the assay 
buffer (5.0 mM K,HP04, 1.0 mM KH2P04, 140 mM NaCI, 0.5 mM glucose [pH 7.4]) at a 
final concentration of 0.46 111M and 0.046 Vlml, respectively, and the buffer was immediately 
used in the assay. Duplicate 250 ~tl aliquots of filtered supernatant were then mixed with 1.05 
ml of assay mixture and incubated for 30 min at 37°C. The reactions were stopped by the 
addition of 5.0 ftl of 1.0 N NaOH. The optical density was recorded at a 610 nm. 
Concentrations were calculated from a standard curve generated for each assay by adding 
known dilutions of 30% H202 to 250-~11 aliquots of control supernatant. Control supernatant 
was heated to 100°C for 20 min before addition of H202 to eliminate catalase activity. 
Finally, the optical density of the culture as well as the number of CPU per milliliter was 
detennil1ed. 
"'esterll blot analysis. One-dimensional SDS polyaclylamide gel electrophoresis was can·ied 
out in the Bio-Rad minigcl systcm with 13% polyacrylamide gels. Bacterial Iysates (0.5 rIg) 
were dissolved in sample buffer (10 mM Tris-HCI, I mM EDTA, 1% SDS, 10 mM 
dithiothreitol, 10% glycerol, 0.01% bromophenol blue [Merck]), boiled for 5 min and subjected 
to elech·ophoresis (24). The proteins in the gel were transfelTed to Immobilon-P membranes 
(Millipore Corp., Bcdford, Mass.) as described by Sambrook et al. (24). The mcmbrancs were 
washed hvice for 10 min with Tris-HCI-buffered saline pH 7.5 supplemented with 0.05% Tween 
20 (TBSt). The membranes were incubated with 2% bovine senlln albumin for I h at room 
temperature, washed twice for 10 min eaeh with TBSt, and incubated with 1: 10,000 diluted anti-
PpmA rabbit serum (16a) tor at least 2 h with constant stirring. Aftcr the washing step, 1 :4,000-
diluted anti-rabbit immunoglobulin-alkaline phosphatase conjugate (Sigma) was added. After I 
h, the membranes were washed in TBSt and then in alkaline phosphatase buffer (100 mM Tris-
HCI [pH 9.5], 100 mM NaCI, 5 mM MgCI,). The blots were incubated with 0.33 mg of 
uitroblue tetrazolium (Sigma) per ml aud 0.17 mg of 5-bromo-4-chloro-3-illdolyl phosphate 
(Sigma) per ml in alkaline phosphatase bufter in the dark. The staining reaction was stopped 
with distilled water. 
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RESULTS 
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Fig. 1. Two-dimensional analysis of the cellular proteins of the opaque (A) and transparent (B) variants of 
pneumococcal clinical isolate p 10. Bacterial proteins were separated by isoelectric focusing (pI 4 to 7) and 
gradient SDS-polyacrylamide gel electrophoresis (20 to 90 kDa). Circles and squares IlHlrk proteins with 
decreased and increased expression in the transparent variant, respectively, compared to the opaque variant. 1, 
2, and 3 refer to the proteins discussed in the text. 
Differentially expressed proteins in phenotypic variants of S. jJllelllllolliae. The relative 
protein expression levels of phenotypic variants of strain PIO with opaque and transparent 
colony morphologies were compared using two-dimensional protein gel electrophoresis 
followed by computerized comparison of the CBB-stained gels. We perfonned this 
experiment with four cultures of opaque pneumococci and four cultures of transparent 
pneumococci. Approximately 200 distinct protein spots were analyzed, The quantity of two 
proteins, designated proteins 1 and 2, was decreased and the expression of protein 3 was 
increased in the opaque variant (Fig. I). Protein I (65 kDa; pI 5.4) was clearly detectable in 
the CBB-stained protein expression profile of the transparent variant, but was not detectable 
in the opaque variant (Fig. 2). The quantity of protein 2 (35 kDa; pI 5.0) in the transparent 
variant was 2.6 times the quantity of this protein in the opaque variant. In contrast, the 
quantity of protein 3 (40 kDa; pI 5.1) was 2.1 fold greater in the opaqne variant. The 
differences in the expression of proteins 1, 2, and 3 in the pneumococcal variants were 
statistically significant. The amounts of proteins 1, 2, and 3 \vere also compared in the 
phenotypic variants of clinical isolate strain P314 (serotype 6B). Again, proteins I and 2 were 
more prevalent in the transparent phenotype and protein 3 was more prevalent in the opaque 
phenotype; the levels of protein I and 2 were 1.3 times higher in the transparent variant and 
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that of protein 3 was 1.4 times higher in the opaque variant. Although the relative expression 
levels of all three proteins were less pronounced in the P314 variants, the trend in the 
differential expression of the proteins is comparable between strains PlO and P314 (Fig. 2). 
protein I protein 2 
strain p 10 
strain p314 
protein 3 
.5 i 25 r-~~~~, 
'" n e'b 20 
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Fig.2. Relatiye expression leyels of proteins 1,2, and 3 as repeatedly observed in four independent experiments 
with the opaque variant (solid bars) and the transparent variant (open bars) ofpneulllococcal clinical isolate PlO 
(serotype 9V) and observed in a single experiment with clinical isolate P314 (serotype 6B). Asterisks depict 
significant difference (I' ~ 0.05) in the relative protein quantity in the opaque and transparent variants. 
The expression of pyruvate oxidase is increased in transparent pneumococcal variants. 
Tryptic digestion products of protein I were analyzed by mass spectrometty. Nine amino acid 
sequences were idcntical to the amino acid sequcnce of the pneumococcal pYlllvate oxidase, 
SpxB, except for leucine 389, which was rep0l1ed as a serine by Spellerberg et al. (26) 
(Genbank accession number L39074) and as an asparagine by TIGR (Fig. 3). Since 
Spellerberg et al. analyzed the nucleotide sequence of spxB of strain R6x (26) and TIGR 
sequenced the genome of a type 4 pneumococcal strain, this discrepancy may be a strain-
specific difference. The calculated SpxB molecular mass of 65,183 Da correlated with the 
molecular ratio determined from two-dimensional protein electrophoresis, supp0l1ing the 
identity of the protein. 
Since SpxB activity is known to result in the production of H201 (26), we measured H202 
production ill the phenotypic variants of strain PI O. Opaque pneumococci produced <0.1 
mmol of H202 per liter in 1 h, which is the detection limit of the assay, whereas transparent 
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pneumococci produced 0.6 mmol ofH,O, pef liter in the same period (5 x 10' CFU/ml). In 
controls, strain D39 generated 0.45 m11101 of H20 2 per liter under similar conditions and the 
SpxB mutant of D39 produced <0.1 mmol of H,O, per liter. The higher production of H,O, 
by the transparent variant cOiTelates with the difference in the amount of protein observed by 
comparison of protein expression pattellls. 
001 MTQGKITASA AMLNVLKTWG VDTIYGIPSG TLSSLMDALA EDKDIRFLQV 
051 RHEETGALAA VMQAKFGGSI GVAWGSGGPG ATHLINGVYD AAMDNTPFLA 
101 ILGSRPVNEL NMDAFQELNQ NPMYNGIAVY NKRVAYAEQL PKVIDEACRA 
151 AISKKGPAW EIPVNFGFQE IDENSYYGSG SYERSFIAPA LNEVEIDKAV 
201 EILNNAERPV IYAGFGGVKA GEVITELSRK lKAPIITTGK NFEAFEWNYE 
251 GLTSAYRVGW KPANEWFEA DTVLFLGSNF AFAEVYEAFK NTEKFIQVDI 
301 DPYKLGKRHA LDASILGDAG QAAKAILDKV NPVESTPWWR ANVKNNQNWR 
-- -
351 DYMNKLEGKT EGELQLYQVY NAINKHADQD AIYSLDVGST TQTSTRHLHM 
401 TPKNMWRTSP LFATMGIALP GGlAAKKDTP DRQVWNIMGD GAFNMCYPDV 
451 ITNVQYDLPV INLVFSNAEY GFIKNKYEDT NKHLFGVDFT NADYGKIAEA 
501 QGAVGFTVDR IEDIDAWAE AVKLNKGGKT WIDARITQH RPLPVEVLEL 
551 DPKLHSEEAI KAFKEKYEAE ELVPFRLFLE ~QSRAIK 
Fig.3. Amino acid sequence of the pneumococcal PYnIvate oxidase (GenBank accession number L39074). 
The amino acid sequences of protein 1 derived by mass spectrometric analysis arc depicted bold and 
underlined. 
Increased expression of a proteinase maturation protein homologue in transparent 
pneulllococcal vadants. Mass spectrometric analysis of protein 2 resulted in seven peptides 
that ,,,ere all identical to a putative translation product from the TIGR pneumococcal genome 
except for amino acid 142 (Fig. 4). This TyrI42-to-Gln/Lys substitution is most probably the 
result of strain-specific differences since TIGR sequenced the genome of a type 4 
pneumococcal strain. Since glutamine and lysine have the same residue mass, it is not 
possible to distinguish between them by mass spectrometIy. The open reading frame 
encoding a hypothetical protein of 322 amino acids is located at nucleotides 7632 to 8597 on 
contig 33 of the T1GR sequence. The calculated molecular mass of this protein (35.4 leDa) is 
similar to the molecular ratio of protein 2 (35 kDa) identified by two-dimensional protein 
electrophoresis, suppoliing the identity of the protein. \Ve designated this pneumococcal 
protein PpmA (for "putative proteinase maturation protein A") because it showed significant 
homology to the proteinase maturation protein (PliM) of Lactobacillus paracasei (S\VISS~ 
PROT accession number Q02473) (Fig. 4). PrtM is essential for the production of active 
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forms of the serine protease PrtP (8, 29). In L. paracasei, the gene encoding PltP is located 
immediately downstream of prIM (11), In S. plleumolliae, no open reading frame homologous 
to serine proteases is found downstream of ppmA. PrtM is a membrane-bound lipoprotein in 
lactic acid bacteria (8). Also, ppmA contains a signal sequence of bacterial lipoproteins (Fig. 
4). 
Protein 2: 8 
PrtM 1 
Protein 2: 54 
PrtM 50 
Protein 2: 104 
PrtM 100 
Protein 2: 154 
PrtM 148 
Protein 2: 204 
PrtM 197 
Protein 2: 254 
PrtM 247 
MKKKLLAGAITLLSVAT----LAACSKGSEGADLISMKGDVITEHQFYEQ 
MKKK+ + L S AT L+ C++ G +TE FY++ 
MKKKMRL-KVLLASTATALLLLSGCQSNQADQKVATYSGGKVTESNFYKE 
VKSNPSAQQVLLNMTIQKVFEKQYGSELDDKEVDDTIAEEKKQYGENYQR 
+K +P+ + +L NM I + YG + K V+D K+QYGEN+ 
LKQSPTTKTMLANMLIYRALNHAYGKSVSTKTVNDAYDSYKQQYGENFDA 
VLSQAGMTLETRKAQIRTSKLVELAVKKVAEAELTDEAYKKAFDEYTPDV 
LSQ G + + K +RT+ L E+A+KK+ ++++ K + Y P V 
FLSQNGFSRSSFKESLRTNFLSEVALKKL--KKVSESQLKAVWKTYQPKV 
TAQIIRLNNEDKAKEVLEKAKAEGADFAQLAKDNSTDEKTKENGGEITFD 
T Q I L +++ + + A G DFA LAK +S D TK+NGG+I+F+ 
TVQHI-LTSDEDTAKQVISDLAAGKDFATLAKTDSIDTATKDNGGKISFE 
SASTEVPEQVKKAAFALDVDGVSDVITATGTQAYSSQYYIVKLTKKTEKS 
S + + K AA+ L + + S 
SNNKTLDATFKDAAYKLKNGDYTQTPVKVTNGYEVIKMINHPAKGTFTSS 
SNIDDYKEKLKTVILTQKQNDSTFVQSIIGKELQAANIKVKDQAFQNIFT 
K + 
KKALTASVYAKWSRDSSIMQRVISQVLKNQHVTIKDKDLADALDSYKKPA 
Protein 2: 304 QYI 306 
PrtM 297 TTN 299 
Fig. 4. The hypothetical pneumococcal protein encoded by nucleotide 7,632 to 8,597 on contig 33 oflhe TIGR 
pneumococcal genome (protein 2) displays 41 % sequence similarity 10 the proteinase maturation protein (PrtM) 
of L. paracasei (SWISS-PROT accession number Q02473). The putath'e lipoprotein signal sequence is 
underlined. The amino acid sequences of protein 2 derived by mass spectrometric analysis are depicted in bold. 
Differences in the amount of PpmA in the phenotypic variants were also demonstrated by 
Western blot analysis. Whole-cell Iysatcs from a ppmARnegative mutant and its parent strain 
demonstrated the PpmA band position (Fig. 5, lanes I and 2). When equivalent amounts of 
bacterial lysates of phenotypic variants of strains P 10 and P314 were compared on Western 
blots, the amount of Ppm A was larger in the transparent variants (lanes 4 and 6). 
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1 2 3 4 5 6 
-43 
-29 
Fig. 5. Western blot analysis of phenotypic variants with anli-PpmA rabbit senUll. The amount of PpmA was 
compared in equivalent amollnts of whole celilysates of opaque (lane 3 and 5) and transparent (lanes 4 and 6) 
variants of pneumococcal clinical isolate P 1 0 (lanes 3 and 4) and P3 I 4 (lanes 5 and 6). The ppmA -deficient 
mutant (lane 2) and its parenl strain 039 (lane 1) were used as controls. Numbers indicate the molecular size 
markers (in kilodaltons). The arrow indicates the PpmA protein band. 
Reduced production of a putative elongation factor Ts in transparent pneumococcal 
variants. Mass spectrometric analysis of tryptic digestion products of protein 3 revealed 
three peptide sequences that were identical to a putative translation product from. the TIGR 
pneumococcal genome (Fig. 6). The open reading frame encoding a hypothetical protein of 
359 amino acids is located at nucleotides 911 to 1987 on contig 50 of S. pneutlloniae. The 
calculated molecular mass (38.9 kDa) cOITelates with the molecular ratio of protein 3 (40 
kDa) determined by two-dimensional protein electrophoresis. This protein showed significant 
homology to elongation factor Ts (EF-Ts) of Helicobacter pylori J99 (SWISS-PROT 
accession number AEOOI567) (Fig. 6). 
DISCUSSION 
Phenotypic variation is an impOliant mechanism that allows bacterial pathogens to adapt to 
different host environments. The ability to survive in different host environments is the result 
of molecular adaptation, e.g., changes in the expression of specific cell surface components 
(10,31). The expression of four previollsly identified proteins has been examined in phase 
variants of S. pneul11oniae. PspA is expressed in larger amounts in the opaque phenotype, 
whereas CbpA and LytA are expressed in larger amounts in the transparent phenotype (13, 
21,33). No difference in pneumolysin expression has been found by \Vestern blot analysis of 
whole cell Iysates of the opaque and transparent variants (13). In this study, we identified and 
characterized three additional proteins that are differentially expressed in phenotypic variants 
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Protein 3: 14 MAEITAKLVKELREKSGAGVHDAKKALVETDGDIEKAIELLREKGMAKAA 
H+ I+A+LVK+LR+ + AG+HD KKALVE GD++KAI+ LREKG++KAA 
EF-Ts 1 HSGISAQLVKKLRDLTDAGr>lHDCKKALVEVAGDLQKAIDFLREKGLSKAA 
Protein 3: 64 KKADRVAAEGLTGVYVNGNV--AAVIEVNAETDFVAKNAQFVELVNTTAK 
KKADR+AAEG+ + V + A ++E+N+ETDFVAKN F ELV T + 
EF-Ts 51 KKADRlAAEGVVALEVAPDFKSAHMVEINSETDFVAKNEGFKELVKKTLE 
Protein 3: 112 VIAEGKPANNEEALALINPSGETLEAAYVSATATIGEKISFRRFALIEKT 
I EE L + + + E S A IGE I R+ A ++ 
EF-Ts 101 TIKTHNIHTTEELLKSPLDN-KPFEEYLHSQIAVIGENILVRKIAHLKAP 
Protein 3: 162 DAQHFGAYQHNGGRIGVISVVEGGDEA-------LAKQLSNHlAAMKPTV 
+Y H+ R+GV+ +E +E LA+ ++HH AANKP V 
EF-Ts 151 SSHIINGYAHSNARVGVLIAIEYNNEKNAPKVVELARNIAHHAAAMKPQV 
Protein 3: 205 
EF-Ts 201 
LSYKELDEQFVKDELAQLNHVIDQDNESRAHVNKPALPHLKYGSKAQLTD 
L K+ FVK E L I++DNE + KP +GS+ +L+D 
LDCKDFSLDFVKKETLALIAEIEKDNEEAKRLGKPLKNIPTFGSRIELSD 
Protein 3: 255 DVIAQAEADIKAELAAEGKPEKINDKIIPGKHDRFHLDNTKVDQAYTLLA 
+V+A + + EL +GKPEKH1DKI+PGKM+RF+ DNT +DQ TLL 
EF-Ts 251 EVLAHQKKAFEDELKEQGKPEKIWDKIVPG~4ERFIADNTLIDQRLTLLG 
Protein 3: 305 
EF-Ts 301 
QVYIMDDSKTVEAYLESV------NASVVEFARFEVGEGIEKAANDF 
Q Y+HDD KT+ + N + E+ RFE+GEGIEK +F 
QFYVNDDKKTIAQVIADCSKEWDDNLKITEYVRFELGEGIEKKTENF 
Fig. 6. The hypothetical pneumococcal protein encoded by nuclcotides 911 to 1987 on contig 50 of the TIGR 
pneumococcal genome (protein 3) displays 61% sequence similarity to EF-Ts of H. pylori J99 (SWISS-PROT 
accession number AEOOI567). The amino acid sequences of protein 3 derived by mass spectrometric analysis 
are depicted in bold. 
of S. jJnewllol1;ae. The minimal protein amount necessary for detection and identification by 
mass spectrometric analysis is about 500 fmol. For this reason, gels were stained with CBB 
and not by the more sensitive silver-stain method, since only proteins visualized by eBB 
staining reached the mass spectromehy analysis detection level. This may explain why we 
did not confi11111he diffential expression of LytA, PspA, and CbpA inlhe phenotypic varianls 
and why we identified differential expression of three proteins only. 
We demonstrated that the expression of pymvate oxidase was increased in the transparent 
variants. PYl11vate oxidases are crucial for aerobic carbohydrate metabolism of several 
streptococci (4). This enzyme decarboxylates pyruvate to acetyl phosphate, resulting in the 
release of H Z0 2 and CO2_ In S. pneul1loniae, the release of H Z0 2 is mainly the result of SpxB 
activity, since a spxBMdefective mutant produces virtually no H Z0 2 in comparison with the 
parent strain (26). Therefore, the higher expression of SpxB in the transparent phenotype 
most probably explains the increased production of hydrogen peroxide. Spellerberg et al. 
have identified pyruvate oxidase as an indirect determinant of virulence in S. pneu1110niae 
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(26). A spxB mutant has a decreased ability to colonize the nasopharynx in a rabbit model. 
This is reflected by the lower capacity of binding to the nasophatyngeal cells and to their 
glycoconjugate receptors. The decreased ability of spxB~defective pneumococcal mutants to 
colonize the nasopharynx and the increased expression of SpxB in transparent variants 
suggests the potentially important role of SpxB in efficient colonization of the nasopharynx 
by transparent variants (26). The expression level of SpxB is unlikely to directly determine 
colony morphology, since the spxB mutant of D39 still varies in colony morphology (J. N. 
Weiser, unpublished data). 
The second protein with increased expression in the transparent variant demonstrated 
significant sequence homology to proteinase maturation protein (PrtM) of 1. paracasei. L. 
pal'acasei and other lactic acid bacteria arc used in the food industry for the production of a 
variety of fermented milk products. During growth, these bacteria produce cell envelope-
located serine proteases that break down caseins, the major proteins in milk. P,1M is a trans-
acting protein involved in the maturation (processing into active proteins) of serine protease, 
PltP (29). PliM belongs to the jhmily ofpeptidyl-prolyl cis/lralls isomerases that are thought 
to assist in protein folding by catalyzing the cis-trans isomerization of the peptidyl-prolyl 
bonds in peptides and proteins (22). PpmA contains an N-terminal lipoprotein signal 
sequence, which suggests that Ppm A, like PrtM (8), is membrane bound. We hypothesize that 
PpmA also functions as a membrane-bound molecular chaperone. In L. paracasei, the gene 
encoding PliP is located inunediately downstream of priM (II). Both priM and prlP were 
found to be transcribed from the same promoter region but in opposite directions (29). In S. 
pllell11loniae, no open reading frame homologous to a serine protease could bc located in the 
direct vicinity of ppmA. The pneumococcal proteins activated by PpmA are currently 
unknown. We demonstrated differential expression of PpmA in the phenotypic variants of S. 
pl/ellmon/ae, which suggests that PpmA may playa role in the pathogenesis of infections. 
PpmA is more prevalent in the transparent phenotype that is selected for during 
nasopharyngeal colonization, suggesting that PpmA is directly involved in adherence through 
maturation of surface proteins with adherence properties or indirectly by the activation of 
proteases or other secreted proteins. 
The expression of the third protein, identified as EF-Ts was increased in the opaque 
phenotype. EF-Ts is essential for the elongation of the polypeptide chain during protein 
synthesis. The protein mediates the regeneration of EF-TU'GDP into the active fon11 EF-
Tu·GTP. This active fonn ofEF-Tu facilitates the entry ofaminoacyl-tRNA to the ribosome, 
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enabling protein synthesis. Differential expression ofEF-Ts has been found previously in the 
gram-negative bacterium Coxiella bl/l'llelii (25), the causative agent of Q fever. This obligate 
intracellular parasite replicates in distinct morphological fonns that may allow potential life 
cycle variants to survive the harsh environment of the phagolysosome, Two distinct 
morphological forms of C. burnetii have been described, a large-cell variant and small-cell 
variant. Large-cell variants are metabolically more active than small-cell variants (15). This is 
supported by data showing that EF-Ts and EF-Tu were more prevalent in large-cell variants 
(25). We hypothesize that the increased presence of elongation factor Ts in the opaque 
variants of S. pneulIlolliae indicates that, like in C. bUl'1Ietii, the opaque variants arc 
metabolically more active, which may explain the rapid invasive growth characteristics of 
these variants. 
This study sho\vs that the combination of two-dimensional protein gel electrophoresis, mass 
spectrometry, and genomics is a powerful tool for the identification of differentially 
expressed proteins in phenotypic variants of S. pneumoll;ae, We have identified differential 
expression of pymvate oxidase, a new member of the family of peptidyl-prolyl cis/trans 
isomerases (PpmA), and EF-Ts in pneumococcal phenotypic variants of type 9V and 6B 
clinical isolates. We hypothesize that the higher expression of both pymvate oxidase and 
PpmA in the transparent phenotype correlates with increased adhesive properties and ability 
to colonize the nasopharynx. The higher expression of EF-Ts in the opaque variant might 
indicate a higher metabolic activity. 
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SUMMARY 
An inverse conelation between colonization of the human nasopharynx by Streptococclis 
pneumolliae and Haemophi/us injluellzae, both common upper respiratory pathogens, has 
been repOlted. Studies ,,,ere undertaken to determine if either of these organisms produces 
substances which inhibit growth of the other. Culture supernatants from S. pnellf1lolliae 
inhibited growth of H. h!(luenzae, whereas culture supernatants from H. i1~fluellzae had no 
effect on the growth of S. pneu11Ioniae. Moreover, coculture of S. pneumol1;ae and H. 
b!!1uellzae led to a rapid decrease in viable counts of H. i1!(luenzae. The addition of purified 
catalase prevented killing of H. il!lluenzae in coculture experiments, suggesting that hydrogen 
peroxide may be responsible for this bactericidal activity. H. h!/luenzae was killed by 
concentrations of hydrogen peroxide similar to that produced by S. pneumoniae. Hydrogen 
peroxide is produced by the pneumococcus through the action of pymvate oxidase (SpxB) 
under conditions of aerobic grmvth. Both an spxB mutant and a naturally occurring variant of 
S. pneulI/oJliae, which is downregulated in SpxB expression, were unable to kill H. 
ir{/luellzae. A catalase-reversible inhibitOIY effect of S. pJlelfmoniae on the growth of the 
respiratOIY tract pathogens ll10raxella catarrhalis and Neisseria mellillgitidis was also 
observed. Elevated hydrogen peroxide production, therefore, may be a means by which S, 
pnellf1loniae is able to inhibit a Variety of competing organisms in the aerobic environment of 
the upper respiratory tract. 
INTRODUCTION 
Bacterial pathogens are generally shtdied individually, although in their natural environment 
they often coexist or compete \vith mUltiple other microbial species. The focus of this report 
is bacterial pathogens that commonly colonize and infect the respiratory tract of humans. The 
results of clinical studies that surveyed the etiologic agents in cases of otitis media in children 
and chronic bronchitis in adults showed that StreptococCllS pnellll10niae and Haemopliilus 
ili/II/ellzae are the most prevalent bacterial pathogens (14, 23). The frequcncy with which 
these two species are isolated from the same specimen, however, is significantly less than 
would be predicted based on their relative prevalence (25, 30). This suggests that there may 
be inhibitOlY effects of one species on the other in vivo. This would not be an unexpected 
finding considering our cun'ent understanding of the pathogenesis of colonization and 
infection by these species. For instance, since both S. pllel/moniae and H. h!/luellzae express 
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cell surface phosphorylcholine, which mediates adherence to the receptor for platelet-
activating factor, there may be competition for the same host cel1 receptor (12, 35, 46), In 
addition, phosphmylcholine is immullogenic, and antibody generated against 
phosphOlylcholine from one species may promote clearance of a heterologous species 
bearing the same epitope (9, 31, 45). However, the presence of phosphoryl choline is required 
for viability in the case of the pneumococcus, while H. in}7uellzae is able to switch off 
expression of this antigen (44, 51). Another example is the neuraminidase secreted by the 
pneumococcus, which has the potential to remove sialic acid residues from bacterial 
competitors known to express this as a cel1 surface stlllcture (6, 10), The lipopolysaccharide 
of the respiratory tract pathogen, Neisseria meningitidis, and at least some strains of H. 
il!/luellzae are sialylated and, in the case of the fonner, this modification acts to increase 
resistance to clearance mediated by complement (17, 21, 28, 29). 
In order to begin to examine the interactions of the coinhabitants of the heavily colonized 
mucosal surface of the human upper respiratOlY tract, we tested the effect of coculture in vitro 
on growth and viability. These studies revealed that the pneumococcus produces an inhibitOlY 
substance that was shown to be hydrogen peroxide. This suggests that the production ofH20 2 
by S. pl1eultlolliae, previously shown to be cytotoxic for cultured alveolar epithelial cells, may 
also be an effective mechanism for limiting or eliminating competitive flora, including 
conunon pathogens such as H. h!fluenzae and N. meningitidis, which share the same 
microenvironment (15). These species, furthennore, are sensitive to levels of peroxide 
generated by the pneumococcus despite their production of catalase, an enzyme that acts to 
eliminate hydrogen peroxide (7, 8, 37). 
MATERIALS AND METHODS 
Bacterial strains, mcdia, and chemicals. Strains used in this study are described in Table 1. 
All strains were cultured in brain heart infusion broth (BHI) with or without 1.5% agar (Difco 
Laboratories, Detroit, Mich.). H. iI!/luenzae was grown in BHI medium supplemented with 
hemin and L~histidine (dissolved in 1 % triethanolamine, each at a final concentration of 2.5 
flg/m!) (sBHI) plus NAD (2.0 flg/ml) (Sigma Chemical Co., St. Louis, Mo.). All organisms 
were grown at 37°C with aeration except streptococci, which were grown without shaking. 
Plates containing streptococci and lleisseriae were incubated in the presence of supplemental 
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carbon dioxide using candle extinction jars. Pneumococci were plated on BHI containing 200 
U of bovine liver catalase per ml (Worthington Biochemical, Freehold, N.J.). 
Supernatant inhibition assays. Cultures of S, plleul110niae P394 were grown in liquid BHI 
medium at 37°C under atmospheric conditions. After rcaching mid-log phase (optical density 
at 620 lllll [OD62o] ~ 0.3 to 0.4), the cultures were harvested and spun at 10,000 x g for 2 min, 
and the supernatant was filtered through 0.2-111m (pore-size) filters. The target organism was 
grown in liquid BHl or sBHl medium to mid-log phase (OD62o ~ 0.3 to 0.4) and then diluted 
10-fold in phosphate-buffered saline (PBS). Bacterial lawns were obtained by spreading 50 ~I 
of diluted culture on BHl or sBHI agar with or without 200 U of catalase per ml. Then, 1 O-~I 
aliqnots of supernatant were spotted onto these plates and allowed to dry prior to incubation 
at 37°C for 16 h. In some experiments, aliquots of supernatant were treated with proteinase K 
(final concentration, 50 flg/ml; Sigma) at 37'C for 1 h or heated to 65'C for 20 min prior to 
adding them to plates containing target organisms. 
Co culture experiments. Bacteria were grown in BRI medium at 37°C until mid~log phase 
(OD62o ~ 0.3 to 0.4), centrifuged for 2 min at 10,000 x g and 4'C, washed in ice-cold Hanks 
balanced saline solution (HBSS; Gibeo BRL, Gaithersburg, Md.), and then resuspended in 
BHI at the original culture volume. Equal volumes of S. p"ellmoniae and the target strain 
were then mixed and incubated at 37'C in 96-well polystyrene microtiter plates (Dynex 
Technologies, Inc., Chantilly, Va.). As a negative control, each strain was mixed with an 
equal amount of BHI alone. Where indicated, individual wells were supplemented with 
catalase (final concentration, 1,000 U/ml). Serial dilutions were then prepared in HBSS, and 
an aliquot was plated on BHI agar plates containing catalase (final concentration, 200 U/ml) 
for viable counts. Dilutions of mixed cultures ,vere spread on BHl plates supplemented with 
2.0% Fildes enrichment (Difco) and grown under atmospheric conditions which selectively 
inhibited the growth of S. pneulIloniae and allowed enumeration of the target species. 
Removal of the Fildes enrichment, which provides a source of hemin and NAD, provided 
selective conditions preventing the growth of H injluenzae. 
Hydl'ogen peroxide sensitivity assays. Bacteria were grown in BHI medium at 37°C until 
mid-log phase (OD62o ~ 0.3 to 0.4), centrifuged for 2 min at 10,000 x g and 4'C, washed in 
ice-cold HBSS, and resuspended in fresh BRI medium. Resuspended bacteria were added to 
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Table 1. Hydrogen peroxide sensitivity and production by various bacterial pathogens 
Species MIC MBC H101 generated Source or reference d 
{mMt (mM)b (111M)' 
Gram-negative 
H. illjlllenzae Rd 0.4 0.5 <0.1 26 
H. b!/lucllzae Eagan 0.4 0.5 <0.1 26 
A~ mel/if/gitidis MC58C3 0.4 5 <0.1 32 
M. catorrhalis Bel 1.1 160 <0,1 Clinical isolate 
E. coli RS218 ND 15 <0.1 I 
S. enlerica serovar Typhil1lurium LT2 ND 20 <0.1 Collection of K. Sanderson 
K. pJleulI/oniae Kp 1 ND 20 <0.1 Clinical isolate 
P. aallgil/osa PAO 1 ND 60 <0.1 ATCC 15692 
Gram-positive 
S. p),ogel1es P87 ND 40 <0.1 Clinical isolate 
s, agalactiae P60 ND 80 <0.1 Clinical isolate 
S. equisimilis PI07 ND 20 <0.1 Clinical isolate 
E. jaeciu/11 P 119 ND 80 <0.1 Clinical isolate 
S. aureus Al ND 10 <0.1 Clinical isolate 
S. pllelflllolliae strains 
P394 (type 4) 1.6 80 TIGR genome strain 
D39 (type 2) 1.2 80 0.44 ± 0.08 4 
P383 (type 68) ND ND 0.53± 0.08 22 
P384 (type 6A) ND ND 0.71 ±0.13 22 
P878 D39 (spxB::Tnp/ZoA) 1.6 80 <0.1 38 
P62 (type 9V opaque variant) ND ND <0.1 22 
P64 (type 9V transparent variant) ND ND 0.43 + 0.13 22 
~The MIC was dctenllillcd as the minimum concentration of H101 necessary to prevent turbid growth of a I-in-
50 inoculum of a stationary-phase culture following ovemight incubation at 37°C. ND, not determined. 
bThe.MBC \vas dctcnnincd as the minimum concentration ofH20 2 necessary for >99.9% killing of washed, log-
phase cells in BHI medium after 30 min at 37°C. 
cH20 2 concentration present in culture supematants after incubating approximately 5 x 107 washed, log-phase 
cells for I h ill BHI medium at 37°C, 
dTIGR, The Institute for Genome Research. 
microtiter plate wells in duplicate containing twofold dilutions of H,O, (Sigma) in BRI 
medium and incubated at 37°C for 30 min. Aliquots from each well were applied to BHI agar 
plates containing 200 U of catalase per ml for viable counts. The concentration of H202 
required to cause a 99.9% decrease in the number of colonies com.pared to the negative 
control without peroxide was recorded as the minimum bactericidal concentration (MBC). 
For MIC determination, 50-fold dilutions of stationary-phase cultures in BHI containing 
twofold dilutions of H20 2 were incubated at 37°C overnight. The minimum concentration 
necessary to prevent turbid grmvth was considered the MIC. 
Hydrogen peroxide production assays. Hydrogen peroxide production was measured in an 
assay developed by Pick and Keisari and modified by Duane and coworkers (15, 36). 
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Bacteria were grown in BHI medium at 37'C until mid-log phase (OD620 ~ 0.3 to 0.4), 
centrifuged for 2 min at 10,000 x g and 4°C, washed in ice~cold HESS, and resuspended in 
BHI medium to twice the original culture volume. Wells for negative controls contained 
1,000 U of catalase per mI. After 1 h of incubation under atmospheric conditions at 37°C, the 
cultures were harvested, spun at 10,000 x g for 2 min, and filtered through a 0.2-rtm (pore-
size) membrane. Immediately prior to the assay, phenol red and horseradish peroxidase were 
added to peroxide assay buffer (5.0 mM K,HPO" 1.0 mM KH,P04, 140 mM NaCl, 0.5 mM 
glucose; pH 7.4) at final concentrations of 0.46 mM and 0.046 U/ml, respectively. Aliquots 
of filtered supcll1atant were added to the assay mixture at a ratio of 1 to 4 and incubated for 
30 min at 37'C in duplicate. After the reactions were stopped by the addition of NaOH (final 
concentration, 0.004 N) the absorbance was recorded at a wavelength of 610 11111. 
Concentrations were calculated in comparison to a standard curve with known amounts of 
H20 2 added to control supematallt from wells containing catalase whieh had been heated to 
100°C for 20 min to eliminate catalase activity. 
Two-dimensional protein gel electrophoresis. Two-dimensional protein gel electrophoresis 
follmved by staining, computerized comparison, and mass spectrometric analysis of the 
proteins, was done as described elsewhere (35a). 
\Vestel'll transfer and immulloblotting. P878 containing an in-frame fusion of TnphoA to 
the gene for pymvate oxidase (spxB) was grown on tIyptic soy agar plates containing catalase 
(200 U/m!) (38). Bacteria were grown for 16 h at 37'C under atmospheric conditions (20% 
O2, 0.03% CO2), in a candle extinction jar (17% 02, 3%C02). or in the GasPak anaerobic 
system «0.01% 0,,10% CO,) (Becton Dickinson, Cockeysville, Md.). Cells were harvested 
from plates, adjusted to equal density based on absorbance at 620 11m, washed in cold PBS, 
and treated at 100'C for 5 min in gel loading buffer (50 mM Tris-CI, pH 6.8; 100 mM p-
mercaptoethanol; 10% glycerol; 2% sodium dodecyl sulfate [SDS), I % bromophenol blue) 
prior to separation in SDS-IO% polyacrylamide gel electrophoresis (pAGE) gels. Equal 
loading was COnfil111ed by measurement of total protein in whole-cell sonicates using the 
Micro BCA Protein Assay (Pierce Chemical Co., Rockford, Ill.). After transfer to Immobilon 
P membranes (IvIillipore Co., Bedford, Mass.), immulloblotting was carried out with an 
antibody raised against PhoA and detected with an antiserum to rabbit immunoglobulin G 
conjugated to alkaline phosphatase as described previously (43). 
142 
Bactericidal eJJect a/peroxide production 
RESULTS 
Bactericidal effect of S. plleul1Iolliae 011 H. illjluellZfle. The hypothesis that pathogens 
inhabiting the same host environment might generate grmvthRinhibitory substances was 
examined. Initial experiments tested the effect of culture supernatant of S. plleu11Ioniae P394 
and H. il~{ltle1/Zae Rd on the growth of the other species. Aliquots of culture supernatant 
filtrates from one organism were added to a lawn of the other organism which had been 
spread on solidified medium which supports the growth of only that species. A zone of 
completely inhibited growth was observed when supernatants from S. pneu1110niae were 
added to lawns of H. il!{llleJlzae, while the inverse showed no observable effect on growth 
(data not shown). This demonstrated that S. pneulIlolliae produced a substance that inhibited 
the growth of H h!{luenzae. Similar results were obtained using three nontypeable clinical 
isolates of H. h!/!uellzae, as well as the type b isolate, Eagan. Likewise, unrelated S, 
pl1eu11loniae clinical isolates of types 2, 6A, and 6B were all capable of inhibiting the aboveR 
mentioned strains of H. h!{luellzae, demonstrating that the observed effect was not strain 
specific, 
To test whether this growthRinhibitory effect was also bactericidal, both species ,vere grmvn 
to midRJog phase and cocultured in liquid medium. When 108 CPU of H. h!{luel1zae Rd per ml 
\vere cocultured with 5 x 107 CFU of S. plleu1Jlolliae P394 per ml, the viable count of H. 
iI/fluellzae decreased to below detectable levels (l04 CFU/ml) within 3 h, whereas the viable 
count of H. ilt/!uellzae cultured in the absence of S. pnell11loniae under the same conditions 
increased to 109 CFU/ml (Fig. 1). In contrast, the viable count of S. pneu11Ioniae increased to 
108 CPU/mI, whether cultured with H illjluenzae or in the absence of H. illjluenzae. These 
observations showed that the substance produced by S. pneu11loniae was not only inhibitory 
but also bactericidal against H. h!{luellzae. 
In similar doseRrcsponse experiments, 107 CFU of S. plleu1t1oniae per ml reduced thc number 
of H. illfluellzae from 108 to 104 CFU/ml within 3 h (Fig, 2), S, pllelllllolliae at 106 CFU/ml 
reduced the equivalent number of H. ht(luellzae approximately 10-fold within 3 h. The 
growth of the equivalent number of H. b!/!uellzae with 105 CFU of S. pneul1lol1iae per ml was 
comparable to that of H. i1!{luenzae grown in the absence of S. pneul1lolliae. 
The bactericidal effect of S. pnelllllolliae is due to hydrogen peroxide production. 
Supernatants from cultures of S. pneu11lolliae treated with proteinase K or heatcd to 65°C for 
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Fig. 1. Effect of coculture of S. plleulllolliae P394 and H il!/lflcllzae Rd. Following growth to mid-log phase, H. 
injluenzae was washed and incubated in sSHl containing heal-inactivated catalase either with (U) or without 
(0) S. pllelllllofliae for the time indicated, and viable COllnts were detennined in duplicate on selective media. 
Viable COUllts of S. pllellmolliae incubated in coculturc with (III) or without (8) H. ill/1llenzae were detennined 
in duplicate by plating on selective mcdia, The same amount of active catalase (1,000 U/ml) was included 
during COCUltUfC of S. pllel/Illoniae (A) and H. illj1uellzae (6.). Values represent the average of three 
independent delemlinations in duplicate, and the error bars represent the standard deviations. 
20 min retained inhibitory activity, suggesting that the inhibitOlY substance was not likely to 
be a protein (data not shown). In addition, the inhibitory effect was diminished when S. 
plleul1Ioniae was grown under less-than-atmospheric levels of environmental oxygen (data 
not shown). It had previously been shown that S. plleulIloniae makes substantial amounts of 
H20, when grown aerobically (2, 34). It was therefore suspected that the inhibitory effect of 
S. pne1l11loniae supernatant might be due to H20 2 production. Further support for this 
possibility came from the observation that the inhibitory effect was inversely proportional to 
the level of hemin in the growth medium (data not shown). Hemin had previously been 
shown to mitigate the effects of oxidative stress on H. i1~/lllellzae, presumably because of its 
ability to decompose hydrogen peroxide (24, 27). Catalase, a heme-containing enzyme which 
specifically degrades H20" was then added to BHI plates at a concentration of200 Vim!' 
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Fig. 2. Dose-dependent killing of H. illjlllellzae Rd by S. pneul/loniae P394. Following growth to mid-log 
phase, H. injillcllzae was washed and cultured alone (triangles) or with 105 (squares), 106 (circles), or 107 
(diamonds) CFU of S. plleulI/olliae per ml and incubated in sBHI for the times indicated; viable counts were 
detennilled on selective media. Values represent the average of two independent detemlinations in duplicate 
This eliminated the inhibitOlY effect of S. pnellmoniae culture supernatants on H. h~fluenzae 
(data not shown). 
The effect of catalase on the bactericidal activity of S. pneufllolliae was then explored using 
quantitative cocuIture experiments with bacteria grown in liquid medium. H. if!lluenzae 
cultured with S. pnellfJloniae in the presence of 1,000 U of catalase per ml grew at the same 
rate as H. if!lluellzae cultured alone, whereas heat-inactivated catalase (lOO°C for 20 min) 
was unable to eliminate the bactericidal activity of S. pneufllolliae (Fig. I). To confirm that 
hydrogen peroxide ,vas responsible for the bactericidal activity of the pneumococcus, 108 
CFU of H. b!flllellZae per 1111 were cocultured with 5 x 107 CPU of an S. pneumoniae strain 
per ml in which the pymvate oxidase gene (spxB) was insertionally inactivated. This mutant 
has previously been shown to produce <1 % of the H20, of its parent strain, D39 (38). As 
expected, the spxB mutant was unable to kill H. injllfellzae in cocuIture experiments, in 
contrast to its parent strain D39 (Fig. 3). The growth ofD39 and that of the spxB mutant were 
indistinguishable under these conditions. 
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Fig. 3. Effect of co culture ofR. bl!1uellzae Rd with S. plleulI/olliae D39 and its spxB mutant, P878. Following 
growth to mid-log phase, H. bl}ltlcllzae was washed and incubated in sBHI alone (0), with D39 (U), or \vith 
P878 ( L:::.) for the times indicated, and viable counts were dctcnnined in duplicate on selective mcdia. Viable 
counts of D39 (III) or P878 ( .... ) incubated in coculture with H. illfluellzae were detennillcd in duplicate by 
plating on selective mcdia. Vollies represent the average oftbree independent detennillutions in duplicate, and 
the error bars represent the standard deviations. 
Bactericidal effect of S. plleumon;ae on other respiratory tract pathogens. The inhibitOlY 
effect of S. pneu1J1oniae was tested on two other common inhabitants of the human 
respiratory tract: a clinical isolate of !J1ol'axella catal'rflalis and an unencapsulated mutant of 
a type b N lIIel/il/gitidis strain (MC58C3). Catalase-reversible inhibition of N. lIIel/il/gitidis 
by supernatants from S. pneulllolliae culture was obsetved on BHI agar. While an illhibitOlY 
effect of pneumococcal slipematant was not seen on lawns of 1\1. catarrhalis, cross-streaking 
of S. plleuf1loniae and M. catarrhalis on BHI agar revealed a catalase-reversible inhibitory 
effect on kf. catarrhalis only in the immediate vicinity of S. pllellf1loniae. Coculture 
experiments to examine the bactericidal effect on these species showed that 108 CFU of N. 
mellillgitidis per 1111 incubated with 5 x 107 CFU/mi S. pl1eumoniae for 1.5 h resulted in a 
catalase-reversible 45 ± 19% decrease in viable count compared to N. mel1ingitidis cultured in 
the absence of S. plleu1l1011iae (Fig. 4). ivl. calarrhalis grown at 108 CFUfml in the presence of 
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5 X 107 CFU of S. pneu11Ioniae per 1111 for 3 h resulted in a catalase-reversible 43 ± 21% 
decrease in viable counts compared to Ai catarrhalis grown alone (Fig. 4). In contrast, the 
viable count of S. pneumoniae increased substantially when grO\vn with either N. meningilidis 
or M. catarrhalis compared to S. jlneul110niae grown alone (Fig. 4). 
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Fig. 4. Effect of coculture of S. pllel/moniac P394 \yith either M. calarrha!is (Bcl) or N. mCllillgitidis (MC58C3). 
Following gro\\1h to mid-log phase, S. pllel/lI/oniae (P394) was washed and incubated in BI-lI alone, \vith N. 
mClIillgitidis (MC58C3) for 1.5 h, or with M. calarrhalis (Bel) for 3 h. Viable counts of N mellillgitidis (stippled 
bar) or M. calarrhalis (hatched bar) incubated in eoculture with S. p"cllmolliac were detennined in duplicate by 
plating on selcctive media. Viable counts of S. pnelfmonitle in coculture with N. mellillgilidis (black bar) or M. 
cata/"rhalis (white bar) were detennined in duplicate Oil selectiyc media. Values rcpresent the change in viable 
count expressed as a percentage of a control culture containing that organism alone. Values arc the average of 
three experiments, and error bars represent the standard deviations. 
Hydrogen peroxide production and sensitivity to hydrogen peroxide. The relative 
sensitivities of S. pneuf1lolliae P394 and the three other respiratOlY tract pathogens to 
hydrogen peroxide were examined using quantitative H202 challenge assays (Fig. 5). After a 
30~lllin exposure to 0.1 mM H202, the survival of S. pneuf1loniae, .Af. catarl'halis, and N. 
meningitic/is ,vas unaffected, whereas the number of viable H. h!{llienzae decreased by 
approximately twofold. At a concentration of 1.0 mM H20 1, the survival of S. pneuf1loniae 
and Arf. cata,.,.halis was unaffected, whereas the number of H. h!{luenzae decreased 
approximately 2,OOO-fold, and the number of N. meningitidis decreased approximately 20-
fold. At a concentration of 10 mM H201, H. iJ!{luellzae and N. meningitidis decreased to 
undetectable levels « I 00 CFU/ml), whereas the number of S. pnellUlolliae decreased only 
threefold, and 1\1. catarl'halis was unaffected. 
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Fig. 5. Effect ofH20 2 on the survival of S. pllel/Illol/iae (P394), M. calarrlwlis (Bel), N. mellillgilidis (MC58C3), 
and H. illjlllellzae (Rd), Following growth to mid-log phase, S. pllelllllolliae (black bars), AI. cafarrhalis (white 
bars), N. lIIellillgitidis (stippled bars), or H. injluellzae (hatched bars) were washed and incubated at 3TC in EI-II 
or sBHl containing the indicated concentration of H101. After 30 min, yiable counts were dctcnnined on DBI or 
sBHI plates containing 200 U of catalase per Illi. Values represent the average of three independent 
detemlinations in duplicate, and the error bars represent the standard deviations. *, Below the limit of detection. 
A survey of bacterial species was made to detennine if the levels of hydrogen peroxide 
production and resistance exhibited by S. jJneumoniae are unusual among human pathogens. 
Of the species tested for peroxide generation, only S. pneumoniae isolates exhibited 
production of detectable levels (>0.1 mM) of hydrogen peroxide using a horseradish 
peroxidase-phenol red assay (Table 1). Survival in different concentrations of exogenously 
added H20! varied widely among the species of gram-negative and gram-positive bacteria 
tested. The species most susceptible to growth inhibition and killing by H20, was H. 
illfluellzae (MIC, 0.4 mM; MBC, 0.5 mM). N. menillgitidis was also relatively sensitive 
(MIC, 0.4 mM; MBC. 5.0 mM). Nf. catarrha/is was relatively insensitive to the effects of 
hydrogen peroxide (MTC, I.ImM; MBC, 160 mM). The pneulllococcus was also relatively 
insensitive (MIC, 1.6 111M; MBC, 80 mM), thus explaining its ability to survive endogenollsly 
produced hydrogen peroxide. 
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Factors affecting hydrogen peroxide production by S. 1'lIeUlllolliae. Strains P62 and P64, 
two naturally OCCUlTing phase variants of the same strain, were tested for H202 production 
after it was determined by comparison of two-dimensional gel electrophoresis of whole 
bacterial proteins followed by micro-sequencing that the major difference in whole-cell 
protein expression was in the higher SpxB expression in P64 compared to P62 (Fig, 6, insert) 
(35a). Phase variation in SpxB expression correlated with difference in H20 2 generation, with 
P64 producing significant amounts of H202, whereas production by P62 was undetectable 
(Table I). The bactericidal effect of these variants on H iJ~flllel1zae was then compared in 
cocuIturc experiments (Fig. 6). After 1.5 h of coculture, the decrease in the viable counts of 
H. iJ~fluel1zae in the presence ofP64 was approximately 100-fold, whereas P62 had no effect. 
The production of H20 2 by the pneumococcus correlated with the concentration of O2 in the 
envirolUuent, being decreased in microaerobic conditions (data not shown). In order to 
determine the effect of environmental oxygen on SpxB expression, Westelll blots were 
performcd on Iysates from strain P878, which contains an in-frame fusion of PhoA to SpxB, 
using an antibody to bacterial alkaline phosphatase. Equal amounts of whole-cell Iysates of 
P878 cultured under various concentrations of 02 and C02 were separated by SDS-PAGE, 
transfen"ed to a membrane, and immunoblotted, A band corresponding to the SpxB-PhoA 
fusion protein was detected in samples grown aerobically but was almost completely absent 
from samples grown anaerobically (Fig. 7). The highest level of expression of SpxB was 
noted in the conditions of high oxygen and increased carbon dioxide, which conoespond to the 
conditions expected of the mucosal surface of the respiratory tract. 
DISCUSSION 
This study documents the production of a soluble antimicrobial substance by S. plleul11oniae. 
Several lines of evidcnce demonstrate that this substance is hydrogen peroxide. The effect of 
the pneumococcus in coculture experiments was completely eliminated by the addition of 
active but not inactivated catalasc. A similar antimicrobial effect was reproduced by the 
addition of exogenous H202 at concentrations shmvn to be generated by the pneumococcus in 
liquid culhue. This effect, furthennore, was absent in a pymvate oxidase (/l]JxB) mutant that 
synthesizes <1 % of parental levels of H202 as well as a spontaneous variant that is 
downregulated in expression of SpxB (35a). Anaerobic growth conditions also lead to a 
diminished expression of SpxB which correlated with a loss of antimicrobial cffect (data not 
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Fig. 6. Effect of coculture of H. il!/luellzae Rd with S. plleulI/olliae opaque (P62) or transparent (P64) variants of a 
type 9V isolate. Following growth to mid-log phase, lI. il!flflellzae was washed and incubated in sBHI either alone 
(0), with P62 ( 6 ), or with P64 (U) for the times indicated, and viable counts were dctcnnined in duplicate on 
selective media. Viable counts of P62 CA) or P64 (II) incubated in coculture with H. il!/luellzae were dctenllined 
in duplicate by plating on selective media. Values represent the average of three independent dctCnllinalions in 
duplicate, and the error bars represent the standard deviations. (Inset) Relative expression of SpxB in S. 
pllel/Illoniae variants P62 (black bar) and P64 (hatchcd bar) as dctcnnincd by two-dimcnsional gel electrophorcsis 
followed by mass spcctromctric analysis. Rcsults represent the average of four independent experiments, with 
error bars representing the standard deviations. 
shown). Finally, the degree of antimicrobial effect against three species was proportional to 
their sensitivity to both growth inhibition and killing mediated by exogenous hydrogen 
peroxide. 
Among the grall1wpositive (n = 6) and granHlegative (11 = 7) species tested, the pneulllococcus 
was the only species that generated concentrations of H20 2 that were >0.1 mM in liquid 
culture when at midwlog phase growth in aerobic conditions. For one of the S. plleumoniae 
strains tested, the average H201 concentration after I h of culture was 1.1 111M. This is 
consistent with the observation that S. pJlellnlolliae produce approximately the same alllount 
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Fig. 7. Western blot showing the effect of environmcntal oxygen and carbon dioxide tension on pymvate 
oxidase (SpxB) expression in S. pllell1ll01liae P878, whieh contains an in-frame fusion to PllOA. Celllysates of 
spxB::pJIOA mutant (P878) grown under 20% 0.-0.03% COl (lane 1), 17% Or3% CO2 (lane 2), or <0.01% Or 
10% CO2 (lane 3) were electrophoresed on an SDS-lO% polyacrylamide gel, transferred to a polyvinylidene 
difluoride membranc, and immuno-blotted with an antibody to PllOA. As a negative control, cell Iysates from 
the parent strain (D39) grown under 17% Or3% CO2 (lane 4) were included. Size markers are in kilodaltons. 
ofH,O, per gram of total cellular protein as neutrophils during the oxidative burst (15). The 
calculated concentrations of H20 2 produced by S. plleullloniae in the present study agree with 
those previously reported for this species (2, 5, 38), Our results, fUlihennore, confirmed that 
the ,\]JxB mutant was deficient in H202 production (38). The mechanism that allows for the 
survival and growth of the pneumococcus, a catalase-negative organism, in substantial 
concentrations of hydrogen peroxide is unknown, S. pneumoniae contains NADH oxidase but 
lacks other systems involved in the oxidative stress response, such as OxyR (3). It was noted 
in this study that the mutant deficient in pymvate oxidase activity often grew to a higher 
density in liquid culture, A similar effect on pneumococcal grmvth in liquid culture was 
observed in the presence of exogenous catalase and in cocuiture with i\1. calarrhalis or N. 
meJlingilidis, species that both produce high levels of catalase (37), Furthermore, the 
pneumocOCCliS requires catalase for optimal growth on solid surfaces where the density of 
organisms is high (42), These observations support previous findings that endogenous 
production of hydrogen peroxide is pemlissive for growth but may have an adverse effect on 
its rate (2, 20, 34). This negative effect of hydrogen peroxide on growth raises the question as 
to why the pneumococcus, an organism that does not express catalase activity, synthesizes 
copious amounts of this highly toxic substance. It has been suggested that H20 2 generated by 
S. ]JlIeu111011iae contributes to the pathogenesis of disease in the respiratOlY tract by its 
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cytotoxic effects on the epithelial barrier of the host (15, \9). This effcct, however, required 
~ lOs CFU/ ml, a density of bacteria unlikely to occur in the commensal state for this 
organism. In contrast, the antimicrobial effect was evident in coculture experiments with as 
few as 106 CFU/ml. Data presented here support the hypothesis that the pneumococcus 
generates unusually high amounts of hydrogen peroxide as a means of inhibiting and/or 
killing other species that may compete for the same environmental niche in the heavily 
colonized human nasopharynx. 
Many lactic acid bacteria produce significant amounts of hydrogen peroxide during aerobic 
growth (50). In fact, several species of lactobacilli and oral streptococci have been shown to 
produce levels ofH,O, in liquid culture similar to that of S. plleulIlolliac (\ to 10 mM) (5, 16, 
18, 47). Organisms shown to be killed or inhibited in vitro due to peroxide production by 
lactic acid bacteria include Neisseria gOllorrhoeae, Staphylococcus aurellS, Corynebacterium 
diphtheriae, and various other members of the oral flora (13, 16,41,50, 52). In the case of 
the pneumococcus, Colebrook was the first to describe its inhibitory activity by cross-
streaking it withN. menillgilidis andM. catal'rhalis on solid medium (11). Similarly, McLeod 
and Gordon repOlied in 1922 the inhibition of grmvth of S. aI/reus due to S. pneumoniae 
culture supernatants, an effect they attributed to the presence of hydrogen peroxide (34). Our 
own study was able to take advantage of a genetically defined mutant that is essentially 
deficient in H20 2 production to confirm this hypothesis about the nature of the inhibitOlY 
substance generated by S. pneu1Iloniae (38), .Moreover, we demonstrate here that this 
antimicrobial effect may be a factor in the ability of the pneumococcus to compete against the 
other major pathogens residing in the upper respiratOlY tract of humans. The antimicrobial 
effect of the pneumococcus against three gram-negative, catalase-positive species that also 
colonize the mucosal surface of the hurnan nasopharynx was assessed. The most dramatic 
effect was seen in coculture experiments with H. i1~f!tlellzae, where there was a 4-log decline 
in viable counts over 3 h due to the presence of 5 x 107 CFU of S. pneullloniae per ml. This 
was the most sensitive bacterial species among those tested to both the inhibitory and the 
bactericidal effects of the pneumococcus. If a similar effect occurs in vivo, this could at least 
in part account for the previously noted lower-than-expected rates of coinfection with S. 
pllelllfloniae and H. lr!f!uellzae in otitis media and chronic bronchitis (25, 30). The inhibitory 
and bactericidal effects of H20 2 on H injluenzae occur despite the measurable expression of 
catalase by this species (8), In other words, a catalase-negative species, S. pneunlolliae, is 
able to efficiently kill a catalase-positive species, H. injluenzae, using H202. The level of 
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catalase activity as measured by the ability to catalyze the decomposition of hydrogen 
peroxide, however, varies widely from species to species, and H. injluenzae seems to be an 
example of a catalase- positive organism with relatively low catalase activity as measured in 
vitro (7, 33). H. btf!uenzae possesses only one gene for catalase, unlike the other gram-
negative species E. coli, Salmonella ellterica serovar Typhimuriull1, and Shigella jiexlIeri, 
which produce two catalases (8). A previously repOlied catalase· deficient mutant of H. 
b!{lllel1Zae, strain AB2593 (Rd:: hktE -) was not significantly more sensitive to the 
antimicrobial effect of the pneumococcus compared to its parent strain, implying that catalase 
does little to protect H. itifillenzae under these conditions (data not shown) (8). H. it!f/lIeIlZae 
may possess an impaired ability to upregulate catalase production in response to elevated 
levels of H20 2, possibly as a result of H. influenzae's inability to synthesize protoporphyrin 
IX, the bjo~synthetic precursor of heme, a required component of catalase (48). This finding 
is consistent with the observation that 108 CPU of exponentially growing H. injluellzae 
produce only 5.7 U of catalase, and this expression level is induced only threefold by 
oxidative stress (8). Furthennore, the addition of H. i1~flllenzae to cultures of S. pnelll'lloniae 
had only a small effect on the hydrogen peroxide concentration, suggesting that the 
endogenous production of catalase by H. i1~flliel1zae was insufficient for these levels of H202 
(data not shown). The effect of the pneumococcus was less dramatic against the 
meningococcus, where growth inhibition and minimal killing were observed after 1.5 h of 
coculture. When 1M. catarrhalis, a target species with markedly greater catalase activity, was 
tested, only a slight inhibitOlY bactericidal effect was evident after 3 h of coculture, although 
a catalase-reversible effect was noted with a higher density of pneumococci when the two 
organisms were cross~streaked on BHI agar. 
Tn considering the contribution of hydrogen peroxide production to pneumococcal carriage, it 
should be noted that the studies presented here are based exclusively on in vitro effects, The 
synthesis of H20 2 by the pneumococcus in vivo has not been detennined, although maximal 
expression of SpxB was noted in an oxygen and carbon dioxide rich enviroruuent, as would 
be expected on the surfhce of the upper respirato!)' tract. In addition, the antimicrobial effect 
correlated with variability in the expression of SpxB and was present in a variant with a 
transparent colony phenotype but not the opaque variant of the same isolate (35a). Only the 
transparent fonn has been shown to persistently colonize the nasopharynx in an animal model 
of carriage (42). This suggests that the increased production of H202 associated with this 
phenotype may contribute to its ability to efficiently colonize a host, whereas the opaque 
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phenotype may be ontcompctcd by the other flora. Another consideration in extrapolating 
these results to the situation in vivo is that host factors on the mucosal surface may act to 
inactivate bacterial hydrogen peroxide. Tn this regard, viridans streptococci, which may 
generate concentrations of hydrogen peroxide similar to that of S. pnewllon;ae, have been 
suggested to prevent colonization of gram-negative bacilli, including H. hif/uenzae, in the 
human oropharynx by a mechanism that may be mediated in part by H201 production (39, 
40). In addition, the spxB mutant of S. pllellf1loniae does not persist within the airway in an 
animal model of colonization in rabbits (38). Althongh the mechanism for this defect in 
carriage is unknown and there afC several plausible explanations, it is possible that it results 
from an inability of the mutant to suppress local competitors. Future studies will address the 
significance of these observations to pneumococcal calTiage and the maintenance of the 
normal micro flora of the upper respiratory tract. 
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SUMMARY 
Surface-exposed proteins often play an imp0l1ant role in the interaction between pathogenic 
bacteria and their host. We isolated a pool of hydrophobic, surface-associated proteins of 
Streptococclfs plleuf1lolliae. The opsonophagocytic activity of hyperimmune scnll11 raised 
against this protein £I'action was high and species specific. Moreover, the opsonophagocytic 
activity was independent of the capsular type and chromosomal genotype of the pneumococcus. 
Since the opsonophagocytic activity is presumed to correlate with in vivo protection, these data 
indicate that the protein fraction has the potential to elicit species-specific immune protection 
with cross-protection against various pneumococcal strains, Individual proteins in the extract 
wcre purified by two-dimensional gel electrophoresis. Antibodies raised against three distinct 
proteins contributed to the opsonophagocytic activity of the senun. The proteins were 
identified by mass spectrometry and N-tenninal amino acid sequencing. Two proteins were 
the previously characterized pneumococcal surface protein A and oligopeptide-binding 
lipoprotein AmiA, The third protein was the recently identified putative proteinase 
maturation protein A (PpmA), which showed homology to members of the family of 
peptidyl-prolyl cis/trails isomerases. ImlTIulloelectron microscopy demonstrated that PpmA 
was associated with the pneumococcal surface. In addition, PpmA was shown to elicit 
species-specific opsonophagocytic antibodies that were cross-reactive with various 
pneumococcal strains. This antibody cross-reactivity was in line with the limited sequence 
variation of ppmA, The importance of PpmA in pneumococcal pathogenesis was 
demonstrated in a mouse pneumonia model. Pneumococcal ppmA-deficient mutants showed 
reduced vimlence, The prope11ies of Ppm A repOited here indicate its potential for inclusion in 
multi component protein vaccines, 
INTRODUCTION 
StreptocoCCllS jJllelll1lolliae is an impOltant human pathogen which causes meningitis, otitis 
media, sepsis, and pneumonia, The precise molecular mechanisms by which the 
pneumococcus invades and damages host tissues are not fully understood. For many years, 
the polysaccharide capsule has been recognized as the major vimlence factor and 
consequently was considered an important vaccine candidate (for review sec references 5 and 
34), The use of a 23-valent vaccine containing capsular polysaccharides from pneumococci 
commonly causing disease has had limited effect in reducing the morbidity and mOltality 
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associated with this organism (1, 16, 19, 41). The current pneumococcal vaccine strategy 
focuses on the use of conjugates, in which a limited number of capsular polysaccharides are 
linked to a carrier protein. The proteins in the conjugate vaccines cause a switch in the 
immune response to polysaccharides from T-cell independent to T-cell dependent. This 
results in an increase in the antibody response and the generation of memory T lymphocytes. 
Conjugate vaccines are more immunogenic in young children than polysaccharide vaccines 
(IS, 18). Although the results of early trials look promising, the long-term efficacy is 
uncertain since large-scale vaccination may over time lead to a shift in serotype distribution 
towards capsular types that are poorly immunogenic or not included in the vaccine. Such a 
shift may be enhanced by the horizontal exchange of capsular genes, as described previously 
(8,22,23). 
Over the past few years, much attention has been focused on the role of pneumococcal 
proteins in pathogenesis and protection. Proteins that are involved in the pathogenesis of 
infections by S. pllellmoniae are considered interesting components for future conjugate or 
muiticomponent protein vaccines. The immunological response against such proteins should 
provide protection against colonization and infection with S. pneumolliae strains of all 
capsular polysaccharide types. Immunization with pneumolysin (36), pneumococcal surface 
protein A (PspA) (33, 45, 53), pneumococcal surface adhesin A (PsaA) (44), and 
neuraminidase (28) clearly confers protection in animal models. 
The purpose of this study was to identify additional pneumococcal proteins with abilities to 
elicit protective inunune responses. \Ve isolated a pool of hydrophobic, potentially sur£1ce-
associated proteins of S. pneumoniae that were able to elicit cross-reactive, species-specific 
antibodies with opsonophagocytic activity. At least three distinct proteins contributed to the 
in vitro opsonophagocytic activity. Two proteins were the previously characterized surface 
proteins PspA and oligopeptide-binding protein AmiA. The third protein was identified as the 
putative proteinase maturation protein A (PpmA) (35a). The potential of PpmA to elicit 
protective immune responses and its role in the pathogenesis of pneumococcal infection arc 
discussed. 
MATERIALS AND METHODS 
Bacterial strains, growth conditions and growth medium. The pneumococcal strains used 
in this study are described in Table 1. Pneumococcal strain FT231 was used for protein 
purification. Bacteria were grown to logarithmic growth phase (optical density at 550 nm = 0.3) 
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Table I. Bacterial strains used in this study. 
Species and strain 
S. pllelllllOlliae 
FT231 
D39 
CDC205 
EF3296 
ATCC6306 
911320 
950357 
SI003 
ATCC6314 
950312 
SIOOI 
800129 
19FG 
ATCC6323 
950110 
S3003 
19FK 
Rxl 
P376 
P765 
P62 
RI89 
MS9 
S. hows 
961008 
E,/acealis 
ATCC29212 
Relevant characteristic (1') 
Serotype 19, clinical isolate 
Serotype 2, clinical isolate 
Serotype 3, clinical isolate 
Serotype 4, clinical isobte 
Serotype 6A, clinical isolate 
Serotype 6A, clinical isolate 
Serotype 9V, clinical isolate 
Serotype 11, clinical isolate 
Serotype 14, clinical isolate 
Serotype 14, clinical isolate 
Serotype 15, clinical isolate 
Serotype 18C, clinical isolate 
Serotype 19F, clinical isolate 
Serotype 23F, clinical isolate 
Serotype 23F, clinical isolate 
Serotype 38, clinical isolate 
Unencapsulated variant of 19F G 
Unencapsulated variant ofD39 
Serotype 6A, opaque variant of isolate P303 
Serotype 6B, transparent variant of isolate P314 
Serotype 9V, opaque variant of isolate PIO 
ermAM containing strain 
D39,ppmA::ermAM 
Clinical isolate 
Clinical isolate 
"CDC, Centers for Disease Control 
J>university of Gotcborg 
C American Type Culture Collection 
Source" or reference 
F. Tenover, CDC, Atlanta, Ga. 
7 
J. Butler, CDC, Atlanta, Ga. 
C. Svanborg, UvGb, Sweden 
ATCCC 
Our laboratory 
Our laboratory 
Our laboratory 
ATCCC 
Our laboratory 
Our laboratory 
Our laboratory 
Our laboratory 
ATCCC 
Our laboratory 
Our laboratory 
Our laboratory 
42 
27 
26 
51 
2 
This study 
Our laboratory 
ATCCC 
in Todd-Hewitt broth (Difco LaboratoIics, Detroit, Mich.) supplemented with 0.5% yeast 
extract (Difco Laboratories; THY broth) at 37°C. 
Extraction of surface-associated hydrophobic proteins of S. jJllellJIIOlliae. Bacterial cells 
were harvested by centrifugation (1,500 x g, 15 min, room temperature) and washed three times 
with an equal volume of phosphate-buffered saline (PBS, pH 7.5). After the final wash Ihe 
bacteria were resuspended in 1125 the volume ofTE buffer (10 mM Tris-HCI, I 111M EDTA). 
The cells were disl11pted by ultrasonic treatment (Branson sonifier 250, Branson Ultrasonics, 
Danburry, Conn.). The method for extraction with sulfobetaine 14 (SBI4) was adapted from that 
of Sehouts and colleagues (40). In brief, cell walls, membranes and other paliiculate material 
were collected by cenlrifugation at 48,400 x g for 20 min. The water-soluble cytoplasmic 
proteins were removed by washing the bacterial lysates five times with PBS. Pellets were 
resuspended in 150 mM NaCI and centrifuged for 20 min al 48,400 x g. The pellets were 
160 
PpmA of StreptocoCCliS pneIJ/1loniae 
incubated for 2 h at room temperature with 0.25% N-tetradecyl-N,N-dimethylammonio-l-
propanesulfonate (SBI4, Serva, Heidelberg, Gennany) in the presence of 150 mM NaCI-IO mM 
MgCI,-IO mM Tris-HCI (PH 8.0) with constant stirring. The hydrophobic, membrane-associated 
proteins were recovcred as described by Wessel and Fliigge (52). Protein concentrations were 
detennined by the method of Bradford (13). 
Protein gel electrophoresis and staining. One-dimensional sodium dodecyl sult1te (SDS) 
polyacrylamide gel electrophoresis was carried out in the Bio-Rad minigel system with 13% 
polyaclylamide gels. The samples were dissolved in sample buffer (10 mM Tris-HCl, I mM 
EDTA, 1% SDS, 10 mM dithiothreitol [DDT], 10% glyccrol, 0.01% bromophenol blue 
inclicator [Merck, DamlStadt, Gennany]), boiled for 5 min and subjected to electrophoresis (39). 
Two-dimensional SDS-polyacrylamide gel electrophoresis includes separation of proteins by 
isoelectric point and by molecular weight, respectively. Isoelectric focusing (PI 4 to 7) was 
perfonned with a Multiphor II electrophoresis unit and Immobiline DlyStripS (phannacia 
Biotech, UppsaJa, Sweden) according to the manufacturer's recommendations, but as modified 
by Rabilloucl and colleagues (37). The proteius were separated in the second dimension by 
gradient (12 to 20%) polyaclylamidc gel electrophoresis. Polyacrylamide gels were stained with 
Coomassie brilliant blue (CBB) (39). 
Hypcl'immune rabbit antiserum. Hyperinunune antiserum was raised against the 
hydrophobic, surface-associated protein pool and distinct CBB-stained two-dimensional 
protein gel spots. Shortly after introduction into a one-dimensional SDS-polyaclylamide gel, 
the SB 14-extracted protein pool of S. pneullloniae FT231 was stained with CBB and excised 
from the gel. The total protein fraction, as well as the individual protein spots cut from the 
two-dimensional polyacrylamide gel, were washed three times with 0.1 M sodium acetate, 
96% ethanol, ground into a fine suspension in 0.5 1111 of PBS, and subsequently mixed with 
0.5 ml of Freund's incomplete adjuvant (Pierce, Rockford, 111.). New Zealand White rabbits 
were injected subcutaneously in four or five places. The primalY injection was followed by 
three booster injections at 4-week intervals. 
Indirect illUllullo-cytometl'ic assay. Pneumococci were grown to logarithmic phase in THY 
broth at 37°C and washed three times in ice-cold PBS. The bacterial pellet was dissolved in 5% 
rabbit serum in PBS (107 bacteria in a 20-~tl final volume) and incubated for 15 min at 4°C with 
shaking. After being washed twice \vith ice-cold PBS, the bacteria were incubated for 15 min at 
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4°C with 20 ftl (1:5 dilution) of f1uorescein-cOl~ugated goal anti-rabbit immunoglobulin G (IgG; 
Jackson TmmunoResearch Laboratories, West Grove, Pa.) with shaking. Finally, the bacteria 
were washcd twice with ice-cold PBS and resuspcndcd in 100 fd of ice-cold frcsh 
parafonnaldehyde (0.5%) in PBS. The samples were analyzed in a F ACScan flow cytomeler 
(Becton Dickinson, Mountain View, Calif.). 
Phagocytosis assay. Analysis of the opsonophagocytic activity of the sera was perfol1ncd as 
described by Alonso DeVelasco et a1. (4) and adapted by Jansen et a1. (24). In our assay, S. 
pneumolliae was grown to logarithmic phase in THY broth without heat-inactivated human 
pooled senlll1 and the bacteria were not inactivated, Phagocytosis \vas defined as the uptake and 
binding of fluorescein isothiocyanate-Iabeled bacteria by human POlYlllOlpholluclear cells 
(PIvINs) because of opsonization with 3ntisenul1. The opsonophagocytic activity is defined as 
the reciprocal of the scnun concentration at which 25% (unless otherwise stated) of the human 
P.MNs were fluorescent. 
"'estern blot analysis. The proteins separated by one-dimensional (0.5 pg) and two-
dimensional (2.5 fig) SDS-polyaclylamide geieleclrophoresis were transferred to Immobilon-P 
membranes (Millipore Corporation, Bedford, Mass.) as described by Sambrook el a1. (39). The 
imllull1ological detection of immobilized proteins was performed as described before (35a). 
Amino acid sequence analysis. For N-tenninal amino acid sequence analysis, the proteins were 
separated by two-dimensional SDS-polyacrylamide gel electrophoresis as described above with 
a few modifications. Recrystallized SDS (Serva) was used for preparing the electrophoresis 
buffers, and sodium thioglycolate (100 mM) was added to the calhodal buffer compm1menl. The 
proteins in the gel were blotted to a Problot membrane (Applied Biosystcms, San Jose, Calif.) 
with the Multiphor II system (phannacia Biotech) according to the manufacturer's instructions 
except that 0.02% p-mercaptoethanol was added to the blotting buffer. The blots were stained 
with amido black (Merck). Amino acid sequence analysis was perfonned with a model 473A 
protein scquenator (Applied Biosystems) as recommended by the manufachlrer. 
For mass spectrometric analysis, the proteins of interest were purified from the gel, digested 
with trypsin, and analyzed by mass spectromehy as described (35a). With Peplide Search 
(29), the deduced (pat1ial) amino acid sequences were analyzed for matching sequences in all 
possible translation products of the December 1998 version of the unfinished pneumococcal 
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genome released by the Institute for Genomic Research (TIGR; 
http://www.tigr.orgldata/s_pneumoniae/) to identify the proteins. With the BLAST algorithm 
(6), putative pneumococcal proteins were analyzed for similarity to sequences deposited in 
the November 1999 version of the nonredundant protein database at the National Center for 
Biotechnology Information (Washington, D.C.). 
IllllllUIloelectl'oll microscopy. Colonies of S, pneul110niae strain FT231 were fixed in a 
mixture of 4% formaldehyde, freshly prepared from parafonnaldehyde, and 0.1 % 
glutaraldehyde in sodium cacodylate buffer, pH 7.4. The bacteria were embedded in 1.5% 
low gelling temperature agarose (Sigma), and fixation was continued for a total of 24 h. 
Small pieces of the agarose-embedded bacteria were dehydrated in ethanol in a CS Auto 
apparatus (Reicluui, Vienna, Austria) with a progressive lowering of temperature and 
embedded in Lowiclyl HM20 resin (TAAB, Reading, United Kingdom) at -40°C. Ultrathin 
sectioning was performed with an Ultracut E microtome (Reiclun1). Sections were collected 
on gold grids and inununolabeled by incubation with anti-PpmA rabbit senUll and anti-PspA 
rabbit serum, rcspectively, diluted 1:200 with buffer A (1% normal goat serum, 1% bovine 
semm albumine [Biocell], 0.1 % Tween 20 [Sigma] in Tris-buffered saline, [pH 8.2]) for two 
h at room temperature. Control specimens were incubated with normal rabbit serum and in 
buffer A without primary antibody. Sections were washed in five 50-~tl droplets of buffer A 
for 5 min each and incubated for 3 h at room temperature in goat anti-rabbit IgG antibody 
labeled with 5-nm-diameter colloidal gold (Biocell, Cardiff, United Kingdom) diluted 1: 100 
with buffer A. Final washing was done twice with buffer A and five times in distilled water. 
Sections \vere stained with uranyl acetate and examined with a Philips CM 12 electron 
microscope (Philips, Eindhoven, The Netherlands) operating at 80 kV. 
Nucleotide sequence analysis of ppIIIA. Nucleotide sequencing was perfonued on ppmA from 
the pneumococcal strains D39, CDC205, EF3296, P376, P765, 950357, P62, S1003, 950312, 
S1001, 800129, FT231, 19F G, 950110, S3003, and Rx 1. Two PCR products of 640 and 643 
nucleotides, that cover the whole gene were generated with an overlap of 140 llucleotides. The 
primers 5'-TCTCATGCTTCGTAAAAATG-3' and 5'-AGCAAAATCAGCACCTTCTG-3' 
were used to amplity the 5' patt of pplIIA. The primers 5'-CTGAATTGACAGATGAAGCC-3' 
and 5'-CCTTGTACTATGCG1TITATTG-3' were used to amplity the 3' patt of pplIIA. PCR 
amplification of ppmA \vas perfonned in a I 00 ~ll PCR mixture as described for penicilin~ 
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binding protein genotyping (35). The PCR products were purified by sodium acetate 
precipitation to remove the uninCOlporated llucleotides and primers (39). Purified templates 
were sequenced with the Themlo Sequenase dye tenninator cycle sequencing premix kit 
(Pharmacia Amersham, Roosendaal, The Netherlands) and 50 pmoi of each peR primer. 
Sequencing was performed on the Applied Biosystems Pdsm 377 (PE Applied Biosystems, 
Nieuwerkerk, The Netherlands) 
Cloning and insertional inactivation of ppmA. ppnlA was amplified from S. pneumoniae 
strain D39 genomic DNA by PCR with primers pmpp-FWI (5'-
GTTTGGAATTCGCAAGCAAATCACTCTCC-3') positioned at nucleotides 369 to 340 
upstream of the ATG start codon and pmpp-REVI (5'-
CAGTAGGATCCTTGTACTATGCGTTTTATTG-3') positioned at nucleotides 1073 to 
1104 downstream of the A TO start codon. The forward and reverse primers contain EeoRl 
and BamHI recognition sequences, respectively. The amplified EcoRl-BamHI digested ppmA 
DNA fragment was cloned into pBluescript KS+ (pMS!) and transformed into Escherichia. 
coli DHSa (39). A ppmA mutant was constmcted by inseliion of an elythromycin resistance 
cassette (ermAJU) in the gene, ermAM was amplified from S. jJnellf1loniae strain R189 
genomic DNA with primers enllAM-F\Vl (5'-
AAAGTTCGAAGCTTAAGTTCAAAACTACTTGCCC-3') and ellllAM-REVI (5'-
AAAGCTGCAGTTCGAATGTCTTCTCACCTTTAG-3'). The amplified el'lIlAM DNA 
fragment was Csp45I-digested and cloned into the Csp451 site of ppmA (nucleotide position 
64 downstream of the ATG start codon) ofpMSI (pMS2). The EcoRl-BalllHl digested pMS2 
DNA fragment was used to transfolm S, pneu11Iolliae D39 as described previously (54). To 
confirm that ppmA was inactivated by ermAJ\I, chromosomal DNA ,vas analyzed by peR 
with primers pmpp-FWI and pmpp-REVl. Expression of PpmA was assessed by \Vestem 
blot analysis with PpmA antibodies. The ppmA mutant MS9 was used in the described 
experiments. 
I\'1ouse pneumonia model. Preparation of the challenge dose and intranasal challenge of 
mice were performed as describcd before (25). Significant differences in the sUlvival time of 
mice challenged with the ppmA knockout mutants and its parent strain D39 were determined 
by the nonparametric Mann-\Vhitney U test, with significance set at a value of P of'-:;0.05. 
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RESULTS 
Surface-associated protein fraction of S. pllelllllolliae is able to elicit opsonophagocytic 
activity. Approximately 30 polypeptides were isolated by the SB 14 extraction procedure in 
relatively high concentrations, as shown by two-dimensional SDS-polyacrylalllide gel 
electrophoresis (Fig. 1). Illllllunocytomctric analysis demonstrated that senllll raised against 
pi 
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68 ... 
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Fig. 1. Two-dimensional analysis of SB14-extracted surface-associated proteins from S. PllculI/olliae strain 
FT231. The proteins were separated by isoelectric focusing (pI 4 to 7) and gradient SDS-polyacrylamide gel 
electrophoresis (10 to 100 kOa) and stained with eBB. Circles mark the proteins recognized by semm raised 
against the SB14-extracted proteins. The numbers 1 to 9 refer to the proteins discussed in the text. 
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the extracted proteins recognized components at the surface of pneumococcal cells of the 
homologous stmin FT231 (Fig. 2) and seven other pneumococcal strains (D39, EF3296, 
911320, 950357, 800129, 19F, and 950110) that represent eight clinically important 
serotypes (types 2, 4, 6A, 9V, 14, ISC, 19F, and 23F, respectively) and display seven distinct 
genotypes (M. Sluijter, unpublished data). The in vitro senun opsonophagocytic activity was 
high (50%,1) when determined with the homologous pneumococcal strain FT23 I (Fig. 3A). In 
addition, the scnUH was invariably opsonophagocytically active against six genotypically 
distinct pneumococcal stmins (EF3296, ATCC6306, ATCC6314, FT231, 19F 01.1, and 
ATCC6323) (M. Sluijter, unpublished data) representing serotypes 4, 6A, 14, 19, and 23F and 
two unencapsulated strains (l9F Kl.l. and Rxl). Tn contrast, a low serum opsonophagocytic 
activity was found against two strains of the genetically closely related species Streptococclls 
hovis and ElIIerococclisfilecalis (Fig. 4). 
o 
o 
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Fig. 2. Indirect imnnmOC)10metric analysis demoll5trating the presence of surface-exposed epitopes in the SB14 
protein fraction of S. plleulllolliae strain FT231. Yaxis, number of pneumococci analyzed. X axis, deh'Tec of 
immunofluorescence. Numbers: 1, bacterial auto-fluorescence; 2, nonspecific binding of tluorescein-conjugated 
goat anti-mbbit IgG; 3, specific binding of sCntl11 to components at the surface of pneumococci. 
PspA, AmiA, and PpmA contribute to serum opsollophagocytic activity. Two-dimensional 
Western blot analysis was performed to identify the proteins that were serologically 
recognized at the surface of pneumococci and responsible for the in vitro opsonophagocytic 
activity. The hyperimmune rabbit senun recognized nine proteins, designated I to 9 (Fig. 1). 
Monospecific rabbit sera were raised against the individual proteins. The monospecific sera 
raised against proteins 2, 3, and 4 were able to facilitate phagocytosis of pneumococci with 
an opsonophagocytic activity of 0.5, 0.7 and 5%'1, respectively (Fig. 3B to D). Protein 2 was 
analyzed by N-tenninal amino acid sequencing, and proteins 3 and 4 were analyzed by mass 
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Fig. 3. The opsollophagocytic activity of hyperimmune rabbit sera raised against the surface-associated 
pneumococcal protein fraction (A) and sera raised against the proteins 2 (B), 3 (C), and 4 (D) using the 
homologous strain FT23 1. The percentage of fluorescent human PMNs was delenruned at various serum 
concentrations. p: pre-immune senuu; Ii: hyperillll11une sennn. 
167 
Chapter 10 
spectrometry. Eighteen of the first 21 amino acids of protein 2 were successfully identified 
(Table 2). The amino acid sequence was identical to that of PspA as published by McDaniel 
and coUeagues (GenBank accession number AAC62252) (31). The molecular size ofPspA 
deduced from the two-dimensional protein gel was approximately 65 kDa and correlates with 
the size range of PspA (60 to 200 kD) (17, 50). Mass spectrometric analysis of protein 3 
resulted in three peptides that were identical to AmiA (GenBank accession number P(8791) 
(Table 2) (30). Mass spectrometric analysis of protein 4 resulted in 12 peptides (Table 2) that 
were pmi of a hypothetical translation product present in the TIGR pneumococcal genome 
encoding a protein of 322 amino acids (7,659 to 8,597, contig 33). The calculated size of this 
hypothetical protein (35.4 kDa) cOlTelated with the size of protein 4 (approximately 35 kDa) 
deduced from the protein gel. This protein has been described before aud designated putative 
proteinase maturation protein A (PpmA) due to its homology to proteinase maturation 
proteins (PrtM) of lactic acid bacteria (35a). 
Table 2. Partial amino acid sequences of surface proteins 2, 3, and 4 identified by amino acid 
sequence analysisa, 
protein 110. 
2 
3 
4 
name Start-end position 
PspA 1-21 
AmiA 40-49 
148-159 
387-394 
PpmA 51-59 
64-66 
74-83 
120-123 
125-137 
142-146 
161-165 
195-198 
221-235 
248-251 
260-264 
268-277 
Sequence 
EEAPVAXQXKAEKDYDAAVXK 
I. VYTADPETLD 
2. DYLSGTSTDFST 
3. VAAQLPAY 
I. PSAQQVLLN 
2.QVF 
3. LDDQEVDDTL 
4. LAVQ 
5. VAEAELTDEAYQQ 
6. YTPDV 
7. EVLEQ 
8. FDSA 
9. VLTATGTQAYSSQYY 
!D.NLDD 
11. LLTQQ 
12. STFVQSLLGK 
31t is not possible to distinguish behveen TIe and Leu, Gin and Lys, and between Pile and oxidized Met by mass 
spectrometry. 
PpmA is located at the surface of S. pnelllllolliae. Since the three proteins PspA, AmiA and 
PpmA are able to elicit opsonophagocytically active antibodies, they are presumed to be 
surface associated. The mOllospecificity of PpmA rabbit senun was confinncd by Western 
blot analysis. PpmA serum recognized a single protein band with the correct molecular size 
(35 kDa) in whole-celllysates (Fig. 5). We performed indirect immunoelectron microscopy 
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Fig. 4. Opsonophagocytic cross-reactivity of hyperimmune rabbit serum raised against the pneumococcal 
protein fraction using the heterologous pneumococcal strains EF3296, ATCC 6306, ATCC 6314, FT231, 
19F G1.1, ATCC 6323, 19F Kl.1, and Rxl, S. bOl'is strain 961008, and E..faecalis strain ATCC 29212. 
The serotype of the pneumococcal strains is indicatcd in parentheses. Yaxis: opsonophagocytic activity, 
defined as the reciprocal of the serum concentration at which 25% of tile human PMNs were fluorescent by 
phagocytosis of fluorescein isothiocyanate-Iabeled bacteria. p, pre-immune senun; h, hyperimnnme senlm 
raised againsllhe surface-associated protein fraction. 
to identify the subcellular location of PpmA. For this purpose, anti-PpmA senllll was used. 
Rabbit sennl1 raised against PspA and 110nnal rabbit seml1l were used as positive and 
negative controls, respectively. Immunoelectron microscopy demonstrated that both PpmA 
and PspA antibodies bound to the surface of pneumococci (Fig. 6). 
PpmA is able to elicit species-specific opsonophagocytic antibodies that are cross-
reactive against various pneumococcal strains. The PpmA antibodies were shown to 
facilitate phagocytosis of eight genetically distinct pneumococcal strains representing 
serotypes 4, 6A, 9V, 14, 18C, 19F, and 23F. Preimmune rabbit semlll was only 
opsonophagocytically active when the unencapsulated variant of strain 19F was used. The 
opsonophagocytic activity of the PpmA antibodies was velY low when S. bovis and E. 
faecalis were used (Fig. 7). 
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Fig, 5. Specificity of PpmA rabbit serum. Whole-celllysates of S. pllelllJlOlliae strain FT231 were separated 
by one-dimensional protein gel electrophoresis, stained with eBB (lane 1) and analyzed by wcstcm blotting 
with PpmA sennn (lane 2). The positions of the size markers are indicated in kilodflltons. 
ppmA is conserved among pneumococcal strains. DNA sequence analysis of ppmA from 
16 pneumococcal strains representing 15 distinct genotypes and 13 serotypes, and including the 
seven serotypcs that cause most of the infections in young children, revealed limited genetic 
variation. The variation in ppmA was randomly distributed, and most of the point mutations 
were synonymous. Compared to the TIGR genome sequence, we found variability in six 
nucleotides: A33G (1/ ~ I), TSIA (1/ ~ 10), T81G (1/ ~ 2), C87T (1/ ~ I), TI14C (1/ ~ 13), 
GI46A (1/ ~ 15), T339C (/1 ~ 3) and GSISA (1/ ~ I). Except for GI46A and GSISA, none of 
the point mutations resulted in an amino acid substitution. Mutation Gl46A results in a 
Ser49Asp substitution, and mutation G818A results in a Ser272Asp substitution. 
PpmA plays a role in the pathogenesis of pneumococcal infections in vivo. A ppmA 
knockout mutant of strain D39 was generated by insertion mutagenesis. Illtermption of ppmA 
in erythromycilH'esistant transfonnants was confirmed by peR analysis (data not shown). In 
addition, absence of PpmA expression V·/aS demonstrated by \Vestem blot analysis (data not 
shown). To confinll that the ppmA mutation did not affect the in vitro growth rate, both the 
mutant and the parent strain were grown ovemight on blood agar, inoculated into THY broth, 
and incubated at 37°C for 8 h. During this period, there was no significant difference in 
growth rate between the ppmAMdeficient strain and wildMtype D39, as judged from the optical 
density of the culture (data not shO\vn). To determine the effect of inactivation of ppmA on 
virulence, mice were challenged via the intranasal route with strain D39 and the ppmA 
mutant, respcctively. Mice challenged with the ppmA mutant sUlvived significantly longer 
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Fig. 6. Cellular localization of PpmA (A) and PspA (B) demonstrated b}' immunoelectron microscopy. Nonnal 
rabbit senlln was used as negative control (C). Electron-dense iml11unogold particles are located mainly 011 the 
bacterial sllrface. Magnit1cation x 1,125,000, scale bar, 100 mn. 
than mice challenged with the parent strain D39 (P = 0.023); median survival times were 51.5 
hand 33.0 h, respectively (Fig. 8). These data demonstrate that pneumococcal pplIIA 
deficiency results in an extended survival time for mice during infection. 
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Fig. 7. 0psollophagocytic cross-reactivity of the monospecific hyperinmulIlc sera raised against PpmA lIsing the 
heterologous pneumococcal strains EF3296, 911320, 950312, FT231, 19F 01.1, 950110, 19F Kl.l, and RxI, S. 
bovis strain 961008 and E. Jaecalis strain ATCC 29212, The serotype of the pneumococcal strains is indicated in 
parenthesis. Yuxis, opsonophagocytic activity, defined as the reciprocal oflhe senlm concentration at which 10% 
of the human PMNs were positive by phagocytosis of fluorescein isothiocyanate-Iabeled bacteria. P. pre-immune 
sennn; h, hyperimll1une serum raised against PpmA. 
DISCUSSION 
Various pneumococcal proteins are displayed on the cell surface. These proteins have a wide 
range of functions, including adherence to host tissues, binding to specific inullune system 
components, protein processing, nutrient acquisition, and uptake of DNA from the 
environment. Immunization with several pneumococcal surface proteins has been shown to 
confer protection against pneumococcal infection in animal models. These include PspA (45), 
PsaA (44), autolysin (9), and neuraminidase (28), To identify novel protection-eliciting 
pneumococcal proteins, we isolated a pool of SB 14~soluble, potentially surface~associatcd 
proteins of S. pllelll1lolliae strain FT231. This protein fraction \vas able to induce antibodies 
that facilitated phagocytosis in vitro, Phagocytosis is a major defense mechanism against 
pneumococci, and the induction of opsonophagocytic antibodies is presumed to con'elate with 
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Fig. 8. Intranasal challenge of mice with ppmA-dcficient S. pllellllloniae. Groups of 10 mice were 
challenged with 106 CFU of S. pllelllllolliae strain D39 (solid circles) and its pplIIA-deticient deriv;ltive 
(open circles). The suryiyaltime of each mouse is presented. Bars represent the median survival time 
for each group. 
in vivo protection against S. jJnellllloniae infection (4). Among the proteins, at least three 
surface-associated proteins contributed to the in vitro opsonophagoeytic activity, 
The pneumococcal proteins were selected for hydrophobicity, immunogenic characteristics, 
and the ability to induce opsonophagocytic antibodies, One of the proteins was the previously 
characterized protein PspA, PspA inhibits complement activation and is proposed to exert a 
vimlence function by recruitment of the alternative complement pathway, thereby reducing 
the effectiveness of complement receptor-mediated pathways of clearance (48). In addition, 
PspA functions as a lactoferrin-binding protein and is suggested to be involved in iron uptake 
and thus to contribute to pneumococcal growth under iron-limited conditions, Le., in the 
hUI11"n host (21). Surf"ce exposure of PspA h"s been demonstmted previously (32, 46) "nd 
this characteristic was confirmed in this study by inullunoclectron microscopy, The 
immullogenic nature of PspA observed in this study has also been demonstrated in previous 
studies (32). In line with thc ability of PspA-specific "ntibodies to induce opsonoph"gocytic 
activity against strains expressing distinct capsular types, PspA has shown to possess immune 
protectivc potentiol (14, 32) with cross-protection (17, 47). 
The second protein that induced opsonophagocytic antibodies was AmiA, which is a 
membrane-bound lipoprotein in S. jJneulllolliae (2) and part of the AmiA-AliAB oligopeptide 
permease that mediates the uptake of oligopeptides (2, 3). Since S. plleullloniae is 
auxotrophic for valine, leucine, arginine, asparagine, histidine, and glutamine, uptake of 
oligopeptides is important from a nutritional point of view (43). So f(\r, no data are available 
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on the possible protective abilities of this protein. Our data derived from phagocytosis 
experiments with AmiA antibodies are the first indications that AmiA may be protective 
against pneumococcal infections. The contribution of the AmiA~AIiAB oligopeptide 
permease system to pneumococcal virulence is currently under investigation. 
The third surface-associated protein which possessed the ability to induce opsonophagocytic 
antibodies was PpmA. Ppm A is a recently identified pneulllococcal protein with significant 
sequence homology to the proteinase maturation protein (PI1M) of lactic acid bacteria (35a), 
Like PrtM from lactic acid bacteria (20), Ppm A contains an N-terminal signal sequence, 
which serves as a label for translocation and cell membrane anchoring, In this Shldy, the 
surface location of PpmA was con finned by immunoelectron microscopy, The protein was 
able to induce antibodies in rabbits with opsonophagocytic activity, Although the affinity of 
the antibodies is unknown, the higher opsonophagocytic activity of PpmA antibodies 
compared to PspA and AmiA antibodies indicates the presence of relatively more PpmA 
molecules at the surface of the pneumococcus, Importantly, the opsonophagocytic activity of 
the PpmA antibodies was species specific and cross-reactive among heterologous 
pneumococcal strains, The observed opsonophagocytic activity of prcinunune semm when 
the unencapsulated pneumococcal strain 190 K was uscd might be due to the absence of the 
capsule leading to the exposure of epitopes that are recognized by the prcimmulle senllll, The 
cross-reactivity of the Ppm A antibodies was in line with the limited sequence variation of 
ppmA, Like PrtM, PpmA is suggested to function as a membrane-bound isomerase (35a), 
P,tM is a h'ons-acting protein involved in the processing of precursors of serine protease PrtP 
into active enzymes (49) and belongs to the family of peptidyl-prolyl cis/trans isomerases, 
These enzymes are thought to assist in protein folding by catalyzing the cis/trans 
isomerization of the peptidyl-prolyl bonds in peptides and proteins (38). However, the 
pneumococcal protein(s) that is activated by PpmA is currently unknown, The differential 
expression of PpmA in phenotypic variants of S. pneuf11onioe indicates that PpmA Illay playa 
role in the pathogenesis of pneumococcal infections (35a), In the transparent phenotype that 
is selectcd for during nasopharyngeal colonization, PpmA is more prevalent, and thereforc 
the protein may be involved in adherence through maturation of surface components or by the 
activation of proteases or other secreted protcins, In this study, Ppm A was demonstrated to be 
involved in virulence, Inactivation of p}JmA signitlcantly reduced the vll11lence of strain 039 
for mice as judged by survival time aftcr intranasal challenge, However, the ppmA mutant 
\vas not completely avi1111ent. Like D39 Illutants deficient in the production of pneul1101ysin 
(12), PspA (10), Nan A (10), and LytA (II) that were also reduced in vimlenee, the PPIIIA 
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mutant was still capable of killing mice in our animal model. The proposed role of PpmA in 
speeding up the folding reactions (cis/trans isomerization of the peptidyl-prolyl bonds) is 
consistent with the significant but limited reduction in villlience of the mutant strain. The rate 
of maturation of target proteins is presumed to slow in the absence of PpmA. This \vill 
subsequently result in a reduction but not elimination of target proteins that are modified in 
their biologically active configuration, Another explanation for the limited reduction in 
virulence of PpmA-deficient mutants might be the presence of other as yet unknown cis/trans 
isomerases that partially substihlte for the Ppm A activity. We conclude that PpmA 
contributes to pneumococcal vil11lence. Based on the surface location of Ppm A and its ability 
to elicit protective species specific antibodies, we also conclude that PpmA may be an 
interesting candidate for inclusion in future muiticomponent protein vaccines, 
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Streptococcus pnellmoniae continues to be a common cause of serious and life-threatening 
infections such as pneumonia, bacteremia, and meningitis, and of noninvasive infections 
such as otitis media and sinusitis (3), Until the 19608, pneulllococci were considered to be 
unifonnly susceptible to penicillin. However, in the last 30 years, increasing numbers of 
penicillitH'csistant pneumococcal clinical isolates with increasing MIC values have been 
isolated all over the world (25). The emergence of high-level resistance to penicillin, 
particularly in combination with other resistance determinants, is a serious threat for current 
treatment strategies. Therefore, much attention is focused on disease prevention. Several 
issues concerning the epidemiology of pneumococcal disease are of importance in order to 
develop good treatment and prevention strategies. In this respect, five questions may be 
raised. How does the organism spread within the human population? Are pmiicular 
subgroups of the pneumococcus responsible for different clinical manifestations of 
infection? Do celiain subgroups dominate within the pneumococcal population? If yes, what 
are the vimlence characteristics and resistance profiles of these subgroups? Will the 
pneumococcal population change after the introduction of vaccines? 
Epidemiological markers provide a means of distinguishing different subgroups within 
species and facilitate the answer to these questions about the epidemiology of pneumococcal 
disease. Serotyping and the analysis of antibiotic resistance profiles remain key methods to 
characterize pneumococci. In addition, several other methods have been developed to assist 
the identification of the relatedness between strains. In our laboratory, restriction fragment 
end labeling (RFEL) analysis is routinely used to generate an international data library of 
pneumococcal DNA fingerprints. This technique provides a high degree of discriminatory 
power, and RFEL profiles have proved to be relatively stable over time and are very suitable 
for computerized comparison. DNA typing methods such as RFEL analysis provide greater 
discrimination and complementary information in epidemiological surveys. BOX PCR 
fingerprinting also provides genomic information that is suitable to identify the relatedness 
between strains. This technique is used in our studies to validate the genetic clustering 
obtained by RFEL analysis. DNA fingerprinting of the penicillin-binding protein (PBP) 
genes is used to investigate the genetic relatedness of the penicillin resistance genes. 
Three molecular epidemiological shldies were performed to investigate the epidemiological 
dynamics of penicillin-nonsusceptibJe pneumococcal isolates. The first shldy (Chapter 2) 
describes all international epidemiological investigation of penicillin-nonsusceptible isolates 
originating from 16 countries aU around the world. In addition, the nahne of the increase in 
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prevalence of penicillin-nonsusceptible pneumococci in Poland (Chapter 3) and Thailand 
(Chapter 4) was studied. In both countries, penicillin resistance has rapidly emerged. The 
pcrcentage of penicillin-nonsusceptible isolates has increased from 0 to 3% in 1990 to 1993 
(5,35) to 14.3% in 1996 (62) and 14.4% in 1997 (61) in Poland, and from 6.7% in 1978 (58) 
to 10.6% in 1987 (36) and 37.2% in 1992 to 1994 (8, 49, 60) in Thailand. The penicillin-
nonsusceptible strains were characterized by serotyping, dmg susceptibility testing, RFEL 
analysis and PBP genotyping. In the Poland and Thailand studies, the genetic relatedness 
identified by RFEL analysis was confirmcd by BOX PCR typing. 
A predominant genetic type that was identical to the genetic type of the pandemic clone 23F 
(48) was observed in 10 countrics. In addition, the genetic type that was displayed by the 
pandemic clone 9V (23) was observed in six countries. Serogroup 6 strains (57) were also 
frequently observed. However, the genetic homogeneity of these strains is limited. This 
finding is consistent with the observations of Harakeh et a1. (30), who have demonstrated 
genetic heterogeneity within serotype 6B pneumococci isolated in the United States. Using 
less stringent genetic cut-off values, the serogroup 6 clone was observed in seven countries. 
These observations suggest that the introduction and subsequent pandemic spread of clone 
6B has occUlTed earlier in the antibiotic era compared with the international clones 23F and 
9V. Consequently, the contribution of clone 6B to the worldwide increasing prevalence of 
penicillin-resistant pneumococci is at present presumed to be overruled by the rapidly 
spreading clones 23F and 9V. The emergence of the pandemic clones 9V and 23F was also 
clearly demonstrated in Poland and Thailand, \Ve conclude that these clones are responsible 
for the high prevalence of penicillin resistance in these countries. In Poland, the nation-wide 
emergence of two novel multidrug-resistant pneumococcal clones that are presumed to be of 
Polish origin has also contributed to the increase in the prevalence of penicillin-
nonsusceptible pneumococci. 
Several genetic clusters identified in these epidemiological studies consisted of two or more 
serotypes. This indicates frequent horizontal transfer of capsular genes. 
PBP genotyping identified type 01-01-0 I as the most predominant PBP genotype in Thailand 
and in II countries included in the international study. This PBP type was displayed by 
many distinct genetic types, suggesting that frequent horizontal exchange of PBP genes has 
resulted in the spread of this PBP genotype among various pneumococcal genetic types. 
Within genetic clusters of the Polish isolates several PBP genotypes were observedJ 
suggesting that PBP genotypes have spread in the Polish population of penicillin-
nonsusceptible pneumococci by horizontal gene transfer. 
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Comparison of the pneumococci with penicillin MIC values <1 ~(glml and those with MIC 
values ;0,1 ~lg/ml clearly demonstrated that the degree of genetic clustering using both RFEL 
typing and PBP typing is higher among the penicillin-resistant isolates displaying MICs ;0,1 
~lg/mL In addition, the penicillin-resistant pneumococci with MIC values ';:::1 pg/ml were 
more frequently multiple-resistant to the antibiotics penicillin, cotrimoxazole, doxycycline, 
and erythromycin. These observations suggest that the epidemic behavior of penicillin-
resistant strains is enhanced with increasing levels of penicillin resistance. Moreover, we 
hypothesize that horizontal co-transfer of antibiotic resistance genes other than PBP genes 
occurs frequently among pneumococci with a high level of resistance to penicillin. 
The molecular mechanism of penicillin resistance in The Netherlands was studied in detail in 
Chapter 5. Pneumococcal isolates express six PBPs: high molecular weight PBPla, PBPlb, 
PBP2a, PBP2b, and PBP2x and low molecular weight PBP3, High molecular weight PBPs 
have transpeptidase activity. PBPla, PBP2a, PBP2b and PBP2x are involved in penicillin 
resistance in S. pneumolliae. PBP2b and PBP2x are the primary targets for ~-lactam 
antibiotics. Low affinity PBP 1 a increases the resistance in strains with low affinity PBP2x 
andlor PBP2b, Many resistant isolates are modified in these three PBPs only (26), The genes 
conferring resistance have a mosaic stmchlre, in which pmis of genes are replaced by genes 
from other species, presumably through horizontal gene transfer (14,25,27). The conserved 
amino acid motifs SXXK (with active site serine), SXN and K(H)T(S)G are imp0l1ant for 
the transpeptidase activity, and are believed to be located at the active site cavity. If one or 
more amino acids change in conserved motifs or adjacent amino acids, ~-Iactams are often 
unable to bind efficiently to PBP, leading to resistance. Pneumococci that have acquired a 
cCltain resistance level can spread, and will subsequently dominate environments where 
exposure to ~-Iactams occurs frequently. In addition, ~-lactam-resistant pneumococci can 
provide donor DNA for transformation of susceptible strains resulting in the acquisition and 
spread of resistance among diffcrent pneumococcal genotypes (15) (Chapter 3), 
Restriction fragment length polymorphism (RFLP) analysis was previously performed to 
characterize pbpJa, pbp2b and pbp2x from penicillin-nonsusceptible strains isolated in The 
Netherlands (32), In this study, we characterized specific gene fragments of pbp/a (42), 
pbp2b (21) and pbp2x (38) representing part of the PBP penicillin-binding domains of these 
clinical isolates. Classification based upon sequence analysis of these pbp fragments 
correlated in general well with the classification according to RFLP analysis, i.e. the deduced 
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genetic clustering of the pneumococcal strains was comparable between both methodologies. 
The identified mutations in the pbp sequences of the Dutch isolates invariably matched with 
the mutations described in pbp sequences of penicillilHlollsusceptible pneumococci isolated 
in other countries (6, 7, 19,20,37,39,43,55,56,66). This observation demonstrates that the 
majority of the mutations and genetic realTallgements that contribute to the penicillinw 
nonsusceptible phenotype of pneumococci present in The Netherlands were already available 
in the current data libraries. In addition, this sUPPOlis the hypothesis that multiple clones of 
penicillinwresistant pneumococci have been imported in The Netherlands. The pbp sequences 
identified in this study clearly demonstrate the acquisition of resistance by DNA transfer 
between non-pneumococcal species (S. milis, S. sanguis, S. Dralis) and pneumococci. 
Interestingly, novel combinations of mosaic structures were identified suggesting horizontal 
exchange of pbp gene fragments among penicillin-nonsusceptible pneumococci. 
A nationwwide molecular epidemiological survey was performed on penicillin-susceptible 
isolates (Chapter 6). The epidemiological characteristics of all S. pne1l111oniae strains isolated 
from patients with rneningitis in The Netherlands in 1994 were investigated. Only few 
studies have documented genotype analysis of penicillin-susceptible strains (32, 54). The 
genetic clustering was much lower among the penicillin-susceptible isolates than among 
penicillin-nonsusceptible isolates repolted in the studies described in Chaptcr 2-4, and in 
other studies (9, 31, 32). In addition, comparison of the penicillin-susceptible isolates \vith 
penicillin-nonsusceptible strains present in the international data library and representing 16 
countries revealed no overlap. 
Horizontal transfer of capsular genes also occurs fl'cquentIy among penicillin-susceptible 
strains, as at least a quarter of the genetic clusters consisted of two or more distinct 
serotypes. Horizontal transfer of capsular genes was described in penicillin-nollsusceptible 
pneumococcal populations (Chapter 2-4). In addition, various other investigators have 
repolied horizontal transfer of capsular genes in penicillilHlonsllsceptible isolates (9, 31, 
32). At present, this is the first study describing horizontal transfer of capsular genes among 
penicillin-susceptible pneumococci. 
PBP genotyping demonstrated limited variation in pbpJa, pbp2h and pbp2x of penicillin-
susceptible strains. The PBP genotypes 02-02-03, 02-02-71 and 02-02-02 were found most 
frequently. 
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Furlhenllore, the genetic relatedness within serotypes was investigated (Chapter 6). Only few 
studies have documented genotype analysis of serotype specific strains (28, 40), The genetic 
types of serotype 6A and 19F strains displayed most heterogeneity. Tn contrast, the genetic 
types of serotype 7F, 9V and 3 strains were found genetically related. Interestingly and in 
agreement with our observations, Canadian penicillin-sllsceptible isolates of serotype 3 and 
7F were also demonstrated genetically more related than isolates of other serotypes (40). 
Moreover, invasive penicillin-susceptible serotype 3 isolates from the United Kingdom tend 
to be mutually more closely related than isolates within other serotypes: the majotity of the 
epidemiologically non-related serotype 3 strains grouped within two genotypes (28). 
\Ve focused on the molecular epidemiological characteristics of epidemiologically unrelated 
serotype 3 pneumococci and extended our serotype 3 collection with isolates form the United 
States, Thailand and Denmark. RFEL analysis demonstrated that serotype 3 strains \vere 
genetically related in spite of the absence of epidemiological relatedness. The vast majority 
of the strains represented two distinct genetic clades. Fmihennore, both clades harbored 
isolates from three countries: the United States, Denmark, and The Netherlands. This 
indicates the international spread of two successful clones. \Ve hypothesize that this serotype 
has evolved recently, The few serotype 3 isolates not belonging to the main clusters are 
presumably the result of horizontal transfer of capsular genes, 
The current vaccine consists of the 23 most prevalent pneumococcal serotypes. The usc of 
this 23-valent vaccine has only provided a minor contribution to the decrease in morbidity 
and 1ll00iaiity associated with S. pllell1lloniae. JmpOIiantly, this vaccine is unable to elicit 
adequate antibody responses in children less than two years of age who are an important risk 
group (18), The current pncumococcal vaccine strategies concentrate on the use of conjugate 
vaccines, in which capsular polysaccharides are linked to a highly immunogenic carrier 
protein thereby switching the immune response against polysaccharides from T~cel1 
independent to T-cell dependent. Consequently, the antibody response towards the 
polysaccharides is increased and a memory response is provided. Hmvever, the number of 
different capsular polysaccharide types that can be included in the vaccine is restricted (50). 
In this respect, the frequency of horizontal transfer of capsular genes is of obvious 
impOIiance once pneumococcal conjugate vaccines will be introduced in the population. 
Horizontal transfer of capsular genes may decrease the long~telln efficacy of pneumococcal 
conjugate vaccination, Indeed, preliminat)' data of conjugate vaccination shldies have shmvn 
that vaccination results in a shift of serotype distribution tmvards those pneumococcal 
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polysaccharide types that are not present in the vaccine (17, 45). Such a shift may be 
enhanced by the frequent horizontal transfer of capsular genes (Chapter 2-4, 6), and may 
lead to the acquisition of non-vaccine capsular types by (penicillin- and multidmg-resistant) 
pneumococcal strains. 
Increased expression of capsular polysaccharide results in a lower degree of competence (51, 
65), whereby the capsule acts as a barrier that prevents competence factor from reaching its 
cellular target (67). Pneumococcal opsonisation with immune-protective anti-polysaccharide 
antibodies raised by vaccination are hypothesized to increase the sterie hindrance by the 
capsule, and affect the efficiency of horizontal gene transfer. The effect of opsonisation on 
pneumococcal competence is repOlied in Chapter 7. 
In vitro DNA transfer experiments demonstrated, that pneumococcal opsonisation with 
capsular type-specific antibodies did not affect the uptake of marker DNA. These data 
indicate that horizontal transfer of capsule loci is not inhibited in the presence of opsonizing 
antibodies and may provide an escape mechanism for pneumococci in vaccinated 
individuals. Since recombination events have the potential to diminish the long-tenll 
effectiveness of CUlTent conjugate vaccination strategies, molecular epidemiological studies 
are needed to monitor pneumococcal colonization and infection of individuals who will be 
vaccinated with conjugate vaccines. 
During the last few years, much attention is focused on the role of pneumococcal proteins in 
the pathogenesis of pneumococcal infection and the potential of these proteins to elicit 
protective immune responses. Proteins that are involved in the pathogenesis of infections by 
S. plleul110lliae are considered interesting components for ftlhlre conjugate or 
multi component protein vaccines. The immunological responses against such proteins 
should ideally provide protection against colonization and infection with pneumococcal 
strains of all capsular polysaccharide types. 
In Chapter 8, proteins were identified that are presumed to playa role in the infectious 
process. The pneumococcus undergoes spontaneous phase variation resulting in opaque and 
transparent colony forms. Differences in colony opacity have been shown to correlate with 
differences in virulence: the transparent variants are more capable of colonizing the 
nasophatynx, whereas the opaque variants shO\\' increased virulence during systemic 
infections. Phenotypic variation is an impOliant mechanism allO\ving bacterial pathogens to 
adapt to different host environments. The ability to survive in the different host 
185 
Chapter 11 
environments is the result of molecular adaptation) c.g. changes in the expression of specific 
cell surface components (29, 64). 
Protein expression pattcl11s of S. pneu11loniae phenotypic variants were compared. Three 
proteins were identified and characterized that arc differentially expressed in the phenotypic 
variants. One of the proteins was overexpressed in the opaque phenotype. This protein revealed 
significant homology with elongation factor Ts (EF-Ts) of Helicobactel' pylori. EF-Ts is 
essential for the elongation of the polypeptide chain during protein synthesis. The protein 
mediates the regeneration of EF-TuoGDP into the active form EF-TuoGTP. This active form 
of EP-Tu facilitates the enby ofaminoacyl-tRNA to the ribosome enabling protein synthesis, 
Differential expression of EF-Ts has previously been described in the granHlegative 
bacterium Coxiella burl/etii (53), the causative agent of Q fever. This obligate intracellular 
parasite replicates in distinct morphological forms that may allow potential life cycle 
variants to survive the harsh environment of the phagolysosome. Two distinct morphological 
forms of C. burnetU have been described, a large cell variant and small celJ variant. Large 
cell variants have demonstrated to be metabolically more active than small cell variants (53). 
This is sUPPOIied by data demonstrating that EF-Ts and EF-Tu were more prevalent in large 
cell variants (53). We hypothesize that the increascd presence of EF-Ts in the opaque 
variants of S. pneul1loniae indicates that, like in C. bU1'11etii, the opaque variants are 
metabolically more active, which may explain the rapid invasive growth characteristics of 
these variants. 
Two proteins were overexpressed in the transparent variant. One of these proteins was 
identified as pymvate oxidase SpxB. Pyruvate oxidases are crucial for aerobic carbohydrate 
metabolism of several streptococci (16). This enzyme dccarboxylates pYl11vate to acetyl 
phosphate resulting in the release of H20 2 and CO2. In S. pnewlIoniae, the release of H202 is 
mainly the result of SpxB activity since a ~pxB-defective mutant produces virtually no lh02 
in comparison with the parent strain (59). Therefore, the higher expression of SpxB in the 
transparent phenotype most likely explains the determined increased production of hydrogen 
peroxide. Spellerberg and colleagues have identified pyruvate oxidase as an indirect 
detefminant of vimlence in S. pneu11Ioniae (59). A spxB-lllutant has a decreased ability to 
colonize the nasopharyn.<'{ in a rabbit model. This is reflectcd by the lower binding capacity 
to the nasopharyngeal cells, and to their glycoconjugate receptors. The decreased ability of 
spxB-defective pneumococcal mutants to colonize the nasophalynx, and the increased 
expression of SpxB in transparent variants suggests the potentially important role of SpxB 
fOf transparent variants to efficiently colonize the nasopharynx (59). The expression level of 
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SpxB is unlikely to directly detennine colony morphology, since the spxB-mutant of D39 
still varies in colony morphology (J. N. Weiser, unpublished data). Interestingly, pymvate 
oxidase was identified to playa direct role in the bactcricidal effect of the pneumococcus on 
Haemophilus h!f!lfenzae and in the inhibitOlY effect on the growth of Moraxella catal'l'ltalis 
and Neisseria meningitic/is (Chapter 9). Expression of SpxB and, consequently, production 
of hydrogen peroxide was demonstrated responsible for these effects. The production of 
hydrogen peroxide is penuissive for growth of the pneumococcus but may have an adverse 
effect on its rate (4, 34, 47). The mechanism that allows for the survival and growth of the 
pneumococcus, a catalase-negative organism, in substantial concentrations of hydrogen 
peroxide is unknown. S. pneumolliae produce approximately the same amount of H20 2 per 
gram of total cellular protein as neutrophils during the oxidative burst (22). The 
pneumococcus thus generates unusually high amounts of hydrogen peroxide and, thereby, 
inhibits andlor kills other species that may compete for the same environmental niche in the 
heavily colonized human nasophatynx. H. it!/luenzae was the most sensitive bacterial species 
among those tested to both the inhibitOlY and bactericidal effects of the pneumococcus. If a 
similar effect occurs in vivo, this could at least in palt account for the previously noted lower 
than expected rates of co-infection with S. pneumolliae and H. injluenzae in otitis media and 
chronic bronchitis (41, 44). The increased production ofH202 associated with the transparent 
phenotype may, therefore, contributes to its ability to efficiently colonize a host; as a result 
of the ability to suppress local competitors. 
The second protein overexpressed in transparent variants revealed significant homology with 
the proteinase maturation protein PltM of Laclocobadllus paracasei, a member of the £1mily 
of peptidylRprolyl dsllrans isomerases. L. paracasei and other lactic acid bacteria are used in 
the food industry for the productiou of a variety of fermented milk products. During growth, 
these bacteria produce cell envelopeR located serine proteases that degrade caseins, the major 
proteins in milk. PltM is a lrans-acting protein involved in the maturation (processing into 
active proteins) of serine protease PrtP (63). PrtM belongs to the family of peptidyl-prolyl 
dsllrans isomerases that is thought to assist in protein folding by catalyzing dsllral1s 
isomerization of peptidyl-prolyl bonds in peptides and proteins (52). The pneumococcal 
putative proteinase maturation protein A, PpmA, contains an N-tcl1uinal lipoprotein signal 
sequence, which suggests that PpmA, like PrtM (24), is membrane-bound. We hypothesize 
that PpmA also functions as a membrane-bound molecular chaperone. In L. pal'acasei, the 
gene encoding the serine protease PrtP is located immediately downstream of prtl\1 (33). 
Both prtl\1 and prtP were found to be transcribed from the same promoter region but in 
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opposite directions (63). In S. pneumoniae, no open reading frame homologous to a serine 
protease could be located in the direct vicinity of ppmA. Which pneumococcal proteins are 
activated by PpmA is currently unknown. The higher prevalence of PpmA in the transparent 
phenotype, which is selected for during nasopharyngeal colonizatioll, suggests that PpmA is 
either directly involved in adherence through maturation of surfhce proteins with adherence 
propcliies or indirectly by the activation of proteases or other secreted proteins. The 
consensus lipoprotein signal sequence suggests that PpmA is located at the surface of the 
pneumococcus, and may playa role in the maturation of surfc'lCc- or secreted proteins. 
Interestingly, tlus protein was also identified in a study aiming to identifY pneumococcal 
proteins with potential to elicit protective immune responses (Chapter 10). In tins study, a pool 
of SB 14-so1uble, potentially surface-associated proteins of S. pneu11Ioniae strain FT231 was 
isolated. This protein fraction Was able to induce antibodies that facilitated phagocytosis in 
vitro. Phagocytosis is a major defense mechanism against pneumococci, and the induction of 
opsonophagocytic antibodies is presumed to correlate with in vivo protection against S. 
pneu1Jloniae infection (2). Among the purified proteins, at least three surface-associated 
proteins contributed to the in vitro opsonophagocytic activity. Two proteins were the 
previously characterized pneumococcal surface protein A (46) and oligopeptide-binding 
lipoprotein AmiA (I). PspA has previously shown to possess immune protective potential 
(13,46). So £1r, no data are available on the possible protective abilities of Ami A. Our data 
derived from phagocytosis experiments with AmiA-antibodies are the first indications that 
AmiA may be protective against pneumococcal infection. The third protein revealed to be 
PpmA. The opsonophagocytic activity of the PpmA antibodies was species-specific and 
cross-reactive among heterologous pneumococcal strains irrespective of the capsular type. 
The cross-reactivity of the PpmA antibodies was in line with the limited sequence variation 
of ppmA. The study also included immunoelectron microscopy, confirming that PpmA was 
indeed associated with the pneumococcal surface as suggested in Chapter 8. The importance 
of PpmA in pneumococcal pathogenesis was demonstrated in a mOllse pneumonia modeL 
Inactivation of ppmA significantly reduced the vimlence of strain D39 for mice as judged by 
survival time after intranasal challenge. However, the ppmA mutant was not completely 
avirulent. Like D39 mutants deficient in the production of other vi111lence fhctors 
(pneumolysin (12), PspA (10), NanA (10), and LytA (II)) that were also reduced in 
virulence, the ppmA mutant was still capable of killing mice in our animal model. The 
proposed role of PpmA in speeding up the folding reactions (cis/trans isomerization of the 
peptidyl-prolyl bonds) is consistent with the significant but limited reduction in vil1llence of 
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the mutant strain. The rate of maturation of target proteins is presumed to slow in the 
absence of PpmA. This will subsequently result in a reduction but not elimination of target 
proteins that are modified in their biologically active configuration. Another explanation for 
the limited reduction in vimlence of PpmARdeficient mutants may be the presence of other as 
yet unknown cis/trans isomerases that partially substitute for the PpmA activity. Due to its 
potential to elicit protective immune responses irrespective of the capsular phenotypes, 
PpmA may be an interesting candidate for inclusion in future Illulticomponent protein 
vaccines. 
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Streptococcus pneumolliae (the pneumococcus) is a human pathogen that is a leading cause 
of invasive diseases including pneumonia, bacteremia and meningitis. The pneumococcus is 
also a major worldwide cause of otitis media and sinusitis. The incidence of pneumococcal 
disease is highest in young children, elderly and inununocompromised individuals. Until the 
1960s, pneumococci were considered unifolTIlly susceptible to penicillin. However, in the last 
30 years, increasing numbers of penicillin-resistant pneumococcal clinical isolates have been 
isolated from all over the world. The emergence of high-level resistance to penicillin, 
patiicularly in combination with resistance to other antibiotics, is a selious threat for CUlTent 
treatment strategies. Therefore, much attention is focused on disease prevention. Several 
issues concerning the epidemiology of pneumococcal disease are of importance in order to 
develop good strategies for treatment and prevention. In this respect, four questions may be 
raised. How does the bacterium spread within the human population? Do certain subgroups 
dominate within the pneumococcal population? If yes, what are the vimlence characteristics 
and resistance profiles of these subgroups? ·Will the pneumococcal population change after 
the introduction of vaccines? The current vaccine consists of the 23 most prevalent 
pneumococcal capsular polysaccharide types. To date, 90 pneumococcal capsular 
polysaccharides have been identified. The use of this 23-valent vaccine has only provided a 
minor contribution to the decrease in morbidity and mOliality associated with S. pneulIIolliae 
infections. ImpOliantly, polysaccharide vaccines are unable to elicit adequate antibody 
responses in children less than two years of age. The current pneumococcal vaccine strategies 
concentrate on the use of conjugate vaccines, in which capsular polysaccharides are linked to 
a highly immunogenic carrier protein thereby switching the immune response against 
polysaccharides from T-cell independent to T-cell dependent. This will result in an increased 
antibody response against the polysaccharides and will induce a memOlY response. However, 
the number of different capsular polysaccharide types that can be included in the conjugate 
vaccine is restricted. During the last few years, much attention is focused on the role of 
pneumococcal proteins in the pathogenesis of pneumococcal infection and the potential of 
these proteins to elicit protective immune responses. Proteins that are involved in the 
pathogenesis of infections by S. pneunJoniae are considered interesting components for future 
conjugate or multi component protein vaccines. 
The aims of my research project were both molecular epidemiological aspects of S. 
pneul1loniae, and the identification of pneumococcal proteins involved in the pathogenesis of 
infections. 
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Three molecular epidemiological studies were performed to investigate the epidemiological 
dynamics of penicillin-nonsusceptible pneumococcal isolates. Chapter 2 describes an 
intemational epidemiological investigation of penicilJin-nonsusceptible isolates originating 
from 16 countries all around the world. The nvo most predominant genetic types cOlTespond 
with a Spanish pandemic clone 23F and a Spanish-French international clone 9V. The 
pandemic behavior of these two clones \vas clearly demonstrated, since they were found in 10 
and six different countries, respectively. Several genetic clusters consisted of nvo or more 
capsular types. This indicates frequent horizontal transfer of capsular genes. In addition, 
identical penicillin-binding protein (PBP) genoypes were oftcn observed within distinct 
genetic types. This observation demonstrates a high frequency of horizontal DNA transfer of 
pcnicillin resistance genes. The vast majority of the strains belonging to the pandemic clones 
23F and 9V shared one PBP type. We hypothesize that the clones 23F and 9V are responsible 
for the worldwide increase of penicillin-resistance, and may serve as an important genetic 
reservoir for sllsceptible pneumococci to acquire penicillin resistance. 
A study on the epidemiologic nature of the increase in prevalence of penicillin-
non susceptible pneumococci in Poland is described in Chapter 3. Four genetically distinct 
clusters of strains were identified among penicilliIHlonsllsccptible strains isolated in 1995 
and 1996 in 16 to\vns across thc country. Two clusters represented the pandemic clones 23F 
and 9V, which have recently emerged all over the world. The two other genetic clusters, 
which represented capsular types 23F and 6B, clcarly predominated in the collection of 
Polish penicillill-nonsusceptible pneumococcal strains. Thcir Polish clonal origin is most 
likely, since the latter clusters did not match any of the genetic types of penicillin-
nOllsusceptible pneumococci collected in 15 other countries. 
In Chapter 4, the epidemiologic nature of the dramatic increase in prevalence of penicillin-
nonsllsceptible pneumococci ill Thailand was investigated. The most predominant Illultidmg-
resistant pneumococcal clones were identical to the pandemic clones 23F and 9V. We 
conclude that these pandemic clones are primarily responsible for the increase in the 
prevalence of pneumococcal penicillin resistance in Thailand. 
The molecular mechanism of penicillin resistance in The Netherlands was studied in detail in 
Chapter 5. Pneumococcal isolates express six PBPs. Many penicillin-non susceptible isolates 
are modified in PBPla, PBP2b and PBP2x only. Tn this study, we characterized fragments of 
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the DNA sequence of pbpJa, pbp2b and pbp2x of Dutch clinical isolates. The pneumococcal 
strains were selected on the basis of differences in restriction fragment length polymorphism 
(RFLP) pattenlS of the complete genes pbpJa, pbp2b and pbp2x. Classification based upon 
sequence analysis of these pbp fragments con'elated well with the classification according to 
RFLP analysis. The mutations in the pbp sequences of the Dutch isolates invariably matched 
with the mutations described in pbp sequences of penicillin-nonsusceptible pneumococci 
isolated in other countries. This observation sUPPolis the hypothesis that multiple clones of 
penicillin-resistant pneumococci have been imported and have spread in The Netherlands. 
Interestingly, novel combinations of mosaic structures were also identified indicating 
horizontal exchange of pbp gene fragments among penicillin-nonsusceptible pneumococci. 
The molecular epidemiologic characteristics of penicillinwsusceptible Dutch strains of S. 
pneumolliae were investigated in Chapter 6. The isolates from all patients with 
pneumococcal meningitis in The Netherlands in 1994 were analyzed. The genetic 
heterogeneity among these penicillin-susceptible strains was substantially higher than that 
among Dutch penicillilHlonsusceptible isolates. Different capsular types were found among 
genetically related strains, indicating that horizontal transfer of capsular genes is common 
among the penicillinwsusceptible strains. This is the first study suggesting the frequent 
occunence of horizontal transfer of capsular genes among penicillin-susceptible strains. The 
genetic relatedness within the specific pneumococcal capsular types was highly variable. The 
genetic heterogeneity was much higher among isolates of capsular types 3, 7F, 9V and 14 
than among isolates of other capsular types i.e. 6A, 6B, 18C, 19F and 23F. We further studied 
the molecular epidemiological characteristics of capsular type 3 pneumococci. Type 3 is 
considered as the most virulent capsular type and is commonly associated with invasive 
disease in adults. Epidemiologically unrelated capsular type 3 isolates from four distinct 
countries were genetically more related than those of other capsular types, suggesting that 
capsular type 3 has evolved only recently or has remained unchanged over large periods. 
The high frequency of capsular gene transfer among pneumococci as described in Chapters 2, 
3, 4 and 6 may have consequences for the long-term efficacy of pneumococcal conjugate 
vaccines. Recently, it was demonstrated that the use of conjugate vaccines with a restricted 
number of capsular polysaccharide types results in a shift in the distribution of capsular types 
towards those pneumococcal polysaccharide types that are not present in the vaccine. The 
horizontal transfer of capsular genes may enhance such a shift. In this respect. capsular 
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switch leading to the acquisition of nonMvaccine capsular types by penicillinM and multidl1lgM 
resistant pneumococcal strains fonns a major threat. In Chaptel' 7, the effect of immune-
protective antibodies raised by large-scale vaccination on horizontal transfer of DNA was 
investigated. To this purpose, the effect of opsonisation of S. pneulllon;ae with capsular 
antibodies on the horizontal transfer of DNA was studied. Opsonisation did not inhibit DNA 
uptake. This suggests that horizontal transfer of capsular genes, which is an impOliant escape 
mechanism of the pathogen, remains a potential threat for the efficacy of conjugate 
vaccination. 
In Chap tel' 8, proteins were identified that are presumed to playa role in the infectious 
process. The pneumococcus undergoes spontaneous phase variation resulting in opaque and 
transparent colony fonns. Differences in colony opacity have been shown to correlate with 
differences in vi11l1ence: the transparent variants are more capable of colonizing the 
nasophatynx, whereas the opaque variants show increased virulence during systemic 
infections. The molecular changes that occur during phase variation were investigated. To 
this purpose, protein expression pattems of pneumococcal phenotypic variants were 
compared. Three differentially expressed proteins were identified and characterized. One 
protein was overexpressed in the opaque phenotype. This protein revealed significant 
homology with elongation factor Ts (EF-Ts). EF-Ts is essential for the elongation of the 
polypeptide chain during protein synthesis. We hypothesized that the increased presence of 
EF-Ts in the opaque variants of S. pneumoniae indicates that the opaque variants are 
metabolically more active, which may explain the rapid invasive grmvth characteristics of 
these variants. Two proteins were overexpressed in the transparent variant. One of these 
proteins was pYl11vate oxidase SpxB. This enzyme decarboxylates pymvate to acetyl 
phosphate resulting in the release of hydrogen peroxide and carbon dioxide. As a spxB-
defective pneumococcal mutant has decreased ability to colonize the nasopharynx, our data 
suggest that SpxB plays an impOltant role in the enhancement of the ability of transparent 
variants to efficiently colonize the nasophalynx. The second protein overexpressed in 
transparent variants revealed significant homology with the proteinase maturation protein 
PrtM of Lactocobacilllls paracase;, a member of the family of peptidyl~prolyl cis/trans 
isomerases. Proteins belonging to the family of peptidylMprolyi cis/trans isomerases are 
thought to assist in protein folding by catalyzing cis/trails isomerization of peptidyl-prolyl 
bonds in peptides and proteins. The pneumococcal putative proteinase maturation protein'A, 
PpmA, contains an N-terminal lipoprotein signal sequence, which suggests that PpmA is 
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membraneRbound. The higher prevalence of Ppm A in the transparent phenotype, which is 
selected for during nasophmyngeal colonization, suggests that PpmA is either directly 
involved in adherence through maturation of surface proteins with adherence propeliics or 
indirectly by the activation of proteases or other secreted proteins. 
In Chapter 9, pymvate oxidase was identificd to playa role in the bactericidal effect of the 
pneumococcus on HaemophUus h~fluel1zae and in the inhibitory effect on the growth of 
lvforaxella catarl'halis and Neisseria meningitidis. The release of hydrogen peroxide by 
pymvate oxidase activity was demonstrated responsible for these effects. S. pneumoniae 
produce approximately the same amount of hydrogen peroxide per gram of total cellular 
protein as neutrophils during the oxidative burst. The pneumococcus thus generates unusually 
high amounts of hydrogen peroxide and, thereby, inhibits and/or kills other species that may 
compete for the same environmental niche in the heavily colonized human nasopharynx. H. 
il~fluel1zae was the most sensitive bacterial species among those tested to both the inhibitory 
and bactericidal effects of the pneumococcus. If a similar effect occurs in vivo, this could at 
least in pali account for the previously noted lower than expected rates of COR infection with S. 
pneu11loniae and H. h!lllienzae in otitis media and chronic bronchitis. The increased 
production of hydrogen peroxide associated with the transparent phenotype may, therefore, 
contribute to its ability to efficiently colonize a host, being in part the result of the ability to 
suppress local competitors. 
In the study described in Chaptef' 10, wc isolated a pool of hydrophobic, surface-associated 
proteins of S. pneumoniae. SurfaceR exposed proteins often play an impoliant role in the 
interaction between pathogenic bacteria and their host. The protein fraction ,vas able to 
induce antibodies that facilitated phagocytosis in vitro. Phagocytosis is a major host defense 
mechanism against pneumococci, and the induction of opsonophagocytic antibodies is 
presumed to correlate with in vivo protection against S. pneumoniae infection. Antibodies 
raised against three distinct proteins contributed to the opsonophagocytic activity of the 
senun. Two proteins were the previously characterized pneumococcal surface protein A and 
oligopeptideRhinding lipoprotein AmiA. The third protein was PpmA, the protein first 
identified in Chapter 8. Immunoelectron microscopy demonstrated that PpmA was associated 
with the pneumococcal surface. PpmA was shown to elicit speciesRspecific opsonophagocytic 
antibodies that were crossRreactive to various pneumococcal strains. This antibody crossR 
reactivity was in line with the limited sequence variation of ppmA. The impOliance of PpmA 
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for pneumococcal pathogenesis was demonstrated in a mouse pneumonia model. 
Pneumococcal ppmA-deficient mutants showed reduction in vimlence, The here reported 
propeliics of Ppm A indicate its potential for use in muiticomponent protein vaccines. 
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StreptocoCCIIS pnewllon;ae (de plleumokok) is een humaan pathogeen en behoort tot de 
belangrijkste veroorzakers van invasieve infecties, zoals longontsteking (pneumonie), 
bloedvergiftiging (sepsis) en hersenvliesontsteking (meningitis), Daarnaast is de pneumokok 
wereldwijd een van de belangrijkste veroorzakers van middenoorontsteking (otitis media) en 
voorhoofdsholte ontsteking (sinusitis), Pneumokokken infecties komen het meest voor bij 
jonge kitHJcren, ouderen en personen met immuunstoornissen, Tot in d9 zestiger jaren ging 
men ervan uit dat aIle pncumokokken gevoelig waren voor het antibioticum penicilline, 
Tijdens de laatste 30 jaar worden wereldwijd cchter steeds meer penicilline-resistente 
pneull1okokken ge'isoleerd, Resistentie tegen penicilline, lllet name in combinatie met 
resistentie tegen andere soorten antibiotica, ZOU kunnen leiden tot een falen van de huidige 
therapeutischc behandelingen, Daarom wordt veel aandacht besteed aan de preventie van 
plleumokokken infectics, Verschillende zaken op het gebied van de verspreiding 
(epidemiologie) van pneumokokken infecties zijn van belang bij het ontwikkelen van goede 
behandel- en prevcntie-strategieen, Zo kUllnen vier vragen gesteld worden, Hoe verspreidt de 
bacterie zich binnen de menselijke populatie? Zijn bcpaalde subgroepen binnen de 
pneulllokokken populatie sterk ve11egemvoordigd? Zo ja, wat zijn de virulentie 
karakteristieken en de resistentie profielen van deze subgroepen? Zal de pncumokokken 
populatie veranderen na grootschalig gebmik van vaccins? Het huidige vacein bestaat uit een 
mix van de 23 meest voorkomende pneumokokkcn kapselpolysaccharide typen, Op dit 
moment zijn 90 verschillende kapselpolysaccharide typen beschreven, Dit 23-valente vacein 
heeft de mortaliteit en morbiditeit veroorzaakt door S. pneul1loniae namvelijks verminderd, 
Een belangrijkc reden hiervoor is dat kinderen die jonger zijn dan 2 jaar niet in staat zijn 
voldoende antllichamen te produceren tegcn polysaccharide vaccins, De huidige 
pneumokokkcn vaccin-strategieen richten zich daarom op het gebruik van conjugaat vaccins, 
Conjugaat vaccins bestaan uit kapselpolysacchadden gekoppeJd aan een zeer immunogeen 
dragereiwit. De antilichaam vonning tegen de polysaccharidcn wordt hierdoor T-cell 
afhankelijk in plaats van T-cell onafllankelijk, dat wil zeggen dat de antilichaam respons 
tegen polysacchariden verhoogd wordt en een inullunologisch gehcugcn opgewekt wordt. 
Een nadeel van conjugaat vaccins is dat het slechts een beperkt aantal verschillende 
polysaccharide typen kan bevatten, De laatste jaren wordt veel onderzoek gedaan naar de 1'01 
van pneumokokkcn eiwitten in het ziekteproces en het venllogen van deze eiwitten om een 
beschennende immuunrespons op tc wckken, Eiwitten die betrokken zijn bij het ziekteproces 
van pneumokokken infecties worden interessant geacht voor toepassing in toekomstige 
conjugaat vaccins of voor de ontwikkeling van veelcomponenten eiwit vaccins, 
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Het doel van mijn onderzoeksproject was het bestuderen van zowel moleculair 
epidemiologische aspecten van S. plleltnJoniae als de identificatie van pneumokokken 
eiwitten die betrokken zijn bij het ziekteproces. 
Drie moleculair epidemiologische studies zijn uitgevoerd om de verspreiding van penicillinc-
ongevoclige pneumokokken isolaten te onderzoeken. Hoofdstuk 2 beschrijft een 
intelllationaal onderzoek naal" de verspreiding van penicil1ine-ongevoelige isolaten afkomstig 
uit 16 verschillende landen uit de hele wereld. De twee meest voorkomende genetische types 
komen overeel1 met een Spaans pal1demische kloon 23F en een Spaans-Frans internationale 
kloon 9V, De wereldwijde verspreiding vall deze klonen is duidelijk aangetoond, want ze zijn 
gevonden in respectievelijk 10 en zes landen. 
Verschillende genetische groepen bevatten twee of meer kapseltypen, Hieruit blijkt het 
frequente voorkomen van horizontale overdraeht van kapselgenen, Daarnaast zijn identieke 
penicilline-bindende eiwit (PBP) gentypen gevonden bij verschillcndc genetische typen. 
Hiemit blijkt dat horizontalc DNA overdracht van penicilline resistentie genen vaak 
voorkomt. De overgrote meerderheid van de stammen, behorende tot de pandemische klonen 
23F en 9V, hebben cen en hetzelfde PBP type. Wij veronderstellen dat de klonen 23F en 9V 
verantwoordelijk zijn voor de wereldwijde toename van penicilline resistentie, en dat deze 
kloncn cen belangrijk genetisch reservoir vonnen voor gevoelige pneumokokkcn om 
penicilline resistentie te verwerven. 
Hoofdstuk 3 beschrijft het epidemiologisch karakter van de toename van penicilline-
ongcvoelige pneumokokken in Polen, Er zijn vier genetisch verschillende groepen 
aangetoond binnen een collectie penicilline-ongevoelige stammen, die zijn gci'soleerd in 16 
verspreid over het land gelegen steden in 1995 en 1996. Twee groepen komen overeen met de 
pande11lische klonen 23F en 9V, die zich recentelijk over de \vereld hebben verspreid. De 
twee andere genetische groepen met kapscltypen 23F en 6V zijn met name belangrijk in de 
onderzochte collectie van Pooise penicilline-ongevoelige pneulllokokken isolaten, De twee 
laatste groepen vinden hun oorsprong waarschijnlijk in Polen, o11ldat de groepen niet overeen 
komen met genctische typen van penicilline-ongevoelige isola ten die verzameld zijn in 15 
andere landen, 
Het epidemiologisch karakter van de explosieve toename van penicilline-ongevoelige 
pneull1okokken in Thailand is onderzocht in Hoofdstuk 4, De belangrijkste 11lultiresistente 
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pneumokokken klollen in Thailand zijn de pandemische klonen 23F en 9V. Daarom 
veronderstellen wij dat deze pandel11ische klonen primair verantwoordelijk zijn voor de 
toename in het voorkomen van pneumokokken penicilline resistentie in Thailand. 
De moleculaire mechanismen van penicilline resistentie in Nederland zijn in detail 
bestudeerd in Hoofdstuk 5. Plleumokokken isola ten brengen zes pellicillilleMbilldende 
eiwitten (PBPs) tot expressie. Veel penicillineMongevoelige isolatell zijn verallderd in aIleen 
PBP I a, PBP2b and PBP2x. [n deze studie hebben we fragmenten gekarakteriseerd van de 
genen pbpJa, pbp2b en pbp2x van Nederlandse klinische isolaten. De pneumokokken 
stanllllen zijn geselecteerd op basis van verschillen in hun restrictie fragm.ent lengte 
polymorfisme (RFLP) patroon van de genen pbp J a, pbp2b en pbp2x. Classificatie van de pbp 
fragmenten op basis van bepalillg van de base volgorde k-\vam goed overeen met de 
classificatie op basis van RFLP analyse. De mutaties in de pbp base volgorde van de 
Nederlandse isolaten blijken allen overeen tc komen met de pbp mutaties zoals beschreven 
bij pellicilline-ongcvoelige isolaten afkomstig uit andere landen. Deze waarnel11ing bevestigt 
dc veronderstelling dat meerdere klonen van penicillineMresistente pneumokokken naal' 
Nederland zijn geYmpolieerd en over het land zijn verspreid. Interessant is dat daamaast ook 
nieuwe combinaties van l11osa'ic stmcturen ge'identificeerd zijn. Dit laatste duidt op DNA 
overdracht van pbp fragmenten tussen peniciliineMongevoeligc isolatcn. 
De moleculair epidemiologische karakteristieken van penicilline-gevoelige Nederlandse S. 
pneullIoniae isolaten zijn bestudeel'd in Hoofdstuk 6. De isolaten van aile pneumokokken 
meningitis patiCnten in Nederland in 1994 zijn geanalyseerd. De genetische diversiteit binl1en 
deze penicilline-gevoelige stammen was substantieel hoger dan binllen Nederlandse 
penicillille-ongevoclige isolaten. Birll1en genetisch gerelateerde stammen zijn verschillende 
kapseltypen gevondcn. Dit duidt op het voorkomen van horizontale overdracht van 
kapselgenen binnen penicillincMgevoelige isolaten. Voar zovcr wij wetcn is dit de eerste 
studic waarin het frequente voorkomen van horizontale overdracht van kapsclgenen birlllen 
pellicilline-gcvoelige stanllllcn gcsuggerecrd wordt. De genctische verwantschap binnen 
stammen mct specifieke pneumokokkell kapseltypen was erg gevaricel'd. Dc genetische 
verscheidenheid was veel groter tussen isolaten met de kapseltypen 6A, 6B, 18C, 19F en 23F 
dan tussen isolaten met de kapscltypen 3, 7F, 9V en 14. De moleculair epidemiologische 
karakteristieken van isolaten met kapseltype 3 zijn uitgebreider bestudeerd. Kapseltype 3 
wordt gezien als het mecst virulente kapseltype en wordt vaak geassocieerd met invasieve 
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infecties in volwassenen. Epidemiologisch niet-gerelateerde kapseltype 3 isolaten, afkomstig 
uit vier verschillende landen, waren genetisch meer verwant dan isolaten met andere 
kapseltypen. Dit duidt op een mogelijk recent ontstaan van kapseltype 3 isolaten of op 
genetische stabiliteit gedurende lange tijd. 
Het frequente voorkomen van overdracht van kapselgenen zoals onder andere beschreven in 
de hoofdstukken 2, 3, 4 en 6 kan consequenties hebben voor de effectiviteit van 
pneumokokken conjugaat vaceins op lange termijn. Recentelijk is aangetoond dat het gebruik 
van conjugaat vaccins met een beperkt aantal kapselpolysaccharide typen leidt tot een 
toename in het voorkomen van kapseltypen die niet in het vaccin opgenomen zijn. 
Horizontale overdracht van kapselgenen zou deze toename kunnen versterken. Men name het 
verkrijgen van niet-vaccin kapseltypen door penicilline- en multi-resistcnte pneumokokken 
vonnt een grote bedreiging. In Hoofdstuk 7 wordt het effect van vaccinatie 01' horizontale 
overdracht van DNA beshldeerd door de efficientie van DNA-opname te bepalen na binding 
van antilichamen gericht tegen het pneumokokken kapsel. Antilichaam-binding heeft geen 
(remmend) effect op de opname van DNA. Daarom is het waarschijnlijk dat horizontale 
overdracht van kapseIgeneu, dat een belangrijk ontsllappillgsmechanisme voor de 
ziektevenvekker is, een potentieie bedreiging blijft voor de effectiviteit van vaccinatie met 
conjugaat vaccins. 
In Hoofdstuk 8 zijn ehvitten gei'dentificeerd die geacht worden een rol te spelen in het 
ziekteproces. De pneumokok ondergaat spontaan fase variatie, waarbij ondoorschijnende 
(opake) kolonievormen en heldere (transparante) kolonievonnen in elkaar overgaan. Verschil 
in de doorzichtigheid van de kolonies correleert met verschillen in virulentie: de transparante 
variant is betel' in staat 0111 de neus-keelholte tc koloniseren, terwijl de opake variant een 
verhoogde virulentie vertoont bij systemische infecties. De moleculaire verallderingen die 
plaatsvinden tijdens deze fase variatie zjjn onderzocht, door de eiwit expressie patronen van 
de twee fenotypische varianten met eIkaar vergelijken. De eiwitten die verschillend tot 
expressie komen, zijn gei'delltificeerd en gekarakteriseerd. Een eiwit dat hoger tot expressie 
komt ill het opake fenotype blijkt hOllloloog te zijn met elongatie factor Ts (EF-Ts). EF-Ts is 
essentieel voor de verlenging van de polypeptide keten tijdens eiwit synthese. Wij 
veronderstellen dat de grotere aanwezigheid van EF-Ts in de opake variant duidt op een 
hogere metabolische activiteit van deze variant. Dit zon de sneBe invasieve groei 
karakteristieken kunnen verklaren van de opake variant. Twee eiwitten zijn in grot ere 
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hocveelheden aanwezig in de transparante variant. Een van deze eiwitten is pyruvaat oxidase, 
SpxB. Dit enzym decarboxyleert pyruvaat tot aeetylfosfaat \vat leidt tot het vrijkomen van 
waterstofperoxide en koolstofdioxide. Omdat een defect in spxB leidt tot een vermindcrd 
vcrmogen van de pneulllokok om de neus-keelholte te koloniseren, sllggereren deze data dat 
pymvaat oxidasc een belangrijke roI speelt in het vermogen van transparante varianten om de 
neus-keelholte te koloniseren. Het tweede eiwit dat hoger tot expressie komt in de 
transparante variant is homoloog aan hct proteinase maturatie eiwit PrtM van Lactobacillus 
paracasei. PrtM is lid van de familie van peptidyl-prolyl cis/trans isomerases. Gedacht wordt 
dat eiwitten die tot deze familie behoren de vouwing van eiwitten vergemakkelijken door de 
cis/trans isomerisatie van peptidyl-prolyl verbindingen in peptiden en eiwitten te katalyseren. 
Het venneende pneumokokken proteinase maturatie eiwit A, PpmA, bevat een N-tel1ninale 
uiteinde dat wijst op membraan binding. De verhoogde productie van PpmA in het 
transparante fenotype, dat tijdens de kolonisatie van de neus-keelholtc geseicetcerd wordt, 
suggereert dat PpmA direct bctrokken is bij de adherentie door het correct vouwen van 
oppervlakte eiwitten met adhesie eigenschappen of indirect door aetivatie van proteases of 
andere gesecreteerde eiwitten. 
In Hoofdstuk 9 is aangetoond dat pymvaat oxidase een rol speeJt in het afdoden van 
Haemoplzillis i1~{luel/zae en het remmen van de groei van j\1ora.rella catarrhalis en Neisseria 
menillgitidis door de pncumokok. Het vrijkomen van waterstofperoxidc door pyruvaat 
oxidase activiteit blijkt verantwoordelijk voor deze effecten. S. pnell11loniae produeeert 
ongebl1likelijk grote hoeveelheden waterstofperoxide vergelijkbaar met fagocyterende 
neutrofielen, De pneumokok remt en/of doodt daarmce andere bacterie-soOtien die 
wedijveren om dezelfde niehe in de stevig gekoloniseerde humane neus-keelholte. H, 
i1!{luel1zae was het meest gevoelig van de getestc bactcric-soorten voor de remmende en 
afdodende werking van de pneumokok. Mogelijk verkaart dit fenomeen de mindel' dan 
verwachte mate van co-infectie van S. pneltf}lolliae en H. injluenzae in otitis media en 
chronische bronchitis. De verhoogde productie van waterstofpcroxide door het transparante 
fenotypc, met als gevolg het ondcl'drukken van lokale concnrrenten, zou daarom bij kunnen 
dragen aan zijn vermogen om de gastheer efficient te kunnen koloniseren. 
Eiwitten die aan het oppervlak liggcn speIcn vaak een belangrijke rol in de interactie tussen 
bacterie en gasthecr. In de studie beschreven in Hoofdstuk 10 hebbcn we een fmctie van 
hydrofobe, opperviakte-geassocieerde eiwittell van S. pneu11loniae ge'isoleerd, De eiwitfractie 
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was in staat antilichamen op te wekken, Deze antilichamen vergemakkelijkten fagocytose in 
vitro, Pagocytose is een bclangrijk afweermeehanisme van de gastheer tegen de pnCUl1lokok. 
De fagocytose capaciteit van antilichamen wordt geacht te correleren met in vivo 
bescherming tegen S. pllellfllOlliae infecties. De antiliehamen, die opgewekt zijn tegen drie 
gelsoleerde ehvitten, droegen bij aan de fagocytose capaciteit van het senllll. Twee eiwitten 
bleken de eerder gekarakteriseerde eiwitten Ilpneul1loeoccal surface protein All en 
"oligopeptide binding lipoprotein AmiA Il te zijn, Het derde eiwit was PpmA: het ciwit dat 
eerder gei'dentificccrd is in hoofdstuk 8. Immunoelectronenmicroscopie heeft aangetoond dnt 
PpmA geassocieerd is aan het oppcrvlak van de pneumokok. PpmA blijkt in staat tc zijn 
soort-specifieke antilichamen met fagoeytose capacitcit op te wekken, die kmisreageren met 
verschillende pneumokokken stammen. Deze kruisreactiviteit komt overeen met de beperkte 
varia tie in base volgorde van ppmA van vel'schillende pneumokokken stammen. Het belang 
van PpmA in het ziekteproees van pneumokokken infeeties is aangetoond in een muis model 
voor longontsteking. Pneuillokokken mutanten met een deficiCntie in ppmA bleken mindel' 
virulent. De gevonden karakteristieken van PpmA maken PpmA eell interessant eiwit voor 
het gebruik in meercomponenten eiwit vaeeins. 
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